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ABSTRACT 
Picolinyl-Assisted Approaches to Stereocontrolled Glycosylation 
Jagodige P. Yasomanee 
Doctor of Philosophy, University of Missouri – St. Louis  
Prof. Alexei V. Demchenko, Advisor 
Although carbohydrates are the most abundant molecules on Earth, our current 
knowledge of these fascinating natural compounds is still limited. Some aspects that are 
already known include the carbohydrate involvement in damaging cellular processes such 
as bacterial and viral infections, development of tumors, metastasis, septic shock, etc. 
Consequently the development of effective methods for the synthesis, isolation, analysis, 
and investigation of complex carbohydrates has become critical in all areas of 
glycoscience. Among various focus areas, stereocontrolled glycosylation has emerged as 
a topic of particular importance. Yet, it remains a remarkable challenge to chemists 
because a new chirality center is formed during glycosylation. A failure to control the 
stereoselectivity of glycosylation reactions will typically lead to mixtures of 1,2-cis and 
1,2-trans diastereomers. The aim of stereocontrolling of glycosylation has been 
approached in a variety of ways and the effect of a neighboring acyl participating group 
has been among the most powerful stereodirecting factors known to date for obtaining 
1,2-trans glycosides.  
The work presented herein is dedicated to broadening the scope of the 
stereodirected glycosylation using the concept of participating groups. Novel to this 
approach is the development of a well-rounded methodology that allows for synthesizing 
either 1,2-cis or 1,2-trans glycosides by simple switching of protecting groups. This is 
accomplished via novel glycosyl donors equipped either with picolinyl (2-pyridylmethyl 
ether) or picoloyl (2-pyridylcarbonyl ester) groups. A mechanistic understanding of 
various modes of action of these groups enhanced our ability to perform stereodirected 
glycosylations with exceptional stereoselectivity. This led to the development of a novel 
concept to stereocontrolled glycosylation that we named Hydrogen-bond-mediated 
Aglycone Delivery (HAD). The HAD concept has been extended to the synthesis of 
various linear and branched oligosaccharides and broadening of all aspects of the 
methodology. Furthermore, this study evolved into the development of a new type of 
glycosyl donors allowing for switchable stereoselectivity.  
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CHAPTER 1 
 
 
 
From stereocontrolled glycosylation to 
expeditious oligosaccharide synthesis 
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1.1.   Introduction 
 
 Carbohydrates are involved in a wide range of fundamental biological processes 
and are often referred to as the “essential molecules of life”.1 Indeed, our life begins with 
fertilization, which is taking place via a very selective carbohydrate-protein recognition 
process.2 Carbohydrates also help us to maintain healthy lifestyle because of their 
involvement into anti-inflammation, immunoresponse, joint lubrication, cell growth, 
antigenic determination, etc.3 Thanks to the explosive growth of the field of 
glycosciences, the improved understanding of the roles of carbohydrates allows us to 
describe them as “molecules of death” due to their sizable contribution into harmful 
processes including bacterial and viral infections, development and growth of tumors, 
metastasis, tissue rejection, septic shock, congenital disorders, etc.4 Many of these 
cellular processes are directly associated with the pathogenesis of deadly diseases of the 
21st century.   
 One of the major focuses of the Glycoworld since 2001 has been set for the 
synthesis of biologically important and therapeutically relevant oligosaccharides 
associated with pathogenesis of cancer, pneumonia, septicemia, etc.  Some targets that 
our laboratory synthesized over the past decade and some current targets are depicted in 
Figure 1.1.5-17  These target molecules are very diverse in their composition: both 
common monosaccharides, such as glucose and galactose, as well as more rare or unusual 
sugars, such as sialic acid or “ManNAcA” are present therein.  Some structures are plain 
oligosaccharides and others are conjugated with other biomolecules of the amino acid or 
lipid origin.  Nevertheless, there is one common thing for all of these structures: all 
monomeric units are connected via O-glycosidic linkages. In spite of significant progress 
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that has emerged in the area of chemical glycosylation, chemical O-glycosylation remains 
challenging and inefficient, particularly when applied to the synthesis of difficult 
linkages. Therefore, the development of new methods for stereocontrolled synthesis of 
glycosidic linkages remains one of the major focuses of research in our laboratory.   
Figure 1.1.  Past and current synthetic targets in our laboratory. 
 
 
1.2    The development of new methods for chemical glycosylation 
 A majority of the biologically and therapeutically active carbohydrates are 
oligosaccharides (or glycoconjugates) in which monosaccharides are linked via O-
glycosidic bonds.  Chemically, this linkage is formed by a glycosylation reaction wherein 
a leaving group (LG) of the glycosyl donor is replaced with a hydroxyl moiety of the 
glycosyl acceptor (Scheme 1.1).18 Other functional groups on both the donor and acceptor 
are temporarily masked with protecting groups (P, R, T). Since the new glycosidic 
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linkage creates a new chirality center, particular care has to be taken with regards to the 
stereoselectivity.  Although mechanistic studies of the glycosylation reaction are still 
scarce, certain conventions have already been established.19 Typical uncontrolled 
glycosylation leads to anomeric mixtures mixtures of 1,2-cis/trans diastereomers. If the 
use of an acyl-type substituent at C-2 is permitted, the synthesis of 1,2-trans glycosides 
becomes relatively straightforward although occasionally even participating acyl moieties 
fail in providing efficient participation via an acyloxonium intermediate.20  In the 
instances where the use of an 2-O-acyl substituent is impossible or impractical, the 
synthesis of 1,2-trans glycosides becomes as challenging as the synthesis of 1,2-cis 
glycosides, for which no universal method is still available,21,22 despite of a plethora of 
methods developed for their synthesis.  Therefore, the major effort has been put into the 
investigation of various factors that may affect the stereoselectivity of glycosylations 
(Scheme 1.1).  Other factors influence the stereoselectivity only up to certain extent and 
in spite of significant progress, chemical O-glycosylation remains among the top 
challenges of modern synthetic chemistry due to the requirement to achieve complete 
stereocontrol and the necessity to suppress side reactions.18   
Scheme 1.1.  Glycosylation reaction and factors affecting its stereoselectivity. 
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 Although a typical glycosylation reaction follows monomolecular mechanism, the 
nature of a leaving group may also have an effect on the anomeric stereoselectivity, and 
these observations led to the development of a large number of different classes of 
glycosyl donors.18 Early methods developed by Fischer23 and Koenigs and Knorr24 have 
been complemented by the development of other leaving groups, amongst which 
thioglycosides25 and O-imidates26 practically revolutionized the field of carbohydrate 
chemistry. These new glycosyl donors have been successfully applied to the synthesis of 
a large variety of natural compounds and unnatural mimetics thereof.  Nevertheless, even 
these very widespread methods have drawbacks. For instance, O-imidates typically 
provide very high selectivity in glycosylations, although low stability of these groups 
makes it impossible to use them as building blocks in oligosaccharide synthesis.  
Conversely, thioglycosides are very stable and as a result fit into many modern strategies 
for oligosaccharide assembly. However, the stereoselectivity obtained with 
thioglycosides is often lower than that achieved with their O-imidoyl counterparts.  
Hence, our initial intention was to design a new class of a leaving group, some sort of a 
hybrid structure between classic thioglycosides and O-imidates.  
Scheme 1.2.  Synthesis and activation of glycosyl thioimidates. 
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 We had anticipated that glycosyl thioimidates, compounds with S-CR1=NR2 
generic leaving group, would be universally applicable and may combine positive traits 
of other known glycosyl donors and would eventually create a new robust method for 
chemical glycosylation. We also assumed that thioimidates can be obtained via a variety 
of modes, all of which were later confirmed (Scheme 1.2), and that their reactivity and 
stability can be tuned to a wide range by varying electronic and/or steric properties of the 
R1 and R2 substituents.  One of the most important reasons to select this platform for 
future studies was the belief that these polyfunctional leaving groups could be activated 
via a variety of modes depicted in Scheme 1.2.  Thus, we assumed that thioimidates can 
be activated directly via the anomeric sulfur, or remotely, a concept proposed by 
Hanessian,27 via the nitrogen atom with the use of electrophilic reagents. Additionally, 
metal coordination can also affect the leaving group ability of the thioimidoyl moiety and 
this could take place via the sulfur, the nitrogen or a combination of both reactivity 
centers. Extensive studies that have been conducted later on have confirmed the viability 
of the pathways proposed vide infra. 
 Over the last decade, the thioimidate method has evolved into a very robust 
methodology for glycosylation.28,29  Particularly, with the introduction of novel S-
benzoxazolyl (SBox) and S-thiazolinyl (STaz) leaving groups, it has become apparent 
that thioimidates can withstand many reaction conditions associated with protecting 
group manipulations.30,31 In addition, thioimidates are easily accessible from a variety of 
simple precursors. This class of glycosyl donors can be typically glycosidated under a 
range of relatively mild activation conditions. Superior stereoselectivity in comparison to 
other glycosylation methods is often achieved, and thioimidoyl moiety could be 
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selectively activated in the presence of other types of leaving groups.  All listed are 
important traits for both glycoside and oligosaccharide synthesis that are rarely found all 
in one class of a leaving group. S-benzimidazolyl (SBiz)32 leaving group that was 
recently introduced among a series of other thioimidoyl leaving groups developed by 
us28,33,34 and others29,35-37 further enhances utility of this leaving group in glycosylation. 
Some illustrative examples of coupling reactions between glycosyl thioimidates and 
various glycosyl acceptors are shown in Scheme 1.3.   
Scheme 1.3.  SBox, STaz, and SBiz glycosyl donors in stereoselective glycoside 
synthesis. 
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Having extensively studied a variety of glycosyl thioimidates, it came to our attention 
that there is very little commonality between these seemingly similar leaving groups. 
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This called for further investigation of the activation pathway and during the course of 
this study we noticed that it is the structure of the leaving group rather than the nature of 
the activation reagent that determine the activation mode, either direct or remote. For 
instance, SBox glycosides are activated via the anomeric sulfur (direct activation) 
regardless of the activation conditions used: NIS/TfOH, AgOTf, or MeOTf.38 More 
recent study with the SBiz glycosyl donors showed that these compounds also follow the 
direct activation pathway.32  Further enrichments of the leaving group ability of glycosyl 
thioimidates require a thorough understanding about applicability of different promoters 
and their activation pathways.  
Figure 1.2.  Direct activation of SBox glycosides and remote activation of STaz 
glycosides.  
 
 
Very differently, STaz leaving group is activated via the remote nitrogen. Side-
by-side comparisons of the SBox and STaz glycosyl donors under alkylation activation 
conditions (MeI, BnBr) allowed to determine the activation mode. The X–ray 
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crystallography of the departed aglycones clearly demonstrated the alkylation mode, Bn-
SBox and Bn-NTaz (Figure 1.2).39  The reactivity difference between slow activation of 
the SBox and fast activation of STaz was sufficient to develop a new orthogonal strategy 
based on these two seemingly similar leaving groups vide infra). 
This observation of the differential activation of SBox and STaz leaving group 
gave us an idea of developing a new type of a leaving group that would be capable of 
both direct and remote activation pathways. Ideally, activation pathways should be 
differentiated by a simple change of the promoter/activator.  In our opinion, if this kind of 
a leaving group were available, it could easily fit into selective or even orthogonal 
activation strategies along with other, common glycosyl donors. To the best of our 
knowledge, among a plethora of leaving groups developed, only glycosyl phosphites 
allow for the differential activation mode.40-42  This trait, however, has not yet been 
employed in multi-step block oligosaccharide synthesis, perhaps due to the relatively 
unstable nature of this leaving group. With this line of thought, we have developed the 
ortho-allylphenyl (AP) leaving group and demonstrated that can be activated for 
chemical glycosylation via both direct anomeric (oxygen) and remote (via alkene) 
pathways.43  Hung and co-workers came up with essentially the same idea and introduced 
the AP leaving group concomitantly.44  The orthogonal-like activation of the AP moiety 
along with common thioglycosides allowed for executing efficient oligosaccharide 
assembly (vide infra). The two activation pathways were confirmed by isolating (O-
allylphenoxy)trimethylsilane (1.16a) from TMSOTf-promoted reaction of 1.15 which 
takes place via the anomeric oxygen atom (direct activation) and 2-iodomethyl-2,3-
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dihydrobenzofuran (1.16b) from NIS/TMSOTf-promoted reaction in which the activation 
with I+ takes place via the remote allyl moiety (Scheme 1.4).43  
Scheme 1.4. Direct and remote activation pathways of ortho-allylphenyl (AP) 
glycosides 
 
 
Having investigated the activation modes of thioimidates and developed a number 
of leaving groups, it came to our attention that very little is known about activation 
modes of common leaving groups in general. For instance, activation of thioglycosides 
has been proposed multiple times25,45-48 although direct evidence of this activation had 
not been acquired prior to our recent study of sulfonium ions as intermediates of 
glycosylation.49  Anomerically pure sulfonium salt 1.17a, obtained by direct alkylation of 
superdisarmed thioglycoside 1.17 with MeOTf, can be isolated and characterized by 
NMR (Scheme 1.5a). A number of other anomeric sulfonium salts have been generated 
and characterized accordingly using MeI/AgClO4 or dimethyl(methylthio)sulfonium 
triflate (DMTST, Scheme 1.5b).49 It is our expectation that dedicated studies of the 
activation pathways and reaction mechanisms would lead to the development of highly 
stereocontrolled glycosylation methodologies. 
 
Yasomanee, Jagodige P. | UMSL 2014 | Page 11 
 
Scheme 1.5.  Direct synthesis of glycosyl sulfonium salts. 
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Other recent mechanistic work in our laboratory involved the investigation of the 
glycosidation of thioglycosides in the presence of bromine.50 It was demonstrated that 
bromine-mediated glycosylation of thioglycoside 1.20 leads to exclusive α-selectivity in 
product 1.21 (Scheme 1.6a). This reaction was monitored by NMR, and this study 
demonstrated that β-bromide is the reactive intermediate that leads to the product 1.21 
with complete stereoselectivity. The NMR experiment showed that β-bromide can 
undergo a relatively rapid anomerization into the α-linked counterpart (Scheme 1.6b), and 
if this anomerization is not suppressed, the yield of the glycosylation product can be low. 
Once formed, α-bromide is totally unreactive under the established reaction conditions, 
but it can be reactivated in the presence of mercury(II)-based promoters.  Being primarily 
applicable to thioglycosides of the unreactive, superdisarmed series, this concept 
complements well-known in-situ anomerization procedure introduced by Lemieux and 
co-workers for reactive bromides51 and further adapted to iodides by Gervay-Hague.52,53  
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Scheme 1.6.  Stereoselective glycosidation of superdisarmed thioglycoside 1.20 via 
reactive β-bromide intermediate. 
 a)     b)    
 
Our laboratory has also introduced a complementary method for the synthesis of 
1,2-trans glycosides.  Differently from a vast variety of other approaches for 1,2-trans 
glycosylation based on the participating effect of the ester neighboring group (vide 
supra)20 this method is based on an ether-type substituent.  We demonstrated that 1,2-
trans selectivity can be achieved with the use of a 2-O-picolinyl moiety, a novel 
neighboring group that is capable of efficient.54 The participation mode was studied by a 
variety of techniques, and the six-membered intermediate shown in Scheme 1.7 was 
proven by extended 2D NMR experimentation. The compatibility of this protocol with 
glycosyl donors of the thioimidoyl, thioglycosyl, and trichloroacetimidoyl series has been 
shown.55 The fact that picolinyl moiety also retains the glycosyl donor in the armed state, 
as opposed to disarming acyl participating moieties, was used as a basis for the 
development of the “inverse armed-disarmed” strategy (vide infra)54,55 that allows to 
Yasomanee, Jagodige P. | UMSL 2014 | Page 13 
 
obtain trans-trans and trans-cis patterned oligosaccharides and expands the scope of 
classic Fraser-Reid’s armed-disarmed approach.56 Currently we are working on 
expanding the application of picolinyl and picoloyl protecting group in stereocontrolled 
glycosidation reactions.57  
Scheme 1.7.  Synthesis of 1,2-trans glycosides assisted by 2-O-picolinyl arming 
participating group. 
 
 
 
In our parallel study of investigating pyridyl-based protecting groups and their 
effect on the stereoselectivity of glycosylation, we observed that a multi-dentate metal 
coordination to the leaving group, along with a protecting group at O-6 and/or O-5, has a 
strong effect on the stereoselectivity of chemical glycosylation (Scheme 1.8).  We 
showed that platinum(IV) complexation of 6-O-picolinyl or 6-O-bipyridyl to the leaving 
group, such as thiazolinyl shown in Scheme 1.8, has a pronounced effect on the 
stereoselectivity of glycosylation.58 While the glycosidation of thioimidate donor 1.22 
with acceptor 1.2 in the presence of Cu(OTf)2 gave the disaccharide 1.24 with poor 
selectivity (α/β = 1.7/1), the complexed glycosyl donor counterpart 1.23 showed a 
significant 5-fold increase in 1,2-cis stereoselectivity (α/β = 9.4/1). In our opinion, this 
β‐H1
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result offers a very promising venue for further investigation of thioglycosyl and 
thioimidoyl donors as ligands for complexes with transition metals.59 
Scheme 1.8.  Effect of metal complexation on the stereoselectivity of glycosylation. 
 
 
Scheme 1.9.  Glycosyl thioimidates led to a discovery of a variety of new strategies 
and concepts for oligosaccharide synthesis. 
 
 
These mechanistic studies along with the major effort to investigate glycosyl 
thioimidates resulted in the development of a number of robust methods for 
stereocontrolled glycosylation. Thioimidates easily fit into the existing strategies for 
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oligosaccharide synthesis and also allowed us to develop a variety of strategies that are 
unique to thioimidates. While working with thioimidates, we have also discovered some 
unusual trends and phenomena, such as the cooperative effect in glycosylation, which 
was later applied to building blocks of other series. Subsequent sections will emphasize 
methods, strategies, and phenomena that have been discovered mainly thanks to the 
unique structural features and reactivity pattern of glycosyl thioimidates (Scheme 1.9). 
 
1.3   A strategic approach to the synthesis of oligosaccharide sequences 
A single-step glycosylation is the only one challenge that researchers are working 
on the oligosaccharide synthesis face. In accordance with the traditional oligosaccharide 
synthesis, the disaccharide that has been formed as a result of the first glycosylation, 
needs to be converted into a glycosyl acceptor or glycosyl donor of the second 
generation.60 This is usually accomplished via additional protecting and/or leaving group 
manipulations, respectively, that are required between each glycosylation step (Scheme 
1.10).  Resultantly, the synthesis becomes increasingly inefficient and often leads to a 
dramatic drop in yield, and as a consequence, the availability of oligosaccharides.  One 
way to circumvent the necessity for additional synthetic steps is to execute an 
advantageous expeditious approach according to which building blocks are activated 
sequentially with no necessity for the interim protecting / leaving group reactivity. The 
differential reactivity of building blocks can be achieved via reactivity tuning by means 
of the protecting groups. Strategic placement of protecting groups leads to a differential 
reactivity of various building blocks that are then activated in accordance with their 
reactivity profile. Following the pioneering study by Fraser-Reid,56 contributions from 
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Ley,61 Wong62 and others63 led to a variety of very effective concepts based on the 
principle of chemoselective differentiation of reactivity.  Usually, protecting groups in 
both reaction components and careful selection of mild reaction conditions have to be 
taken into consideration to allow direct chemoselective activation of the armed glycosyl 
donor over the disarmed glycosyl acceptor.  The convenience of this approach is that the 
same leaving group can be used for all building blocks in the sequence.   
Another general concept to expedite oligosaccharide synthesis is to achieve 
selective activation of different leaving groups, and it is practically independent on the 
nature of protecting groups.  A number of selective activation techniques have been 
developed and selective activation, active-latent, and orthogonal strategies are only few 
to mention.64 Our group studied both chemoselective and selective activation-based 
strategies.  
Scheme 1.10.  Expeditious approach to streamlining oligosaccharide synthesis. 
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1.3.1 Chemoselective oligosaccharide synthesis 
First described by Fraser-Reid, the armed disarmed strategy has attracted notable 
attention in the scientific world.63  Many classes of leaving groups can be activated 
accordingly, and glycosyl thioimidates is no exception: it was determined that both SBox 
and STaz glycosides fit into the general concept of the armed-disarmed approach.56,63,65-67 
The activated (benzylated) thioimidates could be promoted over electronically disarmed 
(benzoylated) glycosyl acceptors equipped with the same leaving group in the presence of 
Cu(OTf)2. For instance, as shown in Scheme 1.11, armed STaz donor 1.7 could be 
chemoselectively activated over the disarmed acceptor 1.25 in the presence of Cu(OTf) 2 
leading to the formation of disaccharide 1.26.54 The disarmed STaz group of the latter can 
be also activated, but requires more powerful promoter AgOTf.   
Scheme 1.11.  Chemoselective activation of STaz and SBox building blocks in 
accordance with the classical armed-disarmed approach. 
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 Resultantly, a cis-trans linked trisaccharide 1.30 was obtained in an excellent 
overall yield without any intermediate functional group manipulations.  Similarly, armed 
SBox donor 1.27 was activated over disarmed SBox acceptor 1.28,68 but again only the 
cis-trans linked sequence was obtained.  These results clearly represent the major 
limitation of the traditional armed-disarmed approach.  As insightfully stated by Fraser-
Reid, “protecting groups do more than protect”65, protecting groups affect the reactivity, 
nevertheless they also determine the stereoselectivity of glycosylation. Therefore, 1,2-
trans glycosides cannot be introduced by using conventions of the traditional armed-
disarmed approach, which is a significant pit fall because trans-trans and trans-cis 
sequences are commonly found in a variety of natural oligosaccharide syntheses.  
Apparently, it is impossible to take the disarmed donor 1.31 and try to couple it with the 
armed acceptor 1.32 using traditional armed-disarmed approach. The cross-coupling 
would not happen, instead, the reactive glycosyl acceptor 1.32 will self-react either intra 
or inter-molecularly. This appealed to us as a significant challenge, and we approached it 
in a variety of modes.   
Scheme 1.12.  Attempts to broaden the scope of the armed-disarmed concept.
 
 
First, by making modifications to the glycosyl donor we developed the inverse 
armed-disarmed approach (Scheme 1.12). Second, by modifying glycosyl acceptor we 
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introduced the temporary deactivation concept. Third, by careful reactivity tuning and 
studying differential protecting group pattern in both glycosyl donor and glycosyl 
acceptor counterparts we discovered the O-2/O-5-cooperative effect in glycosylation. All 
three concepts are discussed below. Concomitantly, a pre-activation-based strategy, 
which was invented to address essentially the same global challenge, was developed by 
Huang,69,70 van der Marel45,71 and others.   
Scheme 1.13.  Inverse armed-disarmed strategy with 2-O-picolinyl glycosyl donor. 
 
 
The inverse armed-disarmed concept was invented based on 2-O-picolinyl, a 
novel arming participating group. The application of the inverse strategy which allowed 
to expand chemoselective activation principle to the synthesis of trans-trans sequenced 
oligosaccharides.54 For instance, when STaz donor 1.33 equipped with 2-O-picolinyl 
group was activated over the disarmed acceptor 1.25, disaccharide 1.34 was obtained 
with complete 1,2-trans stereoselectivity (Scheme 1.13). This is the inverse outcome in 
comparison to the classical armed-disarmed approach resulting in 1,2-cis bond formation 
in the first step (vide supra, see Scheme 1.11).  Subsequent activation of 1.34 with 
AgOTf yielded the trans-trans-linked trisaccharide 1.35.  A possibility of synthesizing a 
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trans-cis-linked trisaccharide using the picolinyl approach along with conventions of the 
cooperative effect was also demonstrated.55  
During our studies we have observed that STaz leaving group can act as a ligand 
for transition metals to form stable non-ionizing complexes. Upon this complexation, 
reactivity of the STaz glycoside was reduced dramatically because the activation site the 
nitrogen was temporarily blocked by the metal.72  This interesting observation allowed us 
to develop the temporary deactivation concept depicted in Scheme 1.14.  
Scheme 1.14.  Temporary deactivation concept.
 
 
First, the deactivated STaz acceptor 1.36 was obtained via metal complexation of 
the STaz moiety of the armed acceptor 1.32 with PdBr2 to form stable, non-ionizing 
metal complex. This temporary deactivation (capping) of the STaz moiety in the acceptor 
1.36 facilitated the successful activation of the “free” STaz leaving group of the disarmed 
glycosyl donor 1.31 in the presence of MeOTf to afford disaccharide 1.37. Upon ligand 
exchange with NaCN “free” disaccharide 1.38 was obtained and could be used in further 
chain elongation directly.  
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The versatility of the temporary deactivation concept was demonstrated by the 
synthesis of octasaccharide 1.46 that consists of two repeating units of Streptococcus 
pneumoniae serotype 14 polysaccharide (Scheme 1.15).10  A number of new leaving 
groups capable of efficient activation for glycosylation and also to form a stable bidentate 
complex with palladium(II) bromide. Amongst various leaving groups/ligands 
investigated, the (4-pyridin-2-yl)thiazole-2-yl thioglycoside (SPT) moiety was proven the 
most advantageous.  As the first step of this synthesis, the “free” STaz donor 39 was 
activated over the complexed SPT acceptor 1.40 in the presence of AgOTf followed by 
desilylation with TBAF to achieve the disaccharide acceptor 1.41.  
Scheme 1.15.  Synthesis of octasaccharide of S. pneumonia serotype 14 using the 
temporary deactivation strategy. 
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The latter was then reacted with SBox lactose donor 1.42 to obtain the pneumococcal 
tetrasaccharide repeating unit 1.43.  Subsequent decomplexation of one portion of 1.43 
with NaCN gave donor 1.44, meanwhile the treatment of another portion of 1.43 with 
dilute TFA afforded acceptor 1.45 with the deactivated SPT leaving group. Having these 
building blocks in hand, coupling of 1.44 and 1.45 in the presence of AgOTf followed by 
decomplexation yielded octasaccharide 1.46.10 
We also reported that a mixed protecting group pattern can have a rather 
unexpected effect on the reactivity of glycosyl donors and glycosyl acceptors.  Upon 
investigating SBox glycosides containing an arming benzyl group at C-2 and disarming 
acyl groups at the remote positions, it was expected that reactivity would fall somewhere 
between that of the armed (per-benzylated) and the disarmed (per-benzoylated) glycosyl 
donors. However, the results acquired with the SBox glycosides of the D-gluco series 
revealed that these “mixed-patterned” glycosyl donors were the least reactive amongst 
the building blocks investigated.68  This allowed for the chemoselective coupling between 
three different building blocks. Thus, the disarmed disaccharide 1.29 obtained by classic 
armed-disarmed approach from building blocks 1.27 and 1.28, (Scheme 1.11), could be 
further chemoselectively activated over superdisarmed building block 1.47 in the 
presence of Cu(OTf)2/TfOH to produce trisaccharide 1.48 as depicted in Scheme 1.16a.68 
We also reported that 2-O-benzoyl-3,4,6-tri-O-benzyl protected glycosyl donors are 
unusually reactive, “superarmed”.73,74  Thus, the superarmed glycosyl donor 1.49 was 
activated over “armed” acceptor 1.50 in the presence of iodine to provide disaccharide 
1.51 (Scheme 1.16b).  The latter was then glycosidated with the disarmed acceptor 1.52 
to provide trisaccharide 1.53, which in turn was glycosidated with glycosyl acceptor 1.2 
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to obtain the target tetrasaccharide 1.54 in which monosaccharide residues are connected 
via alternating trans-cis-trans linkages.75 
Scheme 1.16.  Expansion of the armed-disarmed strategy to (a) superdisarmed 1.47 
and (b) superarmed 1.49 building blocks. 
 
 
Since Fraser-Reid’s armed-disarmed concept rationale,56,66 Ley’s tuning reactivity 
studies,61 and Wong’s programmable oligosaccharide synthesis62 all fail to predict this 
reactivity discrepancy, these unanticipated results were rationalized by the occurrence of 
the O-2/O-5 cooperative effect in glycosylation.68 Thus, in addition to the 
“arming/disarming” nature of the protecting group at O-2, stabilization (or 
destabilization) of the glycosyl cation intermediate must also be taken into consideration.  
First, this stabilization can be achieved from the lone electron pair on the neighboring 
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endocyclic ring oxygen (O-5) like in the armed/superarmed glycosyl donor.  
Additionally, in the superdisarmed donors, the stabilization can be achieved by the 
anchimeric assistance from the C-2 acyl group (Figure 1.3), which is not available for the 
armed donors. Conversely, if electron withdrawing protecting groups are placed near the 
O-5 ring oxygen C-4 and C-6, like in the disarmed/superdisarmed donors, the electron 
density on O-5 will be decreased, effectively suppressing oxacarbenium ion formation.  
In this case, the ability of the system to stabilize via other internal modes becomes 
increasingly important and disarmed donors are partially stabilized via participation of 
the neighboring acyl group, which is not available in the case of superdisarmed donors 
(Figure 1.3).  
Figure 1.3.  O-2/O-5 cooperative effect in glycosylation. 
 
 
Our expanded work with SBox donors revealed the reactivity difference between 
the 2-N-trichloroethoxycarbonyl (Troc) and the 2-N-phthaloyl derivatives as well. We 
have observed that upon the glycosylation with MeOTf, the former is a more reactive 
donor than the latter. This armed-disarmed methodology could be used to synthesize 1,2-
trans-linked oligosaccharides containing aminosugar residues as shown in Scheme 
1.17a.7 The activation of 2-N-Troc-protected glycosyl donor 1.55 over the 2-N-Phth-
protected acceptor 1.56 in the presence of MeOTf resulted in the formation of 
Yasomanee, Jagodige P. | UMSL 2014 | Page 25 
 
disaccharide 1.57. The latter was then activated with AgOTf, a more powerful promoter, 
to give trisaccharide 1.58 upon coupling with acceptor 1.2.  
Scheme 1.17. Chemoselective synthesis of 2-amino-2-deoxy SBox glycosides. 
 
 
Along similar lines, we also studied the reactivity difference of building blocks of 
the D-gluco and glucosamino series.76  Competitive glycosylations clearly showed that 
the aminosugar reactivity with either NTroc or NPhth protection falls in between the 
superarmed and superdisarmed building blocks of the D-gluco series.  For instance, the 
synthesis of trisaccharide 1.62 containing alternating neutral and aminosugar units was 
performed by a two-step chemoselective activation sequence. Thus, glycosidation of 1.49 
with acceptor 1.59 was carried out in the presence of iodine at -20 oC to afford 
disaccharide 1.60 (Scheme 1.17b).76 Subsequent chemoselective activation of the 
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disaccharide donor 1.60 over superdisarmed acceptor 1.61 was successful in the presence 
of iodine at 50 oC to afford the target trisaccharide 1.62.   
 
1.3.2.  Strategies based on selective activation 
The selective activation strategy is easy to envisage. Practically, the leaving group 
of a glycosyl donor is activated over another type of a leaving group on a glycosyl 
acceptor. This sequence is then continued as long as there is a leaving group that would 
be compatible with the activation conditions for the previous stage. One-stage selective 
activations are routinely executed in oligosaccharide synthesis and two-step activations 
also become relatively available. Our recent review comprehensively discusses all recent 
advancements in this field.64   
In our recent effort, we developed a selective activation strategy where six 
different leaving groups could be aligned for the synthesis of hexasaccharide 1.70 as 
depicted in Scheme 1.18.17 First, the thiocyanate donor 1.63 was activated over STaz 
acceptor 1.25 in the presence of Cu(OTf)2 to afford disaccharide 1.64. Then, STaz 
disaccharide 1.64 was activated with benzyl bromide to couple with SBox acceptor 1.28. 
The resulting trisaccharide 1.65 was glycosylated with fluoride acceptor 1.66 in the 
presence of MeOTf to produce tetrasaccharide 1.67.  Then, tetrasaccharide was reacted 
with SEt acceptor 1.52 in the presence of AgClO4/Cp2ZrCl2 to obtain the pentasaccharide 
1.68. Finally, the O-pentenyl acceptor 1.69 was coupled with the pentasaccharide using 
MeOTf as an activator to afford hexasaccharide 1.70.   
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Scheme 1.18.  Synthesis of hexasaccharide via five-step sequential selective 
activation. 
 
 
The selective activation principle was also applied to the synthesis of 
oligosaccharides of Streptococcus pneumonia serogroup 6 and mimetics thereof for the 
development of synthetic vaccine components 8,9,11,12 and for the synthesis of a tumor 
associated glycosphingolipid SSEA-3 analog.6  Nevertheless, the visible ease of the 
synthesis and straightforwardness does not imply that essentially the same selective 
activation sequence would be universally applicable.  The selective activation of multiple 
leaving groups remains challenging and the synthesis of other target molecules may 
require additional extended study.  To address this difficulty, the orthogonal approach 
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might be of general benefit because it requires only two types of leaving groups that can 
be independently activated in presence of each other.  Discovered in 1994 by Kanie, Ito 
and Ogawa 77, original application of F and SPh leaving groups remained the only 
example of orthogonality in oligosaccharide synthesis78-82 until our more recent study that 
begun in 2004 wherein we described STaz vs. SEt orthogonal activation. Thus, it was 
observed that the STaz leaving group remains inert in the presence of NIS in combination 
with catalytic amount of TfOH, common conditions for alkyl/aryl thioglycoside 
activation.30  This finding led to the development of a promising combination of 
orthogonal leaving groups, wherein STaz is activated selectively with AgOTf, whereas 
ethyl thioglycosides are activated with NIS and catalytic TfOH.30   
Scheme 1.19.  Orthogonality of the STaz and SEt glycosides. 
  
 
The synthesis of pentasaccharide 1.74 was executed as depicted in Scheme 1.19.5 
Thus, thioglycoside building blocks 1.71 and 1.72 were orthogonally activated with 
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NIS/cat. TfOH over STaz building block 1.25. In turn, intermediates 1.26 and 1.73 
bearing the anomeric STaz moiety were efficiently activated with AgOTf to glycosylate 
SEt acceptor 1.52. 
Our further studies have shown that even seemingly similar thioimidoyl leaving 
groups can be orthogonally activated over each other. The orthogonality of thioimidates 
is a unique feature of this methodology because conventional orthogonal activation 
requires two different classes of leaving groups. For instance, dedicated study of the 
SBox and STaz leaving groups allowed us to elucidate their activation pathways, direct 
for the SBox glycosides, and remote for the STaz derivatives. This allowed us to develop 
an orthogonal activation using these seemingly similar leaving groups. The key to 
differentiation of these two leaving groups is the choice of activator. For instance, the 
STaz was activated by mild alkylating agent benzyl bromide. Essentially the same 
reagent is extremely slow to benzylate the anomeric sulfur, the reaction that would be 
required for the activation of SBox see (Figure 1.2).  
Scheme 1.20.  Orthogonal activation of STaz and SBox leaving groups. 
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Conversely, SBox can be very readily activated with Bi(OTf)3 whereas STaz 
remains inert. This finding was used in orthogonal activation according to which SBox 
glycosyl donor 1.1 was coupled with STaz acceptor 1.25 in the presence of Bi(OTf)3  as 
depicted in Scheme 1.20.39 Resulting disaccharide 1.64 equipped with the anomeric STaz 
group was then activated over SBox acceptor 1.28 using benzyl bromide to obtain 
trisaccharide 1.65. Along similar lines, we determined the orthogonal-like character of 
glycosyl alkoxyimidates vs. SBox glycosides.84   
Scheme 1.21.  Activation of SBiz vs. SBizAn in the active- latent fashion. 
 
 
Recent studies from our laboratory have shown that S-benzimidazolyl (SBiz) 
glycosides can serve a promising new platform for further exploration of the active-latent 
strategy, a concept introduced by Roy,85-87 and further developed by Fraser-Reid,66,88 
Boons,89,90 Kim91 and others.92 We observed that a simple protection of the SBiz leaving 
group with anisoyl substituent significantly reduces its reactivity in the MeI-promoted 
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glycosylation.  This finding allowed for direct activation of active SBiz donor 1.12 over 
the latent anisoylated SBiz glycosyl acceptor 1.13 to afford disaccharide 1.14 as shown in 
Scheme 1.21.32 The latter was then treated with NaOMe or Bu4NF to affect the 
deprotection of the anisoyl group.  Thereby obtained active SBiz disaccharide 1.75 was 
then reacted with the acceptor 1.2 in the presence of MeI to afford the trisaccharide 1.76. 
Our extended mechanistic study showed that the deactivation of donor 1.12 by means of 
the N-anisoyl group is due to the electron withdrawal effect.32 Since the activation of the 
SBiz moiety follows the direct activation pathway, the anisoyl substituent reduces the 
nucleophilicity of the anomeric sulfur hence decreasing its reactivity in the presence of 
MeI.  In contrast with well-known effect of disarming acyl groups on sugar oxygens, the 
disarming effect herein is achieved via the acylation of the leaving group.   
Scheme 1.22.  Orthogonal activation of the OAP and SPh leaving groups. 
 
 
As aforementioned, allylphenyl (AP) leaving group was specifically designed to 
be compatible with either direct or remote activation pathways on demand. This unique 
feature of the AP glycosides was explored in the orthogonal activation with SPh 
glycosides. Iodonium-based reagents would activate both of these leaving groups, 
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therefore we adopted alkylation conditions for the activation of SPh glycosides.  Thus, 
SPh glycosyl donor 1.77 was coupled with the AP acceptor 1.78 in the presence of 
MeOTf to afford the disaccharide 1.79 as shown in the Scheme 1.22.43  Subsequently, the 
AP disaccharide 1.79 was activated with TMSOTf for the coupling with SPh acceptor 
1.80 to afford the trisaccharide 1.81.   
Recently, we discovered a novel concept for oligosaccharide assembly called the 
“reverse orthogonal strategy”. It was designed to solve the major drawback of the 
traditional orthogonal approach – reduced reactivity and yields with increasing bulk of 
the oligosaccharide glycosyl donor. This drawback was particularly evident during the 
synthesis of longer oligosaccharide sequences. Unlike the classic concept based on 
orthogonal leaving groups, the reverse approach is based on orthogonal protecting 
groups, herein p-methoxybenzyl and 4-pentenoyl. The concept is based on the idea that a 
strategically placed temporary labile substituent would be removed during the 
glycosylation reaction. This strategic adjustment allowed us to perform efficient 
oligosaccharide assembly in the reverse direction elongation of glycosyl acceptor without 
additional steps between glycosylations.93  
Although in principle, this approach can be executed with only one type of a 
leaving group, best yields were obtained with SEt glycoside with 6-O-p-methoxybenzyl 
(pMB) protection 1.82 and SBox glycoside with 6-O-pentenoyl (Pent) protection 1.83.  
Coupling of glycosyl donor 1.82 with acceptor 1.84 was affected in the presence of 
NIS/TfOH/H2O and led to the formation of disaccharide 1.85 (Scheme 1.23).  The latter 
was then glycosylated with SBox donor 1.83 equipped with an O-pentenoyl group using 
TMSI/AgOTf promoter. The resulting trisaccharide 1.86 was then reacted with 1.82 to 
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afford tetrasaccharide 1.87.  In turn, tetrasaccharide 1.87 was coupled with SBox donor 
1.83 to afford pentasaccharide 1.88 in a good over-all yield. 
Scheme 1.23.  Four-step synthesis of pentasaccharide 1.88 via the reverse orthogonal 
strategy. 
 
 
1.4   Innovative technologies for oligosaccharide synthesis 
One-pot techniques for multi-step oligosaccharide synthesis combine two or more 
chemoselective glycosylation steps and offer arguably the shortest pathway to 
oligosaccharides. In fact, the sequential glycosylation reactions are performed in a single 
flask (“one-pot”) and do not require isolation and purification of the intermediates. Many 
variations of the one-pot strategy have been developed.62,70,71,94-102 Among those several 
classes of leaving groups have been investigated and thioimidates are no exception.  We 
have shown that SBox, SEt and STaz building blocks can be activated sequentially to 
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synthesize tetrasaccharide 1.89 in one pot. First, the SBox donor 1.1 was activated over 
SEt galactose acceptor 1.5 with AgOTf (Scheme 1.24).103 Upon completion of the 
coupling step, STaz glycosyl acceptor 1.25 was added to the reaction vessel along with 
NIS and catalytic TfOH to activate the formed SEt disaccharide intermediate. When the 
TLC analysis showed that reactants have been consumed, glycosyl acceptor 1.2 was 
added along with AgOTf promoter required to activate the STaz trisaccharide 
intermediate. Upon completion of the one-pot three-step sequence and purification by 
column chromatography, tetrasaccharide 1.89 was isolated in 73% yield overall 
accounting for about 90% yield per step.103   
Scheme 1.24.  Thioimidate-based one-pot oligosaccharide synthesis. 
 
 
During our further studies carried out to expand the application of glycosyl 
thioimidates to oligosaccharide synthesis, we have shown that SBox building blocks can 
be used in polymer supported (Merrifield’s resin or Tentagel) glycosylations following 
both glycosyl acceptor and glycosyl donor-bound approaches.104  As an extension of this 
study, and in attempt to address major drawbacks of the polymer-supported synthesis, we 
established the Surface-Tethered Iterative Carbohydrate Synthesis (STICS), a novel 
approach to oligosaccharide synthesis using Nano-Porous Gold (NPG) as a solid 
support.105   
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NPG is a high-surface area, sponge-like nanomaterial, it can be utilized as a set of 
NPG plates (8 x 8 x 0.2 mm) assembled in a stacked Teflon mini reactor as shown in top 
figure in Scheme 1.25a. The glycosyl acceptor can be anchored to NPGs using thiolated 
linkers and the oligosaccharide assembly is accomplished via alternating glycosylation, 
washing, deprotection and drying steps as depicted in Scheme 1.25a. The 6-O-TBDPS-
protected SBox glycosyl donor 1.90 was first coupled to the lipoic acid anchored acceptor 
in the presence of MeOTf. Then the tethered disaccharide was treated with Bu4NF to 
deprotect the silyl group and allowed to react with donor 1.1 to obtain the trisaccharide 
1.91. Finally, the latter was cleaved from the NPG plate using NaOMe/MeOH followed 
by benzoylation to give trisaccharide 1.92 (Scheme 1.25b). Pictures in Scheme 1.25b are 
SEM images of NPG plates in two different bar scales (2.5 μm and 200 nm). 
Scheme 1.25.  STICS: Surface-Tethered Iterative Carbohydrate Synthesis. 
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Over-all, STICS approach is a promising new concept for oligosaccharide 
synthesis that allows to address the following important drawbacks of the polymer-
supported synthesis: limited use of the molecular sieves that are hard to separate for the 
polymer beads; extended time for resin swelling/drying, NPG surface only requires 
wetting; large volume of the waste solvent is generated when resin needs to be washed 
while the NPG is simply rinsed; reagent trapping/resin poisoning is not an issue with 
NPG because it does not trap any reagent and can be regenerated to bare surface by 
electrochemical methods if necessary; reusability of resin is a problem while gold is fully 
recoverable.  The limitations of the STICS approach are similar to other standard 
drawbacks of the polymer-supported synthesis and include: difficulty to monitor the 
reaction and analyze intermediates, longer reaction times than those for reactions in 
solution and the requirement to use large (5-10 fold) excess of reagents.  
Some notable drawbacks of the STICS technology that is using simple immersion 
technique have stimulated us to pursue a new experimental set-up based on an 
unmodified HPLC instrument. In brief, a glass Omnifit chromatography column was 
packed with the pre-swelled polymer resin or small NPG chips (see the left panel in 
Scheme 1.26). The column was then connected to the HPLC system consisting of a 
reciprocating pump containing three chambers, a variable UV range detector, and a 
computer with standard HPLC-operating software installed.106 The column was packed 
with the glycosyl acceptor loaded on resin, purged with the solvent and then two separate 
solutions containing glycosyl donor and promoter were delivered concomitantly. After a 
relatively short reaction time, typically 30-60 min, the system was purged (washed) with 
solvent. At this time, the resin is loaded with the disaccharide derivative that can be either 
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cleaved off from the polymer support or the oligosaccharide elongation can be continued 
via alternating deprotection/glycosylation steps. Although we are still currently 
optimizing many aspects of the HPLC-assisted method, we have already applied this 
technology to the synthesis of small oligosaccharides containing various sugar moieties.  
Amongst these, we obtained a series of tri-, tetra-, and pentasaccharides consisting of 
glucose, galactose, and mannose units, all of which are major constituents of many 
natural mammalian and bacterial oligosaccharides and glycoconjugates. One example is 
illustrated here, the synthesis of a pentasaccharide (middle panel) and automation steps 
required to accomplish the synthesis (right panel, Scheme 1.26).  
Scheme 1.26.  HPLC-assisted automated oligosaccharide synthesis. 
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All steps can be monitored using a standard HPLC detection system set up to 
record changes in the UV absorbance of the solution eluting off the column.  A solution 
of reagents can be recirculated to reduce the amount of reagents and ensure complete 
conversion at each reaction step. In our opinion, the improved experimental set up offers 
the following advantages in comparison to that of conventional oligosaccharide synthesis 
on polymer and NPG supports: faster reaction times, real-time reaction monitoring using 
an HPLC detection system, and all steps and sequences can be automated using the 
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standard HPLC-managing computer software. Further optimization of the HPLC-based 
technology and its application to the NPG platform and biological targets described in the 
proposal are currently underway.  
 
1.5.   Conclusions and outlook 
Oligosaccharide sequences are found in numerous natural compounds and 
constitute the core of many modern therapeutics. In spite of recent progress, chemical 
synthesis of even moderately complex oligosaccharides still requires significant 
resources, which makes these targets accessible only to a small circle of glycoscientists 
and questions the feasibility of their industrial production. The development of more 
efficient and dependable techniques for synthesis offers a high level of significance 
because reliable access to oligosaccharides is essential for further innovations and 
practical applications in all areas of glycobiology, glycomics, and glycomedicine. 
The long-term goal of our research program is to make synthetic complex 
carbohydrates more accessible to general chemical, biochemical, medical and industrial 
audiences to keep pace with the exploding area of glycobiology. The achievement of the 
ultimate goal will be simplified by the development of new expeditious strategies for 
oligosaccharide synthesis and by the application of the new HPLC-based experimental 
set up.  We have already applied, and are continuing to apply the developed strategies in 
the synthesis of important oligosaccharide and glycoconjugate targets for biomedical 
studies. As a result, it is our expectation that the methodological advances made in the 
synthetic field will boost innovations in the related fields of glycosciences.  
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2.1.  Introduction 
Complex carbohydrates consist of monosaccharide units, which are connected via O-
glycosidic linkages into elaborate oligosaccharide networks.1,2 Chemically, the O-
glycosidic linkage is formed by a glycosylation reaction, which in the most general sense, 
is a promoter/activator (A) assisted monomolecular nucleophilic displacement of the 
leaving group (LG) of a glycosyl donor with a hydroxyl moiety of a glycosyl acceptor 
(NuH, Scheme 1).3,4 Other functional groups on both glycosyl donor and acceptor are 
temporarily masked with protecting groups (P). Upon the leaving group departure, the 
flattened oxacarbenium ion is formed, which often leads to anomeric mixtures (Scheme 
2.1A).5 Therefore, particular care has to be taken with regards to the stereoselectivity of 
glycosylation.  
Scheme 2.1.  Traditional glycoside synthesis using conventional 2-O-benzyl 
protection vs. 2-O-picolinyl-assisted 1,2-trans-glycosylation. 
 
 
The aim of stereocontrolling of glycosylation has been approached in a variety of ways 
and the participation of a neighboring acyl-type group has been widely used to obtain 
1,2-trans glycosides.6  Recently, our group has expanded methods available for 1,2-trans 
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glycosylation by developing the neighboring 2-O-picolinyl (2-pyridylmethyl, Pic) 
participating group.7,8 It was demonstrated that 2-O-picolinyl-assisted glycosylations 
proceed via a formal six-membered ring intermediate leading to the formation of 1,2-
trans glycosides with complete stereocontrol (Scheme 2.1B). Other unconventional 
methods for participation-assisted or stereodirected glycosylation have also been recently 
introduced.9-15 
Figure 2.1.  Expected vs. detected stereoselectivity that was found to be always syn in 
respect to the remote picolinyl group. 
 
 
2.2.  Results and Discussion 
Upon discovering complete 1,2-trans stereoselectivity obtained via the 2-O-picolinyl 
participation, we decided to broaden the scope of this method and investigate whether a 
similar effect can be achieved with remote picolinyl groups.  Herein, we report the study 
of a series of novel glycosyl donors equipped with picolinyl and picoloyl (2-
pyridinecarbonyl, Pico) groups at remote positions (C-3, C-4, and C-6). The major 
emphasis of this study is to investigate the effect that these remote substituents may have 
on the stereoselectivity of glycosylation. As shown in Figure 2.1, our original expectation 
was to obtain anti substitution due to the anticipated participation of the remote Pic/Pico 
moieties.  
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As the starting comparison point, known glycosyl donors per-O-benzylated and 2-O-
picolinyl substituted thioglycosides, 2.1a16 and 2.1b,8 respectively, were coupled with 
glycosyl acceptor 2.217 under reaction conditions that became standard for 2-O-picolinyl 
glycosyl donors: dimethyl(methylthio)sulfonium triflate (DMTST),18 1,2-dichloroethane, 
-30  42 oC.8 Glycosidation of donor 2.1a was non-stereoselective and the 
corresponding disaccharide 2.3a19 was isolated in 92% yield (α/β = 1/1.9, entry 1, Table 
2.1). As expected, glycosidation of 2-O-picolinyl donor 2.1b provided disaccharide 2.3b8 
with anticipated complete β-stereoselectivity in 83% yield (entry 2). Rather unexpectedly, 
3-O-picolinyl thioglycoside 2.1c gave disaccharide 2.3c in a relatively high 1,2-trans β-
selectivity (84%, α/β=1/5.8, entry 3). In further probing positional isomers 4-O-picolinyl 
donor 2.1d and 6-O-picolinyl donor 2.1e (entries 4 and 5), we noticed that in all cases the 
product was preferentially forming in the syn orientation to that of the picolinyl 
substituent rather than anti as it was originally anticipated (Figure 2.1).  Thus, 4-O-
picolinyl donor 2.1d (the substituent at C-4 is projecting below the ring) showed slight 
preference towards the formation of α-2.3d (α/β = 1.2/1, 88%, entry 4). Conversely, 
glycosidation of 6-O-picolinyl donor 2.1e (substituent projecting above the ring) gave 
disaccharide 2.3e with some β-stereoselectivity (α/β = 1/2.4, 93%, entry 5). 
Clearly, the level of stereoselectivity observed in these preliminary experiments was not 
exceptionally high. Nevertheless, these results suggest that the nature of the remote 
picolinyl effect is perhaps of a more complex origin than the anticipated direct 
participation. It is possible that the remote picolinyl groups affect glycosylation reactions 
via a different mode than that observed for the neighboring 2-O-picolinyl group 
(complete 1,2-trans selectivity, anti in respect to picolinyl, via the direct participation).7,8  
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Intrigued by the unexpected preliminary results, we began a study that would improve 
our understanding of the mode by which the remote picolinyl substituents affect both 1,2-
cis and 1,2-trans stereoselectivity of glycosylation.  
Table 2.1. Comparative investigation of glycosyl donors 2.1a- 2.1e. 
 
Entry Donor Time Yield Product α/β Ratio 
1  
2.1a 
15 min 92% 2.3a 1 / 1.9 
2  
2.1b 
20 h 83% 2.3b β only 
3  
2.1c 
4 h 84% 2.3c 1 / 5.8 
4 
 
2.1d 
4 h 88% 2.3d 1.2 / 1 
5 
 
2.1e 
5 h 93% 2.3e 1 / 2.4 
 
 
One explanation for the stereoselectivity observed is through the intermolecular 
participation of the picolinyl nitrogen at the anomeric center that would result in 
shielding of one face of the oxacarbenium intermediate over another (Figure 2.2A).  To 
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test the viability of this assumption we investigated glycosidations of standard per-O-
benzylated thioglycoside 2.1a in the presence of pyridine, which showed no significant 
Figure 2.2.  Possible rationalization for the stereoselectivity observed. 
 
 
change in stereoselectivity. We also found that the stereoselectivity diminishes 
dramatically in case of glycosyl donors protected with 4,6-O-benzylidene (entry 5, Table 
2.2). The induced rigidity of the pyranose ring should have no significant effect on 
intermolecular participation and would be more indicative of other modes of action. 
Therefore, in our opinion the intermolecular participation is not strongly supported by the 
experimental results. 
Another possibility is that instead of the anticipated direct participation at the anomeric 
center, the remote picolinyl moiety acts as a platform for a hydrogen bond mediated 
aglycone delivery (Figure 2.2B).  In our opinion, this is the most relevant mechanism to 
explain the syn stereoselectivity observed in all preliminary glycosylations.  The fact that 
stereoselectivity decreases in case of 4,6-O-benzylidene protected donor indicates that the 
conformational changes to form all-axial oxacarbenium intermediate5,20-22 are necessary 
to ensure efficient H-bond mediated delivery. If the remote picolinyl group indeed acts as 
the H-bond acceptor for NuH, the benefit of such an action would be two-fold.  First, the 
hydrogen bond tethering would provide enhanced (if not complete) facial selectivity by 
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delivering the glycosyl acceptor from the same face23 in respect to the H-bond acceptor 
(consistent with results described in Table 2.1). Second, picolinyl moiety would 
accelerate the entire reaction by positioning both reaction components in a close 
proximity to each other and also may facilitate deprotonation, the last essential step of the 
glycosylation of neutral aglycones.3  It should be noted that intramolecular hydrogen 
bonding between picolinyl group and the neighboring acetamido group has been reported 
by Crich.24 
To elucidate the reaction pathway and, consequently, improve the stereoselectivity of 
glycosylations we began a systematic study with the emphasis on acquiring the 
experimental evidence supporting the existence of the hydrogen bonding between the 
glycosyl acceptor and donor counterparts.  Having assumed that the orientation of the 
anomeric substituent would be significant for the proposed H-bond mediated aglycone 
delivery to take place, we investigated donor α-2.1c. Indeed, nearly a 3-fold enhancement 
of β-selectivity (α/β = 1/14.5, entry 2, Table 2.2) was observed in comparison to that 
obtained with β-2.1c (α/β = 1/5.8, entry 3, Table 2.1).  Even more dramatically, a 5-fold 
enhancement of β-selectivity was obtained with 6-O-picolinyl donor α-2.1e (α/β = 1/11.8, 
entry 3, Table 2.2) in comparison to that obtained with β-2.1e (α/β = 1/2.4, entry 5, Table 
2.1). For comparison, the use of α- or β-2.1a showed practically no difference in 
stereoselectivity obtained (entry 1, Table 2.1 and entry 2, Table 2.2). 
We also assumed that if the H-bonding between the donor and acceptor counterparts 
indeed were taking place in the reaction medium, the effect of dilution would help to 
enhance the stereoselectivity due to decreased probability of the non-stereoselective 
attack of unbound nucleophiles. In addition, we anticipated that high  
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Table 2.2.  Refining the stereoselectivity obtained with picolinyl and picoloyl-
protected donors 2.1c- 2.1g. 
 
Entry Donor (conc.) Time Yield Product α/β Ratio 
1 
 α-2.1a (50 mM) 
15 min 96% 2.3a 1 / 1.3 
2 
 α-2.1c (50 mM) 
3.5 h 89% 2.3c 1 / 14.5 
3 
 α-2.1e (50 mM) 
4 h 71% 2.3e 1 / 11.8 
4  
2.1c (5 mM) 
3 h 85% 2.3c 1 / 15.6 
5 2.1c (5 mM) 18 ha 64% 2.3f 1 / 7.1 
6  
2.1f (5 mM) 
20 h 77% 2.3f 1 / 2.1 
7  
2.1d (5 mM) 
5 h 86% 2.3d 5.3 / 1 
8  
2.1g (5 mM) 
4 h 73% 2.3g >25 / 1 
9  
2.1h (50 mM) 
1.5 h 96% 2.3h >1 / 25 
 a -Reaction was done at 50 °C starting from the beginning 
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dilution will have very minor effect on the rate of the reaction because the donor-acceptor 
pairs would be pre-assembled rather than separated by solvent molecules like in 
conventional glycosylations. To prove this concept, we performed a glycosylation 
between donor 2.1c and acceptor 2.2 at a 10-fold dilution with 1,2-dichloroethane, 5 mM 
donor concentration vs. 50 mM in standard experiments.  This coupling was even faster 
than that of the standard concentration (3 h vs. 4 h), and a 3-fold enhanced 
stereoselectivity was obtained under high dilution conditions (α/β = 1/5.8, entry 3, Table 
2.1 vs. α/β = 1/15.6, entry 4, Table 2.2).  Interestingly, applying much higher dilution, up 
to 50-fold (1 mM), even faster glycosidation of 2.1c (2.5 h) was observed, whereas 
glycosidation of donor 2.1a was practically ineffective. This result speaks very 
supportively of the postulated mechanism and is consistent with the occurrence of an H-
bond tethering between glycosyl donor and acceptor counterparts.  In this context, Yu and 
co-workers have recently reported a strong concentration effect on N-glycosylation, 
wherein it was attributed to the long-range participation effect.25 Kononov and co-
workers also observed very interesting correlation between concentration and 
stereoselectivity.26 It should be noted that although the comparison of all reactions were 
performed at standard temperature of -30  rt (or 42 oC), experiments at lower or 
ambient temperatures showed a very similar trend and very minor effect on 
stereoselectivity.   
Conversely, we observed a significant loss of stereoselectivity if the reactions were 
performed at 50 oC from the beginning. A result of particular interest was obtained in the 
high dilution experiments wherein reaction at 50 oC was significantly slower (incomplete 
at 18 h) than those at -30 oC or ambient temperature (3 h) and much less stereoselective 
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(entry 5, Table 2.2). On the other hand, introduction of rigidity to the glycosyl donor via 
4,6-O-benzylidene also reduced the stereoselectivity greatly, both in 5mM and 50 mM 
glycosylations, indicating that the ring flexibility also plays an important role in observed 
stereoselectivity through aglycone delivery. (entry 6, Table 2.2).  
At this stage, we also incorporated a series of glycosyl donors equipped with O-picoloyl 
(2-pyridinecarbonyl, Pico) substituent.27,28 In general, these glycosyl donors showed 
comparable stereoselectivity and the dilution effect trend to that observed with the 
picolinyl substituent. On one occasion, however, a significant enhancement in 1,2-cis 
stereoselectivity was observed when the picoloyl substituent was used instead of 
picolinyl at the C-4 position. While reactions with 4-O-picolinyl donor 2.1d performed at 
high dilution gave unexceptional stereoselectivity of α/β = 5.3/1 (entry 7, Table 2.2), 4-O-
picoloyl donor 2.1g led to disaccharide 2.3g with complete α-stereoselectivity (entry 8).  
Further study of the 6-O-picoloyl substituent in donor 2.1h showed excellent 1,2-trans 
stereoselectivity and the resulting disaccharide 2.3h was obtained as pure β-linked 
diastereomer (entry 9).  In our opinion, the set of data summarized in Table 2.2 provides a 
strong evidence of the syn delivery effect of picolinyl and picoloyl substituents while 
offering a practical new methodology for highly stereoselective synthesis of both 1,2-
trans and 1,2-cis linked disaccharides.  Although picoloyl substituent is a weaker H-bond 
acceptor than its picolinyl counterpart, very comparable results have been observed with 
these two groups. In our opinion, the strength of the H-bonding is not the deciding factor 
for excellent stereoselectivity. It is possible that the key importance of the H-bonded 
acceptor is to provide right geometry for the aglycone delivery. Arguably, preferential 
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trans-ester conformation of picoloyl group may offer the beneficial orientation for the H-
bonding mediated delivery.   
Table 2.3.  The effect of non-assisting protecting groups at C-4 on stereoselectivity.a 
 
Entry Donor (conc.) Time Yield Product Ratio 
1 2.1d (5 mM) 5 h 86% 2.3d 5.3 / 1 
2 
 
2.1g (5 mM) 4 h 73% 2.3g >25 / 1 
3 
 
2.1i (5 mM) 
10 h 82% 2.3i 1.5 / 1 
4 
 
2.1j (5 mM) 
10 h 74% 2.3j 1.3 / 1 
5 
 
2.1k (5 mM) 
5 h 93% 2.3k 1 / 2.6 
a -Reactions with m- and p-picoloyl protected donors were sluggish, low yielding, and 
non-stereoselective (no experimental data has been provided) 
 
The stereodirecting effect of other possible isomers of picolinyl, 3-pyridylmethyl (m-
picolinyl) and 4-pyridylmethyl (p-picolinyl), was also tested for comparison. In this 
context, non-stereoselective reactions were observed with glycosyl donors 2.1i and 2.1j 
equipped with m-picolinyl and p-picolinyl groups at C-4 respectively (entries 3 and 4, 
Table 2.3). Correspondingly, glycosidation of donors equipped with m-picoloyl (3-
pyridinecarbonyl) and p-picoloyl (4-pyridinecarbonyl) were sluggish and non-
stereoselective. To elucidate whether or not this enhancement of stereoselectivity is due 
Yasomanee, Jagodige P. | UMSL 2014 | Page 64 
  
 
 
to an electron-withdrawing (or a remote participating) effect of the carbonyl group, we 
tested the corresponding 4-O-benzoylated donor 2.1k. This glycosylation was modestly 
β-stereoselective indicating that the carbonyl group effect by itself is of very minor, if 
any, influence (entry 5).  
Encouraged by these results, we decided to expand the scope of the H-bond mediated 
stereoselective glycosylations to a broader range of substrates and investigated a variety 
of sugar series, common galactose, mannose, and rhamnose, as well as secondary 
glycosyl acceptors. The abbreviated results with the emphasis on the synthesis of 
traditionally challenging 1,2-cis linkages29,30 are listed in Table 2.4. Complete β-
stereoselectivity obtained in galactosylation with 4-O- picolinyl/picoloyl glycosyl donors 
(2.1m/1n) is also noteworthy (entries 2 and 3, Table 2.4). This directing effect represents 
a dramatic change in comparison to the non-stereoselective glycosidation of per-O-
benzylated galactosyl donor 2.1l.  Most remarkably, the high β-stereoselectivity obtained 
with 4-O-picoloyl ester differs drastically from that reported by Boons and co-workers in 
studying a series of 4-O-acylated galactosyl donors wherein high α-selectivity was 
achieved.31  This result is also very indicative of the existence of the H-bond mediated 
glycosylation. Although not particularly high, yet respectable β-stereoselectivity (α/β = 
1/9.5) was recorded for β-mannosylation with 2.1o in the presence of NIS/TfOH (entry 
4). We also obtained complete β-stereoselectivity upon rhamnosylation with 3-O-picoloyl 
donor 2.1q (entry 6) whereas, per-benzylated rhamnosyl donor 2.1p showed no 
selectivity (entry 5). Secondary glycosyl acceptors 2.4,32 2.6,33 and 2.834 were 
glycosylated with glucosyl donor 2.1g equipped with 4-O-picoloyl substituent to provide 
consistently high α-stereoselectivity, particularly at a 10-fold dilution (5 mM, entries 7- 
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Table 2.4.  Broadening the scope of the pic/pico-assisted glycosylation.a 
Entry Donor Acceptor, Conc. Time Yield Product α/β Ratio 
1 
2.1l 2.2 
50 mM 
 
45 
min 87%  
2.3l 
1 / 1.0 
 
2  
2.1m 
2.2 5 mM 3 h 83% 
 
2.3m 
>1 / 25 
3 
2.1n 
2.2 50 mM 5 mM 
1 h 
1.5 h 
96% 
95%  
2.3n 
1 : 24 
>1 / 25 
4  
2.1o 
2.2 5 mM 5 mM 
4 h 
2.5 hb
86% 
87% 
2.3o 
1 / 4.5 
1 / 9.5 
5 
2.1p 
2.2 50mM 45 min 85% 2.3p 1.1 / 1 
6 
2.1q 
2.2 50 mM 15 min 94% 
2.3q 
>1 / 25 
7  
2.1g 2.4 
50 mM 5 h 93% 
 
2.5 
>25 / 1 
8 2.1g 
2.6 
50 mM 
5 mM 
6 h 
16 h 
87% 
81%  
2.7 
10 / 1 
>25 / 1 
9 2.1g 
2.8
50 mM 
5 mM 
16 h 
24 h 
94% 
81%  
2.9 
12 / 1 
21 / 1 
10 2.1q 2.4 50 mM 1 h 90% 
 
2.10 
>1/ 25 
a Unless noted otherwise, the reactions were performed under standard conditions: 
DMTST, 1,2-dichloroethane, -30  25 oC; b  Performed in the presence of NIS/TfOH 
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9). Similarly, 2.1q also showed near complete β-selectivity upon rhamnosylation with 
secondary acceptor 2.4 (entry 10) at 50 mM concentration. 
Fortified with these results we attempted to obtain further sustaining evidence for the 
existence of the intermolecular H-bonding and its key involvement into the glycosylation 
process. The outcome of the following experiments, along with previously discussed 
factors, is summarized in Figure 2.3. First, consistently with the documented 
phenomenon that hydrogen bonding can be disturbed by the addition of DMSO,35 
reactions in the presence of DMSO were much less stereoselective with both α- and β-
directing glycosyl donors. The contribution of glycosyl sulfoxonium ion intermediates 
that could be forming in the presence of DMSO,36 remains to be investigated. However, 
in our opinion, simple formation of other activated species may not have the direct effect 
on the stereoselectivity of H-bond mediated glycosylation. 
Figure 2.3.  A survey of effects that reduce stereoselectivity by disrupting the 
H-bonding. 
 
 
Second, a significant loss of stereoselectivity was observed when reactions were 
performed in the presence of a large excess of DMTST (6 equiv. to donor). Also, the 
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addition of TfOH (1 equiv. in respect to the donor) along with DMTST (2 equiv.) 
significantly decreased the stereoselectivity. The effect of excess electrophilic reagents in 
the reaction medium is arguably due to blocking the H-bond acceptor (pyridyl nitrogen) 
with SMe+ released from DMTST or by protonation. This effect was observed both under 
50 mM and 5 mM reaction conditions.  
Third, the use of TMS-protected counterpart of glycosyl acceptor 2.2 gave very low 
stereoselectivity for both α- and β-directing glycosyl donors. This result clearly confirms 
the essentiality of acceptor proton and the presence of hydrogen bonding for the 
enhanced syn-selectivity. It is possible that these reactions still proceed via sequential 
TMS-deprotection followed by glycosylation, but the generated acceptor has no time to 
establish H-bonding with the donor.  Our further study showed that it is essential to 
premix the donor and acceptor counterparts (1 h standard time) before adding DMTST.   
Figure 2.4.  Temperature dependence of OH chemical shift of acceptor 2.2 in the 
presence of equimolar amount of donor 2.1d (or 2.1f) in 0.05 M solution. 
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Alternatively, if the donor is preactivated before the addition of the acceptor or acceptor 
and DMTST are added concomitantly, no stereoselectivity is observed.   
Fourth, inspired by previous studies by Vasella37,38 and Crich24 we have determined the 
reduced temperature coefficient for equimolar 2.2/ 2.1d and 2.2/ 2.1g combinations in 
CDCl3 to be -3.1 ppbK-1 and -0.9 ppbK-1, respectively, at the linear regression region of 
the Δδ/ΔT plots for δOH at 50 mM concentration (Figure 2.4).24,37,38 This data provides an 
indication that the H-bonding may exist between glycosyl acceptor and donor. We have 
also observed a linear dependence of δOH in 1H NMR spectra of 2.2 recorded at different 
concentrations for equimolar acceptor-donor pairs in CDCl3 at rt (Figure 2.5). The linear 
dependence obtained for both 4-picolinyl donor 2.1d and 4-O-picoloyl donor 2.1g is very 
indicative of the intermolecular hydrogen bonding, as previously shown by Vasella37,39 
and Crich24 for substituted 2-aminosugars. 
Figure 2.5.  Concentration dependence of OH chemical shift of acceptor 2.2 in the 
presence of donor 2.1d (or 2.1f) at 24 ̊C. 
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Last, we found that the stereoselectivity diminishes dramatically in case of glycosyl 
donors protected with 4,6-O-benzylidene (entry 6, Table 2.2). It is possible that the 
induced rigidity of the pyranose ring prevents conformational changes necessary to form 
the all-axial oxacarbenium intermediate.5,20-22 This result indicates that the 
conformational flexibility of the pyranose ring might be essential to ensure efficient H-
bond-mediated aglycone delivery. 
 
2.3.  Conclusions 
We discovered that remote O-picolinyl and O-picoloyl groups can mediate glycosylation 
reactions by providing high or even complete facial selectivity for the attack of the 
glycosyl acceptor. In our opinion, the set of data presented herein provides a strong 
evidence for the hydrogen bond-mediated aglycone delivery while providing a practical 
new methodology for stereoselective glycosylation.  The applicability of this approach 
was demonstrated and found to be consistently effective with various sugar series 
including glucose, galactose, mannose, and rhamnose as well as with both primary and 
secondary glycosyl acceptors.  Further application of this new stereoselective 
glycosylation reaction to other targets and the synthesis of oligosaccharides along with 
further investigation of the mechanism and kinetic profile of this reaction are currently 
underway in our laboratory.   
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2.4.  Experimental Section 
2.4.1.  General Remarks  
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination 
under UV light and by charring with 10% sulfuric acid in methanol. Solvents were 
removed under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl (1,2-DCE) were 
distilled from CaH2 directly prior to application. Pyridine was dried by refluxing with 
CaH2 and then distilled and stored over molecular sieves (3 Å). Anhydrous DMF was 
used as it is. Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and 
activated in vacuo at 390 °C during 8 h in the first instance and then for 2-3 h at 390 °C 
directly prior to application. AgOTf was co-evaporated with toluene (3 x 10 mL) and 
dried in vacuo for 2-3 h directly prior to application. Optical rotations were measured at 
‘Jasco P-1020’ polarimeter.  Unless noted otherwise, 1H-NMR spectra were recorded in 
CDCl3 at 300 or 600 MHz, 13C-NMR spectra were recorded in CDCl3 at 75 MHz.  Two-
dimensional heteronuclear J-resolved spectra (HETERO2DJ)40-42 were recorded in CDCl3 
at 600 MHz.  
 
2.4.2.  Synthesis of Glycosyl Donors 
Ethyl 2,3,4,6-Tetra-O-benzyl-1-thio--D-glucopyranoside (2.1a).  The title compound 
was synthesized according to the standard procedure and the analytical data for 2.1a was 
essentially the same as reported previously.16  
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Ethyl 2,3,4,6-Tetra-O-benzyl-1-thio--D-glucopyranoside (α-2.1a). The title 
compound was synthesized according to the standard procedure and the analytical data 
for α-2.1a was essentially the same as reported previously.43  
 
Ethyl 3,4,6-Tri-O-benzyl-2-O-picolinyl-1-thio--D-glucopyranoside (2.1b). The title 
compound was synthesized according to the standard procedure and the analytical data 
for 2.1b was essentially the same as reported previously.8  
 
Ethyl 2,4,6-Tri-O-benzyl-3-O-picolinyl-1-thio--D-glucopyranoside (2.1c). To a 
solution of ethyl 2-O-benzyl-4,6-O-benzylidene-1-thio--D-glucopyranoside44 (1.0 g, 
2.48 mmol) in DMF (10 mL) NaH (60% in mineral oil, 0.2 g, 5.00 mmol) and picolinyl 
bromide hydrobromide (0.94 g, 3.73 mmol) were added at rt. The reaction mixture was 
stirred for 1.5 h, quenched with ice-water (~10 mL, 30 min) and then extracted with ethyl 
acetate /diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was 
washed with cold water (3 × 30 mL). The organic phase was separated, dried with 
magnesium sulfate, filtered, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to give 
ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picolinyl-1-thio--D-glucopyranoside (2.1f) as 
a white amorphous solid in 90% yield (1.1g, 2.23 mmol).  Analytical data for 2.1f: Rf = 
0.58 (ethyl acetate/hexane, 1/1, v/v); []D26 -50.4 (c = 1.0, CHCl3); 1H-NMR: δ, 1.21 (t, 
3H, J = 7.4 Hz, SCH2CH3), 2.65 (m, 2H,  SCH2CH3), 3.35 (m, 1H, H-5), 3.41 (dd, 1H, 
J2,3 = 8.3 Hz, H-2), 3.59-3.71 (m, 2H, H-4, 6a), 3.73 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.24 
(dd, 1H, J5,6b = 5.0 Hz J6a,6b = 10.4 Hz, H-6b), 4.47 (d, 1H, J1,2 = 9.8 Hz, H-1), 4.76 (dd, 
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2H, 2J = 10.2 Hz, CH2Ph), 4.92 (dd, 2H, 2J = 13.4 Hz, CH2Ph), 5.44 (s, 1H, >CHPh), 
6.90-7.50 (m, 13H, aromatic), 8.40 (d, 1H, aromatic) ppm; 13C-NMR: δ, 15.2, 25.3, 68.8, 
70.3, 75.6, 76.0, 81.4, 81.5, 83.7, 85.9, 101.3, 121.6, 122.3, 126.1 (×2), 128.0, 128.3 (×2), 
128.5 (×4), 129.1, 136.6, 137.2, 137.9, 149.0, 158.8 ppm; HR FAB MS [M+H]+ calcd for 
C28H32NO5S 494.2001, found 494.2005. 
To a stirring mixture of 2.1f (0.5 g, 1.00 mmol) in CH2Cl2 (10 mL), water (150 μL) and 
trifluoroacetic acid (TFA)/CH2Cl2 (1/9, v/v, 1.0 mL) were added at rt. The reaction 
mixture was stirred for 3 h, then neutralized with Et3N (3 mL) and then diluted with 
dichloromethane (200 mL) and washed with cold water (20 mL), sat. aq. NaHCO3 (20 
mL), and cold water (20 mL).  The organic phase was separated, dried with magnesium 
sulfate, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (methanol - dichloromethane gradient elution) to afford ethyl 2-O-benzyl-3-
O-picolinyl-1-thio--D-glucopyranoside as a white amorphous solid in 92% yield (0.38 g, 
0.93 mmol). Analytical data: Rf = 0.40 (methanol/dichloromethane, 1/9, v/v); []D25 -34.6 
(c = 1.0, CHCl3);  1H-NMR:  δ, 1.25 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.70 (m, 2H, 
SCH2CH3), 3.28-3.42 (m, 3H, H-2, 5, OH), 3.52 (dd, 1H, J3,4 = 8.7 Hz, H-3), 3.67 (dd, 
1H, J4,5 = 9.1 Hz, H-4), 3.78 (dd, 1H, J5,6b = 5.5 Hz, J6a,6b = 11.7 Hz, H-6b), 3.93 (dd, 1H, 
J5,6a = 3.4 Hz, H-6a), 4.46 (d, 1H, J1,2 = 9.7 Hz, H-1), 4.71 (d, 1H, 2J = 10.6 Hz, ½ 
CH2Ph), 4.81-4.98 (m, 3H, 1½ CH2Ph), 7.05-7.70 (m, 8H, aromatic), 8.51 (d, 1H, J = 4.9 
Hz, aromatic) ppm; 13C NMR: δ, 15.1, 24.9, 62.9, 71.0, 74.0, 75.4, 79.9, 81.4, 85.0, 89.1, 
121.6, 122.8, 127.8, 128.1 (×2), 128.3 (×2), 137.3, 138.1, 148.6, 158.0 ppm; HR FAB 
MS [M+Na]+ calcd for C21H27NO5SNa 428.1508, found 428.1912.  
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To a solution of ethyl 2-O-benzyl-3-O-picolinyl-1-thio--D-glucopyranoside (0.38 g, 0.93 
mmol) in DMF (5.0 mL), NaH (60% in mineral oil, 0.19 g, 4.69 mmol) and benzyl 
bromide (0.33 mL, 2.79 mmol) were added at rt. The reaction mixture was stirred for 2 h, 
then quenched with ice water (15 mL, 30 min) and extracted with ethyl acetate/ diethyl 
ether (1/1, v/v, 3 × 30 mL). The combined organic extract (~90 mL) was washed with 
cold water (3 × 10 mL). The organic phase was separated, dried with magnesium sulfate, 
filtered, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to give the title compound as a white 
amorphous solid in 87% yield (0.48 g, 0.82 mmol). Analytical data for 2.1c: Rf = 0.47 
(ethyl acetate/hexane, 2/3, v/v); []D25 +0.10 (c = 1.2, CHCl3); 1H NMR: δ, 1.24 (t, 3H, J 
= 7.4 Hz, SCH2CH3), 2.68 (m, 2H, SCH2CH3), 3.36-3.47 (m, 2H, H-2, 4), 3.52-3.74 (m, 
4H, H-3, 5, 6a, 6b), 4.39 (d, 1H, J1,2 = 9.7 Hz, H-1), 4.49 (dd, 2H, 2J = 12.2 Hz, CH2Ph), 
4.59 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.73 (dd, 2H, 2J = 10.1 Hz, CH2Ph), 4.95 (dd, 2H, 2J 
= 12.8 Hz, CH2Ph), 7.05-7.70 (m, 18H, aromatic), 8.48 (d, 1H, J = 4.8 Hz, aromatic) 
ppm; 13C NMR: δ, 15.3, 25.2, 69.2, 73.6, 75.2, 75.6, 76.3, 78.0, 79.2, 81.7, 85.2, 87.1, 
121.5, 122.4, 127.8, 127.9 (×2), 128.0, 128.3 (×2), 128.5 (×7), 128.6 (×2), 136.7, 138.0, 
138.1, 138.3, 149.3, 158.7 ppm; HR FAB MS [M+H]+ calcd for C35H40NO5S 586.2627, 
found 586.2612. 
 
Ethyl 2,4,6-Tri-O-benzyl-3-O-picolinyl-1-thio--D-glucopyranoside (-2.1c).  To a 
solution of ethyl 2-O-benzyl-4,6-O-benzylidene-1-thio--D-glucopyranoside44 (1.0 g, 
2.48 mmol) in DMF (10 mL), NaH (60% in mineral oil, 0.2 g, 5.00 mmol) and picolinyl 
bromide hydrobromide (0.94 g, 3.73 mmol) were added at rt. The reaction mixture was 
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stirred for 1 h, then quenched with ice water (20 mL, 30 min) and extracted with ethyl 
acetate/ diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~ 150 mL) 
was washed with cold water (3 × 30 mL). The organic phase was separated, dried with 
magnesium sulfate, filtered, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate/ hexane gradient elution) to give ethyl 
2-O-benzyl-4,6-O-benzylidene-3-O-picolinyl-1-thio--D-glucopyranoside as a white 
amorphous solid in 91% yield (1.1g, 2.26 mmol). Analytical data: Rf = 0.53 (ethyl 
acetate/hexane, 1/1, v/v); []D25 +175.7 (c = 1.0, CHCl3); 1H NMR: δ, 1.27 (t, 3H, J = 7.4 
Hz, SCH2CH3), 2.54 (m, SCH2CH3), 3.64 (dd, 1H, J4,5 = 9.2 Hz, H-4), 3.74 (m, 1H, H-
6b), 3.83-3.40 (m, 2H, H-2, 3), 4.18-4.36 (m, 2H, H-5, 6a), 4.71 (dd, 2H, 2J = 11.8 Hz, 
CH2Ph), 4.99 (dd, 2H, 2J = 14.0 Hz, CH2Ph), 5.40 (d, 1H, J1,2 = 5.4 Hz, H-1), 5.54 (s, 1H, 
>CHPh), 7.00-7.65 (m, 13H, aromatic), 8.47 (d, 1H, aromatic) ppm; 13C NMR: δ, 15.0, 
23.9, 62.9, 69.0, 72.7, 75.8, 79.0, 81.9, 84.1, 101.6, 121.6, 122.2, 126.3 (×2), 128.0, 128.2 
(×2), 128.4 (×2), 128.5 (×2), 129.1, 136.5, 137.4, 137.8, 148.9, 159.3 ppm; HR FAB MS 
[M+H]+ calcd for C28H32NO5S 494.2001, found 494.1963. 
To a stirred solution of ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picolinyl-1-thio--D-
glucopyranoside(0.5 g, 1.00 mmol) in CH2Cl2 (10 mL), water (150 μL) and 10% 
TFA/CH2Cl2 (1/9, v/v, 1.0 mL) were added at rt. The reaction mixture was stirred for 3 h, 
neutralized with Et3N (~3 mL) and then diluted with CH2Cl2 (200 mL) and washed with 
cold water (20 mL), sat. aq. NaHCO3 (20 mL), and water (20 mL).  The organic phase 
was separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (methanol - dichloromethane gradient 
elution) to afford ethyl 2-O-benzyl-3-O-picolinyl-1-thio--D-glucopyranoside as a white 
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amorphous solid in 91% yield (0.37 g, 0.91 mmol). Analytical data: Rf = 0.44 (methanol/ 
dichloromethane, 1/9, v/v); []D22 +99.2 (c = 1.0, CHCl3); 1H NMR: δ, 1.23 (t, 3H, J = 
7.4 Hz, SCH2CH3), 2.51 (m, 2H, SCH2CH3), 2.90 (br. s, 1H, OH), 3.61-3.94 (m, 5H, H-2, 
3, 4, 6a, 6b), 4.02(m, 1H, H-5), 4.67 (dd, 1H, 2J = 11.8 Hz, CH2Ph), 4.94 (dd, 2H, 2J = 
15.2 Hz, CH2Ph), 5.38 (d, 1H, J1,2 = 5.2 Hz, H-1), 7.05-7.80 (m, 8H, aromatic), 8.48 (d, 
1H, J = 4.6 Hz, aromatic) ppm; 13C NMR: δ, 14.8, 23.6, 62.9, 70.9, 72.0, 72.2, 73.6, 79.3, 
82.9, 84.6, 121.6, 122.8, 128.0, 128.1 (×2), 128.5 (×2), 137.3, 138.0, 148.6, 158.5 ppm; 
HR FAB MS [M+H]+ calcd for C21H28NO5S 406.1688, found 406.1697.  
To a solution of ethyl 2-O-benzyl-3-O-picolinyl-1-thio--D-glucopyranoside (0.37 g, 0.91 
mmol) in DMF (5 mL), NaH (60% in mineral oil, 0.18 g, 4.56 mmol) and benzyl bromide 
(0.33 mL, 2.73 mmol) were added at rt. The reaction mixture was stirred for 2 h, then 
quenched with ice water (15 mL, 30 min) and extracted with ethyl acetate/ diethyl ether 
(1/1, v/v, 3 × 30 mL). The combined organic extract (~90 mL) was washed with cold 
water (3 × 10 mL). The organic phase was separated, dried with magnesium sulfate, 
filtered, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to give the title compound as a white 
amorphous solid in 85% yield (0.45 g, 0.77 mmol). Analytical data for -2.1c: Rf = 0.49 
(ethyl acetate/hexane, 2/3, v/v); []D25 +128.9 (c = 1.0, CHCl3); NMR: δ, 1.23 (t, 3H, J = 
7.4 Hz, SCH2CH3), 2.47 (m, 2H, SCH2CH3), 3.30-3.94 (m, 5H, H-2, 3, 4, 6a, 6b), 4.15 
(m, 1H, H-5), 4.53 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.56 (dd, 2H, 2J = 10.2 Hz, CH2Ph), 
4.59 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.96 (dd, 2H, 2J = 12.9 Hz, CH2Ph), 5.37 (d, 1H, J1,2 
= 4.7 Hz, H-1), 6.92-7.63 (m, 18H, aromatic), 8.47 (d, 1H, J = 4.8 Hz, aromatic) ppm; 
13C NMR: δ, 14.8, 23.7, 68.5, 70.4, 72.2, 73.5, 75.0, 76.2, 77.5, 79.2, 83.0, 83.1, 121.6, 
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122.2, 127.7, 127.8, 127.9, 128.0 (×4), 128.1 (×2), 128.3 (×2), 128.4 (×4), 136.4, 137.8, 
137.9, 138.2, 149.1, 158.9 ppm; HR FAB MS [M+H]+ calcd for C35H40NO5S 586.2627, 
found 586.2735. 
 
Ethyl 2,3,6-Tri-O-benzyl-4-O-picolinyl-1-thio--D-glucopyranoside (2.1d). To a 
solution of ethyl 2,3,6-tri-O-benzyl-1-thio--D-glucopyranoside45 (0.5 g, 1.01 mmol) in 
DMF (5 mL), NaH (60% in mineral oil, 0.12 g, 3.03 mmol) and picolinyl bromide 
hydrobromide (0.51 g, 2.02 mmol) were added at rt. The reaction mixture was stirred for 
2.5 h, then quenched with ice water (15 mL, 30 min) and extracted with ethyl acetate/ 
diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was washed 
with cold water (3 × 15 mL). The organic phase was separated, dried with magnesium 
sulfate, filtered, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to give the title 
compound as a white amorphous solid in 88% yield (0.51 g, 0.87 mmol). Analytical data 
for 2.1d: Rf = 0.48 (ethyl acetate/hexane, 1/1, v/v); []D25 +1.5 (c = 1.0, CHCl3);  1H 
NMR: δ, 1.31 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.75 (m, 2H, SCH2CH3), 3.44 (dd, 1H, J2,3 = 
8.9 Hz, H-2), 3.50 (m, 1H, H-5), 3.60-3.79 (m, 4H, H-3, 4, 6a, 6b), 4.46 (d, 1H, J1,2 = 9.8 
Hz, H-1), 4.54 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.72 (dd, 2H, 2J = 11.4 Hz, CH2Ph), 4.84 
(dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.90 (dd, 2H, 2J = 12.6 Hz, CH2Ph), 7.05-7.65 (m, 18H, 
aromatic), 8.51 (d, 1H, J = 4.8 Hz, aromatic) ppm; 13C NMR: δ, 15.3, 25.1, 69.3, 73.5, 
75.6, 75.8, 75.9, 78.7, 79.2, 81.8, 85.1, 121.5, 122.5, 127.6, 127.8 (×3), 128.0 (×2), 128.4 
(×4), 128.5 (×3), 128.5 (×2), 136.6, 138.1, 138.3, 138.5, 149.2, 158.3 ppm; HR FAB MS 
[M+H]+ calcd for C35H40NO5S 586.2627, found 586.2619. 
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Ethyl 2,3,4-Tri-O-benzyl-6-O-picolinyl-1-thio--D-glucopyranoside (2.1e). To a 
solution of ethyl 2,3,4-tri-O-benzyl-1-thio--D-glucopyranoside46 (0.5 g, 1.01 mmol) in 
DMF (5 mL), NaH (60% in mineral oil, 0.12 g, 3.03 mmol) and picolinyl bromide 
hydrobromide (0.51 g, 2.02 mmol) were added at rt. The reaction mixture was stirred for 
2.5 h, then quenched with ice water (15 mL, 30 min) and extracted with ethyl acetate/ 
diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was washed 
with cold water (3 × 15 mL). The organic phase was separated, dried with magnesium 
sulfate, filtered, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to give the title 
compound as a white amorphous solid in 87% yield (0.52 g, 0.89 mmol). Analytical data 
for 2.1e: Rf = 0.42 (ethyl acetate/hexane, 1/1, v/v); []D24 +4.3 (c = 1.0, CHCl3);  1H 
NMR: δ, 1.33 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.78 (m, 2H, SCH2CH3), 3.47 (dd, 1H, J2,3 = 
8.7 Hz, H-2), 3.53 (m, 1H, H- 5), 3.66 (dd, 1H, J4,5 = 8.9 Hz, H-4), 3.72 (dd, 1H, J3,4 = 8.6 
Hz, H-3), 3.78 (dd, 1H, J6a,6b  = 10.9 Hz, H-6a), 3.84 (dd, 1H, J5,6b = 1.9 Hz, H-6b), 4.50 
(d, 1H, J1,2 = 9.7 Hz, H-1), 4.70 (d, 2H, 2J = 4.4 Hz, CH2Ph), 4.74 (dd, 2H, 2J = 9.7 Hz, 
CH2Ph), 4.83 (dd, 2H, 2J = 10.2 Hz, CH2Ph), 4.91 (dd, 2H, 2J = 13.2 Hz, CH2Ph), 7.05-
7.50 (m, 17H, aromatic), 7.66 (dd, 1H, J = 7.7 Hz, aromatic), 8.53 (d, 1H, J = 4.8 Hz, 
aromatic) ppm; 13C NMR:  δ, 15.3, 25.1, 70.0, 74.3, 75.2, 75.7, 75.9, 78.0, 79.1, 81.9, 
85.2, 86.8, 121.4, 122.4, 127.8, 127.9 (×2), 128.0 (×2), 128.1 (×2), 128.5 (×4), 128.6 
(×4), 136.7, 138.1 (×2), 138.6, 149.1, 158.7 ppm; HR FAB MS [M+H]+ calcd for 
C35H40NO5S 586.2627, found 586.2695. 
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Ethyl 2,3,4-Tri-O-benzyl-6-O-picolinyl-1-thio--D-glucopyranoside (-2.1e).  To a 
solution of ethyl 2,3,4-tri-O-benzyl-1-thio--D-glucopyranoside47 (0.5 g, 1.01 mmol) in 
DMF (5 mL), NaH (60% in mineral oil, 0.12 g, 3.03 mmol) and picolinyl bromide 
hydrobromide (0.51 g, 2.02 mmol) were added at rt. The reaction mixture was stirred for 
2 h, then quenched with ice water (15 mL) and extracted with ethyl acetate/ diethyl ether 
(1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was washed with cold 
water (3 × 15 mL). The organic phase was separated, dried with magnesium sulfate, 
filtered, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to give the title compound as a white 
amorphous solid in 94% yield (0.56 g, 0.95 mmol). Analytical data for 2.1e: Rf = 0.38 
(ethyl acetate/hexane, 1/1, v/v); []D24 +146.9 (c = 1.0, CHCl3); 1H NMR: δ, 1.32 (t, 3H, 
J = 7.4 Hz, SCH2CH3), 2.59 (m, 2H, SCH2CH3), 3.72 (dd, 1H, J4,5 = 8.5 Hz, H-4), 3.78 
(dd, 1H, J5,6a = 1.8 Hz, J6a,6b = 10.8 Hz, H- 6a), 3.85-3.93 (m, 2H, H-2, 6b), 3.94 (dd, 1H, 
J3,4 = 9.5 Hz, H-3), 4.29 (m, 1H, H-5), 4.69 (dd, 2H, 2J = 13.6 Hz, CH2Ph), 4.75 (dd, 2H, 
2J = 11.5 Hz, CH2Ph), 4.77 (dd, 2H, 2J = 11.0 Hz, CH2Ph), 4.92 (dd, 2H, 2J = 10.8 Hz, 
CH2Ph), 5.47 (d, 1H, J1,2 = 4.8 Hz, H-1), 7.10-7.50 (m, 17H, aromatic), 7.65 (dd, 1H, J = 
7.7 Hz, aromatic), 8.54 (d, 1H, J = 4.2 Hz, aromatic) ppm; 13C NMR: δ, 14.9, 23.8, 69.5, 
70.5, 72.4, 74.3, 75.1, 75.8, 77.6, 79.6, 82.7, 83.2, 121.3, 122.4, 127.7, 127.8, 127.9 (×2), 
128.0, 128.2 (×4), 128.5 (×6), 136.6, 137.9, 138.4, 138.8, 149.0, 158.4 ppm; HR FAB 
MS [M+H]+ calcd for C35H40NO5S 586.2627, found 586.2702. 
 
Ethyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-1-thio--D-glucopyranoside (2.1g).   To a 
solution of ethyl 2,3,6-tri-O-benzyl-1-thio--D-glucopyranoside47  (0.5 g, 1.01 mmol) in 
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CH2Cl2 (10 mL), picolinic acid (0.19 g, 1.52 mmol), N,N'-dicyclohexylcarbodiimide 
(0.31 g, 1.52 mmol), and 4-dimethylaminopyridine (25 mg, 0.20 mmol) were added at rt. 
The reaction mixture was stirred for 15 min under argon, the solid was filtered off and 
rinsed successively with CH2Cl2. The combined filtrate (~100 mL) was washed with 
brine (2 x 10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to give the title compound as a white amorphous 
solid in 89% yield (0.54 g, 0.90 mmol). Analytical data for 2.1g: Rf = 0.44 (ethyl 
acetate/hexane, 1/1, v/v); []D25 -38.7 (c = 1.0, CHCl3); 1H NMR: δ, 1.50 (t, 3H, J = 7.4 
Hz, SCH2CH3), 2.95 (m, 2H, SCH2CH3), 3.74 (dd, 1H, J2,3 = 9.3 Hz, H-2), 3.80-3.85 (m, 
2H, H- 6a, 6b), 4.02 (m, 1H, H-5), 4.10 (dd, 1H, J3,4 = 9.1 Hz, H-3), 4.63 (s, 2H, CH2Ph), 
4.74 (d, 1H, J1,2 =9.8 Hz, H-1), 4.92 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 5.01 (dd, 2H, 2J 
=10.3 Hz, CH2Ph), 5.58 (dd, 1H, J4,5 = 9.7 Hz, H-4), 7.15-7.65 (m, 16H, aromatic), 7.89 
(dd, 1H, J = 7.7 Hz, aromatic), 8.14 (d, 1H, J = 7.7 Hz, aromatic), 8.87 (d, 1H, J = 3.9 
Hz, aromatic) ppm; 13C NMR: δ, 15.1, 24.9, 69.6, 72.3, 73.4, 75.4, 77.2, 81.5, 83.6, 85.1, 
125.5, 126.9, 127.3, 127.4, 127.5 (×2), 127.8 (×2), 127.9, 128.1 (×5), 128.3 (×3), 136.9, 
137.7, 137.8, 137.9, 147.4, 149.7, 164.1 ppm; HR FAB MS [M+H]+ calcd for 
C35H38NO6S 600.2420, found 600.2427. 
 
Ethyl 2,3,4-Tri-O-benzyl-6-O-picoloyl-1-thio--D-glucopyranoside (2.1h).   To a 
solution of ethyl 2,3,4-tri-O-benzyl-1-thio--D-glucopyranoside46 (0.5 g, 1.01 mmol) in 
CH2Cl2 (10 mL), picolinic acid (0.19 g, 1.52 mmol), N,N'-dicyclohexylcarbodiimide 
(0.31 g, 1.52 mmol), and 4-dimethylaminopyridine (25 mg, 0.20 mmol) were added at rt. 
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The reaction mixture was stirred 10 min under argon, the solid was filtered off and rinsed 
successively with CH2Cl2. The combined filtrate (~100 mL) was washed with brine (2 x 
10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to give the title compound as a white amorphous 
solid in 87% yield (0.53 g, 0.88 mmol). Analytical data for 2.1h: Rf = 0.47 (ethyl 
acetate/hexane, 1/1, v/v); []D24 +18.7 (c = 1.2, CHCl3); 1H NMR: δ, 1.23 (t, 3H, J = 7.4 
Hz, SCH2CH3), 2.69 (m, 2H, SCH2CH3), 3.46 (dd, 1H, J2,3 = 9.4 Hz, H-2), 3.63 (dd, 1H, 
J4,5 = 9.4 Hz, H-4), 3.70 (m, 1H, H-5), 3.72 (dd, 1H, J3,4 = 8.6 Hz, H-3), 4.51 (d, 1H, J1,2 = 
9.7 Hz, H-1), 4.53-4.68 (m, 3H, H-6a, 6b, ½ CH2Ph), 4.73 (d, 1H, 2J = 10.2 Hz, ½ 
CH2Ph), 4.80-5.00 (m, 4H, 2 × CH2Ph), 7.10-7.50 (m, 16H, aromatic), 7.78 (dd, 1H, J = 
7.7 Hz, aromatic), 8.02 (d, 1H, J = 7.8 Hz, aromatic), 8.81 (dd, 1H, J = 4.7 Hz, aromatic) 
ppm; 13C NMR: δ, 15.3, 25.2, 64.6, 75.2, 75.7, 76.0, 77.0, 78.0, 81.9, 85.2, 86.7, 125.2, 
127.0, 127.9 (×2), 128.0, 128.1, 128.2 (×2), 128.4 (×2), 128.5 (×2), 128.6 (×4), 137.0, 
137.7, 137.9, 138.3, 147.9, 150.1, 164.7 ppm; HR FAB MS [M+H]+ calcd for 
C35H38NO6S 600.2420, found 600.2430. 
 
Ethyl 2,3,6-Tri-O-benzyl-4-O-(pyrid-3-ylmethyl)-1-thio--D-glucopyranoside (2.1i).  
NaH (60% in mineral oil, 40.8 mg, 1.02 mmol) and 3-(bromomethyl)pyridine 
hydrobromide (191.8 mg, 0.76 mmol) were added to a solution of ethyl 2,3,6-tri-O-
benzyl-1-thio--D-glucopyranoside45 (250 mg, 0.51 mmol) in DMF (3 mL) and the 
resulting mixture was stirred for 6.5 h at rt. After that, the reaction mixture was poured 
into ice-water (10 mL), stirred for 30 min, and extracted with ethyl acetate/ diethyl ether 
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(1/1, v/v, 3 × 30 mL). The combined organic extract (~90 mL) was washed with cold 
water (3 × 10 mL). The organic phase was separated, dried with magnesium sulfate, 
filtered, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate/ hexane gradient elution) to give the title compound in 89% 
yield (265 mg, 0.45 mmol) as a white amorphous solid. Analytical data for 2.1i: Rf = 0.38 
(ethyl acetate/hexane, 1/1, v/v); []D21 +5.0 (c = 1.0, CHCl3); 1H NMR: δ, 1.93 (t, 3H, J = 
7.4 Hz, SCH2CH3), 2.83 (m, 2H, SCH2CH3), 3.45-3.58 (m, 2H, H-2, 5), 3.67-3.85 (m, 
4H, H-3, 4, 6a, 6b), 4.53 (d, 1H, J1,2 = 9.8 Hz, H-1), 4.64 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 
4.72 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.90 (dd, 2H, 2J = 10.6 Hz, CH2Ph), 4.92 (dd, 2H, 2J 
= 11.7 Hz, CH2Ph), 7.15-7.52 (m, 17H, aromatic), 8.44 (d, 1H, J = 0.9 Hz, aromatic), 
8.55 (d, 1H, J = 4.7 Hz, aromatic) ppm; 13C NMR: δ, 15.3, 25.1, 68.9, 72.4, 73.6, 75.6, 
75.8, 78.0, 79.0, 81.9, 85.2, 86.7, 123.4, 127.7 (× 2), 127.8 (× 3), 127.9 (× 2), 128.0, 
128.4 (× 2), 128.5(× 3), 128.6 (× 2), 133.6, 135.5, 138.0, 138.1, 138.5, 149.2 (× 2) ppm; 
HR FAB MS [M+H]+ calcd for C35H40NO5S 586.2627, found 586.2673. 
 
Ethyl 2,3,6-Tri-O-benzyl-4-O-(pyrid-4-ylmethyl)-1-thio--D-glucopyranoside (2.1j).  
NaH (60% in mineral oil, 40.8 mg, 1.02 mmol) and 4-(bromomethyl)pyridine 
hydrobromide (191.8 mg, 0.76 mmol) were added to a solution of ethyl 2,3,6-tri-O-
benzyl-1-thio--D-glucopyranoside45 (250 mg, 0.51 mmol) in DMF (3 mL) and the 
resulting mixture was stirred for 6 h at rt. After that, the reaction mixture was poured into 
ice-water (10 mL), stirred for 30 min, and extracted with ethyl acetate/ diethyl ether (1/1, 
v/v, 3 × 30 mL). The combined organic extract (~90 mL) was washed with cold water (3 
× 10 mL). The organic phase was separated, dried with magnesium sulfate, filtered, and 
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concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate/ hexane gradient elution) to give the title compound 91% yield (269 mg, 
0.45 mmol) as a white amorphous solid. Analytical data for 2.1j: Rf = 0.35 (ethyl 
acetate/hexane, 1/1, v/v); []D21 +2.5 (c = 1.0, CHCl3); 1H NMR: δ, 1.39 (t, 3H, J = 7.4 
Hz, SCH2CH3), 2.82 (m, 2H, SCH2CH3), 3.45-3.56 (m, 2H, H-2, 4), 3.62-3.85 (m, 4H, H-
5, 6a, 6b), 4.53 (d, 1H, J1,2 = 9.7 Hz, H-1), 4.61 (dd, 2H, 2J = 12.2 Hz, CH2Ph), 4.71 (dd, 
2H, 2J = 12.9 Hz, CH2Ph), 4.88 (dd, 2H, 2J = 11.1 Hz, CH2Ph), 4.88 (dd, 2H, 2J = 10.2 
Hz, CH2Ph), 7.05-7.52 (m, 17H, aromatic), 8.53 (d, 2H, J = 5.7 Hz, aromatic) ppm; 13C 
NMR: δ, 15.3, 25.2, 69.0, 73.1, 73.6, 75.6, 75.9, 78.3, 79.0, 82.0, 85.3, 86.7, 121.7 (× 2), 
127.8 (× 3), 127.9 (× 3), 128.1, 128.5 (× 4), 128.6 (× 4), 138.0, 138.1, 138.4, 147.4, 149.9 
(× 2) ppm; HR FAB MS [M+H]+ calcd for C35H40NO5S 586.2627, found 586.2681. 
 
Ethyl 4-O-Benzoyl-2,3,6-tri-O-benzyl-1-thio--D-glucopyranoside (2.1k).  The title 
compound was synthesized according to standard procedures and the analytical data for 
2.1k was essentially same as previously reported.48 
 
Ethyl 2,3,4,6-Tetra-O-benzyl-1-thio--D-galactopyranoside (2.1l).  The title compound 
was synthesized according to the standard procedure and the analytical data for 2.1l was 
essentially the same as reported previously.49  
 
Ethyl 2,3,6-Tri-O-benzyl-4-O-picolinyl-1-thio--D-galactopyranoside (2.1m).   To a 
solution of ethyl 2,3,6-tri-O-benzyl-1-thio--D-galactopyranoside50 (0.5 g, 1.01 mmol) in 
DMF (5 mL), NaH (60% in mineral oil, 0.12 g, 3.03 mmol) and picolinyl bromide 
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hydrobromide (0.51 g, 2.02 mmol) were added at rt. The reaction mixture was stirred for 
1.5 h, then quenched with ice water (15 mL, 30 min) and extracted with ethyl acetate/ 
diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was washed 
with cold water (3 × 15 mL). The organic phase was separated, dried with magnesium 
sulfate, filtered, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to give the title 
compound as a white amorphous solid in 90% yield (0.53 g, 0.90 mmol). Analytical data 
for 2.1m: Rf = 0.46 (ethyl acetate/hexane, 1/1, v/v); []D25 -5.9 (c = 1.0, CHCl3);  1H 
NMR: δ, 1.31 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.75 (m, 2H, SCH2CH3), 3.54-3.75 (m, 4H, 
H-3, 5, 6a, 6b), 3.82 (dd, 1H, J2,3 = 9.4 Hz, H-2), 4.06 (d, 1H, J4,5 = 2.8 Hz, H-4), 4.39-
4.53 (m, 3H, H-1, CH2Ph), 4.67-4.53 (m, 4H, 2 × CH2Ph), 4.88 (d, 1H, 2J = 10.2 Hz, ½ 
CH2Ph), 5.12 (d, 1H, 2J = 13.4 Hz, ½ CH2Ph), 7.05-7.80 (m, 18H, aromatic), 8.51 (d, 1H, 
J = 4.8 Hz, aromatic) ppm; 13C NMR: δ, 15.2, 25.0, 68.6, 72.8, 73.7, 75.2, 75.8, 75.9, 
77.1, 78.5, 83.7, 85.5, 121.7, 122.3, 127.8, 127.9 (×4), 128.1 (×2), 128.5 (×6), 128.6 (×2), 
136.7, 137.8, 138.3, 138.4, 148.6, 159.2 ppm; HR FAB MS [M+H]+ calcd for 
C35H40NO5S 586.2627, found 586.2612.  
 
Ethyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-1-thio--D-galactopyranoside (2.1n).   To a 
solution of ethyl 2,3,6-tri-O-benzyl-1-thio--D-galactopyranoside50 (0.5 g, 1.01 mmol) in 
CH2Cl2 (10 mL), picolinic acid (0.19 g, 1.52 mmol), N,N'-dicyclohexylcarbodiimide 
(0.31 g, 1.52 mmol), and 4-dimethylaminopyridine (25 mg, 0.20 mmol) were added at rt. 
The reaction mixture was stirred 10 min under argon, the solid was filtered off and rinsed 
successively with CH2Cl2. The combined filtrate (~100 mL) was washed with brine (2 x 
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10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to give the title compound as a colorless syrup in 
91% yield (0.55 g, 0.90 mmol). Analytical data for 2.1n: Rf = 0.56 (ethyl acetate/ hexane, 
1/1, v/v); []D25 +23.0 (c = 1.0, CHCl3); 1H NMR: δ, 1.35 (t, 3H, J = 7.5 Hz, SCH2CH3), 
2.80 (m, 2H, SCH2CH3), 3.53-3.69 (m, 2H, H-6a, 6b), 3.69 (dd, 1H, J2,3 = 9.2 Hz, H-2), 
3.76 (dd, 1H, J3,4 = 3.1 Hz, H-3), 3.87 (dd, 1H,  H-5), 4.47 (dd, 2H, 2J = 11.7 Hz, CH2Ph), 
4.57 (d, 1H, J1,2 = 9.3 Hz, H-1), 4.58 (d, 1H, 2J = 11.3 Hz, ½ CH2Ph), 4.80 (dd, 1H, 2J = 
10.2 Hz, CH2Ph), 4.89 (d, 1H, 2J = 11.3 Hz, ½ CH2Ph), 5.97 (dd, 1H, J4,5 = 2.8 Hz, H-4), 
7.10-7.50 (m, 16H, aromatic), 7.79 (dd, 1H, aromatic), 8.07 (d, 1H, J = 7.8 Hz, aromatic), 
8.81 (dd, 1H, J = 4.8 Hz, aromatic) ppm; 13C NMR: δ, 15.2, 25.1, 68.2, 68.5, 72.1, 73.8, 
75.9, 76.0, 77.9, 81.1, 85.6, 125.5, 127.8 (×2), 127.9, 128.1 (×2), 128.4 (×11), 137.0, 
137.5, 137.6, 138.1, 147.6, 150.3, 163.9 ppm; HR FAB MS [M+H]+ calcd for 
C35H38NO6S 600.2420, found 600.2431. 
 
Ethyl 2,3,4-Tri-O-benzyl-6-O-picoloyl-1-thio--D-mannopyranoside (2.1o).   To a 
solution of ethyl 2,3,4-tri-O-benzyl-1-thio--D-mannopyranoside51 (0.5 g, 1.01 mmol) in 
CH2Cl2 (10 mL), picolinic acid (0.19 g, 1.52 mmol), N,N'-dicyclohexylcarbodiimide 
(0.31 g, 1.52 mmol), and 4-dimethylaminopyridine (25 mg, 0.20 mmol) were added at rt. 
The reaction mixture was stirred 10 min under argon, the solid was filtered off and rinsed 
successively with CH2Cl2. The combined filtrate (~100 mL) was washed with brine (2 x 
10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
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(ethyl acetate - hexane gradient elution) to give the title compound as colorless syrup in 
91% yield (0.55 g, 0.92 mmol). Analytical data for 2.1o: Rf = 0.39 (ethyl acetate/hexane, 
1/1, v/v); []D24 +93.0 (c = 1.0, CHCl3); 1H NMR: δ, 1.18 (t, 3H, J = 7.4 Hz, SCH2CH3), 
2.52 (m, 2H, SCH2CH3), 3.82-3.93 (m, 2H, H-2, 3), 4.03 (dd, 1H, J3,4 = 9.3 Hz, J4,5 = 9.2 
Hz, H-4), 4.28 (m, 1H, H-5), 4.50-4.70 (m, 7H, H-6a, 6b, 2 ½ CH2Ph), 4.90 (d, 1H, 2J = 
10.9 Hz, ½ CH2Ph), 5.34 (s, 1H, H-1), 7.05-7.60 (m, 17H, aromatic), 7.92 (d, 1H, J = 7.8 
Hz, aromatic), 8.64 (d, 1H, J = 1.7 Hz, aromatic) ppm; 13C NMR: δ, 14.8, 25.2, 64.1, 
70.1, 71.7, 71.8, 74.1, 74.8, 76.2, 80.1, 81.6, 124.9, 126.5, 127.4 (×2), 127.5 (×3), 127.6 
(×2), 127.8 (×2), 128.1 (×5), 128.2 (×2), 136.5, 137.8 (×2), 147.5, 149.7, 164.2 ppm; HR 
FAB MS [M+H]+ calcd for C35H38NO6S 600.2420, found 600.2426. 
 
Ethyl 2,3,4-Tri-O-benzyl-1-thio-β-L-rhamnopyranoside (2.1p).  NaH (60% in mineral 
oil, 0.43 g, 10.8 mmol) and benzyl bromide (0.86 mL, 7.2 mmol) were added to a 
solution of ethyl 1-thio-β-L-rhamnopyranoside52 (S7, 0.25 g, 1.2 mmol) in DMF (5.0 mL) 
and the resulting mixture was stirred for 2 h at rt. After that, the reaction mixture was 
poured into ice-water (30 mL), stirred for 30 min, and extracted with ethyl acetate/ 
diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was washed 
with cold water (3 × 15 mL). The organic phase was separated, dried with magnesium 
sulfate, filtered, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate/ hexane gradient elution) to give the title 
compound in 89% yield (0.51 g, 1.1 mmol) as a white amorphous solid. Analytical data 
for 2.1p: Rf = 0.61 (ethyl acetate/hexane, 2/3, v/v); [α]D22 +80.8 (c = 1.0, CHCl3); 1H 
NMR: δ, 1.27 (t, 3H, J = 7.4 Hz, SCH2CH3), 1.35 (d, 3H, J5,6  = 6.2 Hz, C-6), 2.68 (q, 2H, 
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J = 7.4 Hz, SCH2CH3), 3.33 (m, 1H, H-5), 3.55 (dd, 1H, J3,4 = 9.4 Hz, H-3), 3.67 (dd, 1H, 
J4,5 = 9.2 Hz, H-4), 3.96 (d, 1H, J2,3 = 2.5 Hz, H-2), 4.51 (s, 1H, H-1), 4.60- 4.75 (m, 3H, 
1½ CH2Ph), 4.89 (dd, 2H, 2J = 11.6 Hz, CH2Ph), 4.93 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 
7.15-7.55 (m, 15H, aromatic) ppm; 13C NMR: δ, 15.2, 18.3, 25.9, 72.3, 75.1, 75.6, 76.5, 
77.3, 80.1, 84.3, 84.4, 127.7 (× 3), 127.8, 127.9, 128.2 (× 2), 128.3 (× 2), 128.5 (× 4), 
128.6 (× 2), 138.4, 138.5 (× 2) ppm; HR-FAB MS [M+H]+ calcd for C29H35O4S 
479.2256, found 479.2586. 
 
Ethyl 2,4-Di-O-benzyl-3-O-picoloyl-1-thio--L-rhamnopyranoside (2.1q).    2,6-
Lutidine (0.79 mL, 7.2 mmol) was added to a soln. of ethyl 2,3-O-isopropylidene-1-thio-
β-L-rhamnopyranoside52 (0.9 g, 3.6 mmol) in anhydrous THF (10 mL) and the resulting 
mixture was stirred under argon for 10 min at rt. After that, the mixture was cooled to -78 
oC, TBDMSOTf (5.5 mmol, 1.2 mL) was added. The resulting reaction mixture was 
stirred for 15 min at -78 oC and the volatiles were evaporated in vacuo. The residue was 
diluted with CH2Cl2 (~200 mL) and washed with 20% aq. NaHCO3 (40 mL) and water (3 
x 40 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to afford ethyl 4-O-tert-butyldimethylsilyl-2,3-
O-isopropylidene-1-thio-β-L-rhamnopyranoside in 89% yield (1.2 g, 2.7 mmol) as a 
white amorphous solid. Analytical data: Rf = 0.69 (ethyl acetate/hexane, 1/4, v/v); [α]D22 
+62.3 (c = 1.0, CHCl3); 1H NMR: δ, 0.03, 0.09 (2s, 6H, 2 × Si(CH3)3), 0.84 (s, 9H, 3 × 
C(CH3)3), 1.18-1.35 (m, 6H, C-6, SCH2CH3), 1.31, 1.50 (2s, 6H, 2 × C(CH3)2), 2.71 (q, 
2H, J = 7.5 Hz, SCH2CH3), 3.10-3.25 (m, 1H, H-5), 3.38 (dd, 1H, J4,5 = 9.1 Hz, H-4), 
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3.89 (dd, 1H, J3,4 = 6.6 Hz, H-3), 4.20 (dd, 1H, J2,3 = 5.6 Hz, H-2), 4.77 (d, 1H, J1,2 = 2.1 
Hz, H-1) ppm; 13C NMR: δ -4.9, -3.9, 14.9, 18.2, 18.4, 25.9, 26.0 (× 3), 26.6, 28.2, 75.8, 
76.0, 76.6, 80.7, 80.9, 110.1 ppm; HR-FAB MS [M+H]+ calcd for C17H35O4SSiNa 
363.2025, found 363.2113. 
To a stirring mixture of ethyl 2,3-O-isopropylidene-4-O-tert-butyldimethylsilyl-1-thio-β-
L-rhamnopyranoside (0.42 g, 1.2 mmol) in CH2Cl2 (10 mL), water (150 μL) and a soln. 
of TFA in CH2Cl2 (1/9, v/v, 1.2 mL) were added at rt.  The reaction mixture was stirred 
for 30 min, then neutralized with Et3N (~3.0 mL), diluted with CH2Cl2 (~200 mL) and 
washed with water (20 mL), sat. aq. NaHCO3 (20 mL), and water (3 x 20 mL). The 
organic phase was separated, dried with magnesium sulfate, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (methanol - 
dichloromethane gradient elution) to afford ethyl 4-O-tert-butyldimethylsilyl-1-thio-β-L-
rhamnopyranoside in 83% yield (0.31 g, 0.9 mmol) as a white amorphous solid. 
Analytical data: Rf = 0.36 (ethyl acetate/hexane, 3/7, v/v); [α]D22 +63.0 (c = 1.0, CHCl3); 
1H NMR: δ, 0.05, 0.10 (2s, 6H, 2 × Si(CH3)3), 0.85 (s, 9H, 3 × C(CH3)3), 1.20-1.35 (m, 
6H, C-6, SCH2CH3), 2.51 (br. s, 1H, OH), 2.67 (m, 2H, SCH2CH3), 3. 22 (m, 1H, H-5), 
3.32-3.45 (m, 2H, H-3, 4), 3.96 (s, 1H, H-2), 4.59 (d, 1H, J1,2 = 0.9 Hz, H-1) ppm; 13C 
NMR: δ, -4.4, -3.6, 15.2, 18.4, 18.5, 25.4, 26.1 (× 3), 72.7, 75.0, 75.5, 77.4, 83.8 ppm; 
1JC1,H1 = 151.7 Hz; HR-FAB MS [M+Na]+ calcd for C14H30O4SSiNa 345.1532, found 
345.1687. 
NaH (60% in mineral oil, 0.23 g, 5.8 mmol) and benzyl bromide (0.46 mL, 3.9 mmol) 
were added to a solution of ethyl 4-O-tert-butyldimethylsilyl-1-thio-β-L-
rhamnopyranoside (0.31 g, 0.96 mmol) in DMF (5.0 mL) and the resulting mixture was 
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stirred for 1.5 h at rt. After that, the reaction mixture was poured into ice-water (~20 mL), 
stirred for 30 min, and extracted with ethyl acetate/ diethyl ether (1/1, v/v, 3 × 50 mL). 
The combined organic extract (~150 mL) was washed with cold water (3 × 15 mL). The 
organic phase was separated, dried with magnesium sulfate, filtered, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate - 
hexane gradient elution) to give ethyl 2,4-di-O-benzyl-3-O-tert-butyldimethylsilyl-1-thio-
β-L-rhamnopyranoside in 81% yield (0.39 g, 0.78 mmol) as a white amorphous solid. 
Analytical data: Rf = 0.66 (ethyl acetate/hexane, 1/4, v/v); [α]D21 +47.8 (c = 1.0, CHCl3); 
1H NMR: δ, 0.00, 0.05 (2s, 6H, Si(CH3)3), 0.85 (s, 9H, C(CH3)3), 1.10-1.25 (m, 6H, C-6, 
SCH2CH3), 2.60 (q, 2H, J = 7.4 Hz, SCH2CH3), 3. 22 (m, 1H, H-5), 3.44 (dd, 1H, J4,5 = 
8.9 Hz, H-4), 3.63-3.72 (m, 2H, H-2, 3), 4.42-4.56 (m, 2H, H-1, ½ CH2Ph ), 4.78 (d, 1H, 
2J = 11.3 Hz, ½ CH2Ph), 4.79 (dd, 2H, 2J = 11.2 Hz, CH2Ph), 7.15-7.45 (m, 10H, 
aromatic) ppm; 13C NMR: δ, -4.7, -4.0, 15.2, 18.1, 18.2, 25.8, 26.1 (× 3), 75.4, 75.8, 76.4, 
77.7, 80.7, 82.0, 84.4, 127.4, 127.6, 127.8 (× 4), 128.1 (× 2), 128.2 (× 2), 138.4, 138.8 
ppm; HR-FAB MS [M+H]+ calcd for C28H42O4SSiNa 525.2573, found 525.2463. 
1M soln. of tert-butylammonium fluoride in THF (0.5 mL, 0.5 mmol) was added to a 
solution of ethyl 2,4-di-O-benzyl-3-O-tert-butyldimethylsilyl-1-thio-β-L-
rhamnopyranoside (0.25 g, 0.50 mmol) in THF (3.0 mL) and the resulting mixture was 
stirred for 30 min at rt. After that, the reaction mixture was neutralized with Et3N (~0.5 
mL), diluted with CH2Cl2 (~150 mL) and washed with cold water (15 mL), sat. aq. 
NaHCO3 (15 mL), and water (3 x 15 mL). The organic phase was separated, dried with 
magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford ethyl 2,4-
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di-O-benzyl-1-thio-β-L-rhamnopyranoside in 93% yield (0.18 g, 0.46 mmol) as a white 
amorphous solid. Analytical data: Rf = 0.43 (ethyl acetate/hexane, 3/7, v/v); [α]D21 +132.3 
(c = 1.0, CHCl3); 1H NMR: δ, 1.30 (t, 3H, J = 7.5 Hz, SCH2CH3), 1.37 (d, 3H, J5,6= 5.7 
Hz, C-6), 2.17 (d, 1H, J = 8.7 Hz, OH), 2.74 (q, 2H, J = 7.4 Hz, SCH2CH3), 3.25-3.37 
(m, 2H, H-4, 5), 3.64 (m, 1H, H-3), 3.86 (d, 1H, J2,3 = 3.2 Hz, H-2), 4.57 (d, 1H, J1,2 = 0.6 
Hz, H-1), 4.73 (dd, 2H, 2J = 11.1 Hz, CH2Ph), 4.82 (dd, 2H, 2J = 11.5 Hz, CH2Ph), 7.16-
7.50 (m, 10H, aromatic) ppm; 13C NMR: δ, 15.2, 18.4, 26.1, 75.3, 75.6, 76.1, 76.2, 80.9, 
81.9, 84.3, 128.0, 128.2 (× 3), 128.5 (× 2), 128.6 (× 2), 128.7 (× 2), 138.2, 138.4 ppm; 
HR-FAB MS [M+Na]+ calcd for C22H28O4SNa 411.1606, found 411.1713. 
Picolinic acid (95 mg, 0.77 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (197 
mg, 1.03 mmol), and 4-dimethylaminopyridine (12.6 mg, 0.10 mmol) were added to a 
solution of ethyl 2,4-di-O-benzyl-1-thio-β-L-rhamnopyranoside (200 mg, 0.52 mmol) in 
CH2Cl2 (6.0 mL) and the resulting mixture was stirred under argon for 45 min at rt. The 
reaction mixture was diluted with CH2Cl2 (~100 mL) and washed with 20% brine 
solution (2 x 10 mL). The organic phase was separated, dried with magnesium sulfate, 
and concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate/ hexane gradient elution) to give the title compound in 90% yield (229 
mg, 0.46 mmol) as a colorless syrup. Analytical data for 2.1q: Rf = 0.44 (ethyl 
acetate/hexane, 2/3, v/v); [α]D22 +122.0 (c = 1.0, CHCl3); 1H NMR: δ, 1.31 (t, 3H, J = 7.4 
Hz, SCH2CH3), 1.42 (d, 3H, J5,6 = 6.1 Hz, C-6), 2.74 (q, 2H, J = 7.5 Hz, SCH2CH3), 3.51 
(m, 1H, H-5), 3.90 (dd, 1H, J4,5 = 9.4 Hz, H-4), 4.21 (d, 1H, J2,3 = 3.2 Hz, H-2), 4.63- 
4.87 (m, 5H, H-1, 2 × CH2Ph), 5.22 (dd, 1H, J3,4 = 9.8 Hz, H-3), 7.02-7.50 (m, 12H, 
aromatic), 7.75 (m, 1H, aromatic), 7.91 (m, 1H, aromatic), 7.87 (d, 1H, J = 4.0 Hz, 
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aromatic) ppm; 13C NMR: δ, 15.2, 18.3, 25.9, 75.3, 75.7, 76.3, 78.0, 78.3, 78.5, 84.2, 
125.2, 127.1, 127.6, 127.7, 128.0 (× 2), 128.1 (× 2), 128.3 (× 2), 128.5 (× 2), 136.9, 
137.8, 138.0, 147.5, 150.1, 164.4 ppm; HR-FAB MS [M+H]+ calcd for C28H32O5 
494.2001, found 494.2005. 
 
2.4.3.  Synthesis of Disaccharides 
General procedure for glycosylation in the presence of DMTST.  A mixture of a 
glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4 Å, 200 mg) in (ClCH2)2 (2.6 mL, 50 mM or 26 mL, 5 mM) was 
stirred under argon for 1 h. The mixture was cooled to -30 °C, DMTST18 (0.26 mmol) 
was added, and the resulting mixture was allowed to warm to rt over a period of 1 h. The 
external heating was then applied and the reaction mixture was stirred at 42 °C for the 
time specified in tables. Alternative procedure involved stirring at rt as indicated in 
tables. Upon completion, Et3N (0.3 mL) was added and the resulting mixture was stirred 
for 30 min. The mixture was then diluted with CH2Cl2 (10 mL), the solid was filtered off, 
and the residue was washed sucessively with CH2Cl2. The combined filtrate (~30 mL) 
was washed with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). The organic phase 
was separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate - hexane gradient elution). 
Anomeric ratios (or anomeric purity) were determined by comparison of the integral 
intensities of relevant signals in 1H NMR spectra.  
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Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl--D-glucopyranosyl)--D-
glucopyranoside (2.3a). The title compound was obtained as a white amorphous solid 
from glycosyl donor 2.1a and acceptor 2.2 in 92% (= 1/1.9, 50 mM) and 85% yield 
( = 1/1, 5 mM) under regular and high dilution reaction conditions, respectively. 
Analytical data for 3a was in accordance with that reported previously.19  
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(3,4,6-tri-O-benzyl-2-O-picolinyl--D-
glucopyranosyl)--D-glucopyranoside (2.3b). The title compound was obtained as a 
white amorphous solid from glycosyl donor 2.1b and acceptor 2.2 in 83% yield ( only, 
50 mM). Analytical data for 2.3b was essentially the same as reported previously.7 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,4,6-tri-O-benzyl-3-O-picolinyl--D-
glucopyranosyl)--D-glucopyranoside (2.3c).   The title compound was obtained as a 
white amorphous solid from glycosyl donor 1c and acceptor 2.2 in 84% (= 1/5.8, 50 
mM) and 85% yield ( = 1/15.6, 5 mM) under regular and high dilution reaction 
conditions, respectively. Analytical data for -isomer of 3c: Rf = 0.63 (ethyl 
acetate/hexane, 1/1, v/v); 1H NMR: δ, 3.25 (s, 3H, OCH3), 3.28-3.66 (m, 9H, H-2, 2’, 3’, 
4, 4’, 5, 6a, 6a’, 6b’), 3.76 (m, 1H, H-5'), 3.92 (dd, 1H, J3,4 = 9.3 Hz, H-3), 4.11 (dd, 1H, 
J5,6b = 1.8 Hz, J6a,6b = 10.8 Hz, H-6b), 4.27 (d, 1H, J1’,2’ = 7.8 Hz, H-1’), 4.49 (dd, 2H, 2J = 
13.2 Hz, CH2Ph), 4.53 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.54 (dd, 2H, 2J = 9.8 Hz, CH2Ph), 
4.58 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.64 (dd, 2H, 2J = 12.4 Hz, CH2Ph), 4.75 (dd, 2H, 2J 
= 9.8 Hz, CH2Ph), 4.80 (dd, 2H, 2J = 10.8 Hz, CH2Ph), 4.93 (dd, 2H, 2J = 12.9 Hz, 
CH2Ph), 7.00-7.90 (m, 32H, aromatic), 7.47 (dd, 1H, J = 7.7 Hz, aromatic), 8.46 (dd, 1H, 
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J = 4.1 Hz, aromatic) ppm; 13C NMR: δ, 55.3, 68.6, 69.0, 70.0, 73.3, 73.5, 74.8, 74.9, 
75.0, 75.0 (× 2), 75.5, 76.2, 77.8, 78.1, 79.8, 81.7, 82.0, 85.3, 98.1, 103.8, 121.4, 122.2, 
127.5, 127.6, 127.7 (× 5), 127.8, 127.9 (× 3), 128.0 (× 2), 128.1 (× 2), 128.2 (× 2), 128.3 
(× 2), 128.4 (× 9), 128.5 (× 2), 136.5, 138.0, 138.2, 138.3 (× 2), 138.4, 138.9, 149.1, 
158.7 ppm; HR-FAB MS [M+Na]+ calcd for C61H65NO11Na 1010.4455, found 
1010.4442. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-picolinyl--D-
glucopyranosyl)--D-glucopyranoside (2.3d).    The title compound was obtained as a 
white amorphous solid from glycosyl donor 2.1d and acceptor 2.2 in 88% (= 1.2/1, 
50 mM) and 86% yield ( = 5.3/1, 5 mM) under regular and high dilution reaction 
conditions, respectively. Analytical data for  isomer of 2.3d: Rf = 0.59 (ethyl 
acetate/hexane, 1/1, v/v);  1H NMR: δ, 3.31 (s, 3H, OCH3), 3.39 (dd, 1H, J1,2 = 3.6 Hz, 
J2,3 = 9.6 Hz, H-2), 3.45-3.83 (m, 9H, H-2’, 4, 4’, 5, 5’, 6a, 6a’, 6b, 6b’), 3.92 (dd, 1H, 
J3’,4’ = 9.2 Hz, H-3’), 3.94 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.44 (dd, 2H, 2J = 12.1 Hz, 
CH2Ph), 4.60 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.51 (d, 1H, J1,2 = 3.4 Hz, H-1), 4.56-4.67 
(m, 2H, CH2Ph), 4.69 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.71 (dd, 2H, 2J = 10.8 Hz, 
CH2Ph), 4.76 (dd, 1H, 2J = 10.8 Hz, ½ CH2Ph), 4.84-4.98 (m, 5H, H-1’, 2 × CH2Ph), 
7.05-7.56 (m, 33H, aromatic), 8.47 (d, 1H, J = 4.8 Hz, aromatic) ppm; 13C NMR: δ, 55.4, 
66.3, 68.7, 70.4, 70.5, 72.6, 73.6 (× 2), 75.2, 75.6, 75.7, 75.9, 78.0, 78.3, 80.2, 80.3, 81.5, 
82.3, 97.5, 98.2, 121.3, 122.3, 127.6, 127.7, 127.8 (× 4), 128.0 (× 4), 128.1, 128.2 (× 4), 
128.3 (× 2), 128.4 (× 5), 128.6 (× 8), 136.6, 138.1, 138.4, 138.6, 138.8, 139.0, 149.1, 
Yasomanee, Jagodige P. | UMSL 2014 | Page 93 
  
 
 
158.8 ppm; HR-FAB MS [M+Na]+ calcd for C61H65NO11Na 1010.4455, found 
1010.4476. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-picolinyl--D-
glucopyranosyl)--D-glucopyranoside (2.3e).    The title compound was obtained as a 
white amorphous solid from glycosyl donor 1e and acceptor 2.2 in 93% (= 1/2.4, 50 
mM) and 84% yield ( = 1.1/1, 5 mM) under regular and high dilution reaction 
conditions, respectively. Selected analytical data for -isomer of 3e: Rf  = 0.44 (ethyl 
acetate/hexane, 1/1, v/v);  1H NMR: δ, 3.36 (s, 3H, OCH3), 4.22 (dd, 1H, J5,6b = 1.7 Hz, 
J6a,6b = 10.6 Hz, H-6b), 4.24 (dd, 1H, J5’,6b’ = 5.0 Hz, J6a’,6b’ = 10.5 Hz, H-6b’), 4.39 (d, 
1H, J1’,2’ = 7.7 Hz, H-1’) ppm; 13C NMR: δ, 98.2, 104.0 ppm; HR-FAB MS [M+Na]+ 
calcd for C61H65NO11Na  1010.4455, found 1010.4523. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2-O-benzyl-4,6-O-benzylidene-3-O-picolinyl--D-
glucopyranosyl)--D-glucopyranoside (2.3f).    The title compound was obtained as a 
white amorphous solid from glycosyl donor 2.1f and acceptor 2.2 in 76% (= 1/2.4, 50 
mM) and 77% yield ( = 1/2.1, 5 mM) under regular and high dilution reaction 
conditions, respectively. Selected analytical data for isomer of 2.3f: Rf = 0.64 (ethyl 
acetate/hexane, 1/1, v/v); 1H NMR: δ, 3.34 (s, 3H, OCH3), 3.35-3.41 (m, 1H, H-6’a), 
3.50-3.58 (m, 3H, H-2, 2’, 4), 3.67-3.74 (m, 2H, H-4’, 6a), 3.75-3.82 (m, 3H, H-3’, 5, 5’), 
4.00 (dd, 1H, J3,4 = 9.4 Hz, H-3), 4.13 (dd, 1H, J5,6b = 1.9 Hz, J6a,6b = 10.8 Hz, H-6b), 4.32 
(dd, 1H, J5’,6b’ = 5.0 Hz, J6a’,6b’ = 10.5 Hz, H-6b’), 4.47 (d, 1H, J1’,2’ = 8.2 Hz, H-1’), 
4.61(d, 1H, J1,2 = 3.6 Hz, H-1), 4.62 (dd, 2H, 2J = 11.2 Hz, CH2Ph), 4.63-4.72 (m, 2H, 
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CH2Ph), 4.77-4.84 (m, 2H, CH2Ph), 4.88-4.95 (m, 2H, CH2Ph), 5.00 (dd, 2H, 2J = 13.5 
Hz, CH2Ph), 5.53 (s, 1H, >CHPh), 7.05 (m, 28H, aromatic), 8.50 (m, 1H, aromatic) ppm; 
13C NMR: δ, 55.4, 62.7, 66.2, 68.9 (× 2), 69.9, 73.6, 75.1, 75.5, 75.8, 75.9, 78.0, 79.9, 
81.4, 81.9, 82.1, 98.3, 101.4, 104.2, 121.7, 122.4, 126.2 (× 2), 126.3, 127.7, 127.8 (× 2), 
128.1 (× 6), 128.3 (× 2), 128.4 (× 2), 128.5 (× 2), 128.6 (× 5), 128.7, 129.2, 136.7, 137.3, 
138.2, 138.3, 138.5, 138.9, 148.9, 159.0 ppm.  Selected analytical data for isomer of 
2.1f: Rf = 0.64 (ethyl acetate/hexane, 1/1, v/v); 1H NMR: δ, 3.35 (s, 3H, OCH3), 3.43 (dd, 
1H, J1,2 = 3.6 Hz, J2,3 = 9.6 Hz, H-3), 3.56-3.66 (m, 3H, H-2’, 4, 4’), 3.69-3.74 (m, 1H, H-
5’), 3.65- .74 (m, 2H, H-4’, 6a), 3.75- 3.83 (m, 1H, H-5), 3.91 (m, 1H, H-6a’), 3.97- 4.06 
(m, 2H, H-3, 3’), 4.22 (dd, 1H, J5’,6b’ = 4.9 Hz, J6a’,6b’ = 10.2 Hz, H-6b’), 4.44- 5.08 (m, 
12H, H-1, 1’, 5 x CH2Ph), 5.53 (s, 1H, >CHPh), 7.05 (m, 28H, aromatic), 8.50 (m, 1H, 
aromatic) ppm; 13C NMR: δ, 55.4, 62.5, 66.5, 69.3, 70.6,72.9, 75.2, 75.6, 75.9, 77.8, 79.0, 
79.4, 80.2, 82.1, 82.2, 82.3, 98.2 (× 2), 101.6 ppm; HR-FAB MS [M+H]+ calcd for 
C54H58NO11 896.4010, found 896.4050. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (2.3g).    The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1g and acceptor 2.2 in 85% (= 2.8/1, 50 mM) 
and 73% yield ( > 25/1, 5 mM) under regular and high dilution reaction conditions, 
respectively. Analytical data for 2.3g: Rf = 0.50 (ethyl acetate/hexane, 1/1, v/v);  [α]D23 
+42.3 (c = 1.0, CHCl3); 1H NMR: δ, 3.30 (s, 3H, OCH3), 3.38 (dd, 1H, J2,3 = 9.6 Hz, H-
2), 3.42-3.60 (m, 2H, H-6a’, 6b’), 3.55-3.67 (m, 2H, H-4, 2’), 3.69-3.82 (m, 3H, H- 5, 6a, 
6b), 3.93 (dd, 1H, J3,4 = 9.1 Hz, H-3), 4.03 (m, 1H, H- 5’), 4.07 (dd, 1H, J3’,4’ = 9.5 Hz, H-
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3’), 4.37 (dd, 2H, 2J = 10.5 Hz, CH2Ph), 4.50 (d, 1H, J1,2 = 3.8 Hz, H-1), 4.60 (s, 2H, 
CH2Ph), 4.62 (dd, 2H, 2J = 10.1 Hz, CH2Ph), 4.65 (dd, 2H, 2J = 11.4 Hz, CH2Ph), 4.74 
(dd, 2H, 2J = 11.1 Hz, CH2Ph), 4.83 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 5.00 (d, 1H, J1’,2’ = 
3.4 Hz, H-1’), 5.34 (dd, 1H, J4’,5’ = 9.7 Hz, H-4’), 6.85-7.70 (m, 31H, aromatic), 7.67 (dd, 
1H, J = 7.7 Hz, aromatic), 7.82 (d, 1H, J = 7.8 Hz, aromatic), 8.66 (d, 1H, J = 3.3 Hz, 
aromatic) ppm; 13C NMR: δ, 55.3, 66.1, 68.9, 70.7, 72.0, 72.7, 73.6, 73.7, 75.1, 75.2, 
75.9, 77.4, 77.9, 78.6, 79.9, 80.3, 82.3, 97.5, 98.1, 125.6, 127.0, 127.4, 127.5, 127.7, 
127.8 (× 3), 127.9 (× 2), 128.1 (× 4), 128.2 (× 7), 128.3 (× 2), 128.5 (× 3), 128.6 (× 6), 
137.0, 138.0, 138.3, 138.4, 138.5, 138.6, 139.0, 147.9, 150.0, 164.1 ppm; HR-FAB MS 
[M+Na]+ calcd for C61H63O12NNa  1024.4248, found 1024.4273. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (2.3h).    The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1h and acceptor 2.2 in 96% (> 1/25, 50 mM) 
and 92% yield ( > 1/25, 5 mM) under regular and high dilution reaction conditions, 
respectively. Analytical data for 2.3h: Rf = 0.57 (ethyl acetate/hexane, 3/2, v/v); [α]D23 
+32.5 (c = 1.0, CHCl3); 1H NMR: δ, 3.27 (s, 3H, OCH3), 3.46-3.57 (m, 3H, H-2, 2’, 6b), 
3.59-3.71 (m, 4H, H-3’, 4, 4’, 5’), 3.76 (m, 1H, H-5), 3.94 (dd, 1H, J3,4 = 9.3 Hz, H-3), 
4.11 (dd, 1H, J5,6b = 1.5 Hz, J6a,6b = 9.3, H-6b), 4.37 (d, 1H, J1’,2’ = 7.8 Hz, H-1’), 4.44 (d, 
1H, 2J = 11.2 Hz, ½ CH2Ph), 4.48-4.69 (m, 6H, H-1, 6a’, 6b’, 1½ CH2Ph), 4.70- 4.85 (m, 
4H, 2 × CH2Ph), 4.93 (dd, 4H, 2J  = 10.6 Hz, 2 × CH2Ph), 7.05-7.52 (m, 31H, aromatic), 
7.73 (dd, 1H, J = 7.7 Hz, aromatic), 7.99 (d, 1H, J = 7.7 Hz, aromatic), 8.72 (d, 1H, J = 
3.9 Hz, aromatic) ppm; 13C NMR: δ, 55.4, 64.5, 68.8, 69.9, 73.1, 73.6, 75.1, 75.2, 75.3, 
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75.9, 76.1, 77.4, 78.1, 79.9, 82.1, 82.2, 85.0, 98.2, 104.0, 125.4, 127.1, 127.8 (× 5), 128.0 
(× 3), 128.1 (× 2), 128.2 (× 4), 128.3 (× 2), 128.4 (× 2), 128.5 (× 2), 128.6 (× 4), 128.7 (× 
6), 137.0, 137.9, 138.3, 138.4, 138.5 (× 2), 139.0, 147.9, 150.2, 164.8 ppm; HR-FAB MS 
[M+Na]+ calcd for C61H63O12NNa  1024.4248, found 1024.4246. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-(pyrid-3-ylmethyl)--D-
glucopyranosyl)--D-glucopyranoside (2.3i).    The title compound was obtained as a 
white amorphous solid from glycosyl donor 2.1i and acceptor 2.2 by in 87% (= 1.1/1, 
50 mM) and 82% yield ( = 1.5/1, 5 mM) under regular and high dilution reaction 
conditions, respectively. Selected analytical data for 2.3i: Rf = 0.45 (acetone/toluene, 
3/17, v/v).  Selected 1H NMR data for β-isomer of 2.3i: δ, 3.34 (s, 3H, OCH3), 3.41 (m, 
1H, H-5’), 3.48- 3.58 (m, 3H, H-2, 2’, 4), 3.59-3.88 (m, 6H, H-3’, 4’, 5, 6a, 6’a, 6’b), 
3.97-4.40 (m, 1H, H-3), 4.19 (dd, 1H, J6a, 6b = 11.2 Hz, H-6b), 4.36 (d, 1H, J1’,2’ = 7.6 Hz, 
H-1’), 4.39 (d, 1H, 2J = 11.2 Hz, ½ CH2Ph), 4.90-5.40 (m, 14H, H-1, 6½ x CH2Ph), 7.10-
7.50 (m, 32H, aromatic), 8.28-8.56 (m, 2H, aromatic) ppm.  Selected 1H NMR data for α-
isomer of 2.3i: δ, 3.37 (s, 3H, OCH3), 3.45 (dd, 1H, J2,3 = 10.0 Hz, H-2), 3.48-3.58 (m, 
2H, H-2’, 5’), 3.59-3.88 (m, 7H, H- 4, 4’, 5, 6a, 6b, 6’a, 6’b), 3.94 (dd, 1H, J3’,4’ = 9.0 Hz, 
H-3’), 3.97-4.40 (m, 1H, H-3), 4.40 (d, 1H, 2J = 12.3 Hz, ½ CH2Ph), 4.90-5.40 (m, 15H, 
H-1, 1’, 6½ x CH2Ph), 7.10-7.50 (m, 32H, aromatic), 8.28-8.56 (m, 2H, aromatic) ppm.  
Selected 13C NMR data for the sugar region of α/β-2.3i: δ, 55.3, 55.4, 66.3, 68.3, 68.8, 
68.9, 70.0, 70.2, 70.5, 72.4 (× 2), 72.5, 73.6 (× 2), 73.7 (× 2), 75.0, 75.1 (× 3), 75.7, 75.9 
(× 2), 76.0, 77.4, 77.9, 78.1, 78.2, 79.9, 80.2, 80.3, 81.7, 82.2, 82.3 (× 2), 84.9, 97.4, 98.2 
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(× 2), 104.0 ppm. HR-FAB MS [M+Na]+ calcd for C61H65NO11Na  1010.4455, found 
1010.4521. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-(pyrid-3-ylmethyl)--D-
glucopyranosyl)--D-glucopyranoside (2.3j).    The title compound was obtained as a 
white amorphous solid from glycosyl donor 2.1j and acceptor 2.2 in 82% (= 1/1.6, 50 
mM) and 74% yield ( = 1.3/1, 5 mM) under regular and high dilution reaction 
conditions, respectively. Selected analytical data of 2.3j: Rf = 0.49 (acetone/toluene, 3/17, 
v/v).  Selected 1H NMR data for β-isomer of 2.3j: δ, 3.34 (s, 3H, OCH3), 3.43 (m, 1H, H-
5’), 3.45- 3.60 (m, 7H, H-2, 2’, 4, 5, 6b, 6’a, 6’b), 3.84-3.89 (m, 1H, H-3), 4.01 (m, 1H, 
H-3), 4.19 (dd, 1H, J6a, 6b = 10.9 Hz, H-6b), 4.35- 4.41 (m, 2H, H-1’, ½ CH2Ph), 4.48-
5.40 (m, 14H, H-1, 6½ x CH2Ph), 6.90-7.55 (m, 32H, aromatic), 8.45-8.55 (m, 2H, 
aromatic) ppm.  Selected 1H NMR data for α-isomer of 2.3j: δ, 3.38 (s, 3H, OCH3), 3.45-
3.60 (m, 6H, H-2, 2’, 4, 4’, 6a’, 6b’), 3.84-3.89 (m, 1H, H-5’), 3.95 (dd, 1H, J3’,4’ = 9.1 
Hz, H-3’), 4.01 (m, 1H, H-3), 4.36-4.41 (m, 1H, ½ CH2Ph), 4.48-5.40 (m, 15H, H-1, 1’, 
6½ x CH2Ph), 6.90-7.55 (m, 32H, aromatic), 8.45-8.55 (m, 2H, aromatic) ppm.  Selected 
13C NMR data for the sugar region of α/β-2.3j: δ, 55.3, 55.4, 66.4, 68.3, 68.8, 68.9, 70.0, 
70.2, 70.5, 72.5, 73.0, 73.1, 73.6 (× 3), 73.7, 75.0 (× 3), 75.1, 75.7, 75.9 (× 2), 76.0, 77.4, 
77.9, 78.2, 78.3, 79.9, 80.1, 80.3, 81.6, 82.1, 82.2, 82.3, 84.8, 97.4, 98.2 (× 2), 104.0 
ppm.  HR-FAB MS [M+Na]+ calcd for C61H65NO11Na  1010.4455, found 1010.4732. 
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Methyl 2,3,4-Tri-O-benzyl-6-O-(4-O-benzoyl-2,3,6-tri-O-benzyl-α/β-D-
glucopyranosyl)--D-glucopyranoside (2.3k).    The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1k and acceptor 2.2 in 97% (= 1/2.5, 50 mM) 
and 93% yield ( > 1/2.6, 5 mM) under regular and high dilution reaction conditions, 
respectively. Analytical data for the title compound was in accordance with that reported 
previously.48 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α/-D-galactopyranosyl)--D-
glucopyranoside (2.3l).   The title compound was obtained as a white amorphous solid 
from glycosyl donor 2.1l and acceptor 2.2 in 87% yield (= 1/1.0, 50 mM). Analytical 
data for 2.3l was in accordance with that reported previously.36,53  
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-picolinyl--D-
galactopyranosyl)--D-glucopyranoside (2.3m).  The title compound was obtained as a 
white amorphous solid from glycosyl donor 2.1m and acceptor 2.2 in 89% (= 1/10, 
50 mM) and 83% yield ( > 1/25, 5 mM) under regular and high dilution reaction 
conditions, respectively. Analytical data for 2.3m: Rf = 0.54 (ethyl acetate/hexane, 1/1, 
v/v);  [α]D23 +19.9 (c = 1.0, CHCl3); 1H NMR: δ, 3.23 (s, 3H, OCH3), 3.35-3.64 (m, 7H, 
H-2, 3’, 4, 5, 5’, 6a, 6a’), 3.71-3.81 (m, 2H, H-2’, 3), 3.85-3.96 (m, 2H, H-4’, 6b’), 4.07 
(dd, 1H, J5,6b = 1.6 Hz, J6a,6b = 10.8 Hz, H-6b), 4.22 (d, 1H, J1’,2’ = 7.7 Hz, H-1’), 4.37 (s, 
2H, CH2Ph), 4.51 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.53 (dd, 2H, 2J = 11.2 Hz, CH2Ph), 4.63 
(dd, 2H, 2J = 12.2 Hz, CH2Ph), 4.70 (d, 2J = 10.2 Hz, CH2Ph), 4.77 (dd, 2H, 2J = 10.6 Hz, 
CH2Ph), 4.79 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.83 (dd, 2H, 2J = 13.3 Hz, CH2Ph), 7.00-
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7.55 (m, 33H, aromatic), 8.40 (d, 1H, J = 4.7 Hz, aromatic) ppm; 13C NMR: δ, 55.3, 68.5, 
68.8, 70.1, 72.9, 73.4, 73.5, 73.7, 75.0, 75.1, 75.3, 75.8, 76.0, 78.2, 79.3, 80.0, 82.0, 82.2, 
98.1, 104.5, 121.8, 122.2, 127.5, 127.7 (× 3), 127.8 (× 4), 127.9, 128.0 (× 3), 128.1 (× 2), 
128.2 (× 2), 128.3 (× 2), 128.4 (× 2), 128.5 (× 8), 128.6 (× 4), 136.6, 137.9, 138.3, 138.4, 
138.5, 138.8, 139.0, 148.6, 159.2  ppm; HR-FAB MS [M+Na]+ calcd for C61H65NO11Na  
1010.4455, found 1010.4503. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
galactopyranosyl)--D-glucopyranoside (2.3n).   The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1n and acceptor 2.2 in 96% (= 1/24, 50 mM) 
and 95% yield ( > 1/25, 5 mM) under regular and high dilution reaction conditions, 
respectively. Analytical data for 2.3n: Rf = 0.43 (ethyl acetate/hexane, 1/1, v/v); [α]D23 
+36.9 (c = 1.0, CHCl3); 1H NMR: δ, 3.25 (s, 3H, OCH3), 3.41-3.72 (m, 8H, H-2, 2’, 3’, 4, 
5’, 6a, 6a’, 6b’), 3.75 (m, 1H, H-5), 3.91 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.09 (dd, 1H, J6a,6b 
= 11.0 Hz, J5,6b = 1.8 Hz, H-6b), 4.26 (d, 1H, J1’,2’ = 7.5 Hz, H-1’), 4.37 (dd, 2H, 2J = 11.8 
Hz, CH2Ph), 4.52 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 4.54 (d, 1H, J1,2 = 3.7 Hz, H-1), 4.64 
(dd, 2H, 2J = 12.3 Hz, CH2Ph), 4.65 (dd, 2H, 2J = 11.5 Hz, CH2Ph), 4.73 (dd, 2H, 2J = 
10.8 Hz, CH2Ph), 4.79 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 5.79 (dd, 1H, J4’,5’ = 2.7 Hz, H-4’), 
7.05-7.45 (m, 33H, aromatic), 7.69 (dd, 1H, J = 7.7 Hz, aromatic), 7.95 (d, 1H, J = 7.8 
Hz, aromatic), 8.70 (d, 1H, J = 3.4 Hz, aromatic) ppm; 13C NMR: δ, 55.4, 68.2, 68.4, 
69.0, 70.1, 72.3, 72.5, 73.6, 73.9, 75.0, 75.5, 75.8, 78.0, 78.9, 79.6, 80.0, 82.2, 98.3, 
104.5, 125.7, 127.1, 127.6, 127.7 (× 2), 127.8 (× 3), 127.9, 128.1 (× 5), 128.2 (× 2), 128.3 
(× 2), 128.4 (× 4), 128.5 (× 7), 128.6 (× 2), 137.0, 137.7, 137.8, 138.3, 138.5, 138.6, 
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139.0, 147.8, 150.4, 164.2 ppm; HR-FAB MS [M+Na]+ calcd for C61H63O12NNa  
1024.4248, found 1024.4271. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-picoloyl--D-
mannopyranosyl)--D-glucopyranoside (2.3o).  The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1o and acceptor 2.2 in 89% (> 1/3.5, 50 mM) 
and 86% yield ( > 1/4.5, 5 mM) under regular and high dilution reaction conditions, 
respectively. Alternatively, the title compound was prepared as follows. A mixture of 
glycosyl donor 2.1o (0.13 mmol), glycosyl acceptor 2.2 (0.10 mmol), and freshly 
activated molecular sieves (4 Å, 200 mg) in (ClCH2)2  (2.6 mL, 50 mM or 26 mL, 5 mM) 
was stirred under an argon for 1 h. The mixture was cooled to -30 °C, NIS (0.26 mmol) 
and TfOH (0.026 mmol) were added, and the reaction mixture was allowed to warm to rt 
and stirred until the completion (see tables). The resulting mixture was diluted with 
CH2Cl2 (~10 mL), the solid was filtered off and the residue was washed with CH2Cl2. The 
combined filtrate (~30 mL) was washed with 10% aq. Na2S2O3 (10 mL) and water (3 x 10 
mL). The organic phase was separated, dried with MgSO4 and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate - hexane 
gradient elution) to afford the title compound in 91% (= 1/5.3, 50 mM) and 87% 
yield ( = 1/9.5, 5 mM).  Analytical data for isomer of 2.3o: Rf = 0.46 (ethyl 
acetate/hexane, 3/2, v/v); 1H NMR: δ, 3.20 (s, 3H, OCH3), 3.31 (dd, 1H, J4,5 = 9.7 Hz, H-
4), 3.36- 3.47 (m, 3H, H-2, 3’, 6a), 3.53 (m, 1H, H-5’), 3.65-3.77 (m, 2H, H- 5, 2’), 3.84-
3.96 (m, 2H, H-3, 4’), 4.06 (dd, 1H, J5,6b = 1.7 Hz, J6a,6b = 10.5 Hz, H-6b), 4.13 (s, 1H, H-
1’), 4.45-4.58 (m, 3H, H-1, 6a’, 6b’), 4.51 (dd, 2H, 2J  = 4.4 Hz, CH2Ph), 4.56 (dd, 2H, 2J 
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= 11.3 Hz, CH2Ph), 5.63 (dd, 2H, 2J = 12.3 Hz, CH2Ph), 5.71 (dd, 2H, 2J = 10.8 Hz, 
CH2Ph), 5.77 (dd, 2H, 2J = 12.3 Hz, CH2Ph), 5.82 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 7.05-
7.43 (m, 31H, aromatic), 7.49 (dd, 1H, J = 7.8 Hz, aromatic), 7.90 (d, 1H, J = 7.8 Hz, 
aromatic), 8.64 (d, 1H, J = 3.9 Hz, aromatic) ppm; 13C NMR: δ, 55.2, 65.2, 68.6, 69.9, 
71.8, 73.5, 73.7, 73.9, 74.0, 74.8, 75.0, 75.4, 76.0, 77.9, 80.0, 82.2, 82.3, 98.0, 101.8 
(1JC1,H1 = 165.2 Hz, 1JC1’,H1’ = 154.6 Hz), 125.6, 126.9, 127.6, 127.7, 127.8 (× 3), 127.9 (× 
2), 128.0, 128.2 (× 3), 128.2 (× 2), 128.4 (× 5), 128.5 (× 2), 128.6 (× 8), 128.7 (× 2), 
137.1, 138.1, 138.2 (× 2), 138.4, 138.9, 139.0, 150.1, 164.8 ppm; HR-FAB MS [M+Na]+ 
calcd for C61H63O12NNa  1024.4248, found 1024.4293 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-α/β-L-rhamnopyranosyl)-α-D-
glucopyranoside (2.3p).   The title compound was obtained as a colorless syrup from 
glycosyl donor 2.1p and acceptor 2.2 in 85% yield ( 1.1/1, 50 mM).  Analytical data 
for 2.3p: Rf = 0.59 (ethyl acetate/hexane, 2/3, v/v).  Selected 1H NMR data for β-isomer 
of 2.3p: δ, 1.36 (d, 1H, J5’,6’ = 5.9 Hz, C-6’), 3.27 (s, 3H, OCH3), 3.30-3.36 (m, 1H, H-
5’), 3.42-3.52 (m, 2H, H-2, 3’), 3.57-3.73 (m, 3H, H-4, 4’, 6a), 3.75 (m, 1H, H-5), 3.93- 
4.20 (m, 2H, H-2’, 3), 4.29 (dd, 1H, J5,6b = 3.5 Hz, J6a,6b = 11.2 Hz, H-6b), 4.44 (s, 1H, H-
1’), 4.36- 5.02 (m, 13H, H-1, 6 x CH2Ph), 7.15-7.50 (m, 30H, aromatic) ppm; Selected 1H 
NMR data for α-isomer of 2.3p: δ, 1.31 (d, 3H, J5’,6’ = 5.9 Hz, C-6’), 3.20-3.85 (m, 4H, 
H-4, OCH3), 3.42-3.52 (m, 2H, H-2, 3’), 3.57-3.73 (m, 3H, H-5, 5’, 6a), 3.81-3.86 (m, 
2H, H-4’, 6b), 3.93-4.20 (m, 1H, H-3), 4.36-5.02 (m, 14H, H-1, 1’, 6 x CH2Ph), 7.15-7.50 
(m, 30H, aromatic).  Selected 13C NMR data for the sugar region of α/β-2.3p: δ,18.1, 
18.2, 55.2, 55.4, 66.2, 67.4, 68.2, 70.0, 70.2, 71.5, 72.2, 72.5, 72.9, 73.5, 73.7, 74.2, 74.4, 
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75.1, 75.2, 75.4, 75.6, 75.7, 75.9, 76.0, 77.4, 78.0 (× 2), 79.9, 80.0, 80.1, 80.4, 80.8, 82.1 
(× 2), 97.9, 98.4, 98.5, 101.6 ppm. HR-FAB MS [M+Na]+ calcd for C55H60NaO10 
903.4084, found 903.4221. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,4-di-O-benzyl-3-O-picoloyl-β-L-
rhamnopyranosyl)-α-D-glucopyranoside (2.3q).  The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1q and acceptor 2.2 in 94% yield (> 1/25, 50 
mM).  Analytical data for 2.3q: Rf = 0.47 (acetone/toluene, 3/17, v/v); [α]D22 +79.9 (c = 
1.0, CHCl3); 1H NMR: δ, 1.33 (d, 3H, J5,6 = 6.0 Hz, C-6), 3.30 (s, 3H, OCH3), 3.36-3.50 
(m, 2H, H-2, 5’), 3.56 (dd, 1H, m, 1H, J4,5 = 9.3 Hz, H-4), 3.62-3.73 (m, 2H, H-5, 6a), 
3.77 (dd, 1H, J4’,5’ = 9.4 Hz, H-4’), 3.92 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.11 (d, 1H, J2’,3’ = 
3.2 Hz, H-2’), 4.20 (dd, 1H, J5,6b = 3.3 Hz, J6a,6b = 11.3 Hz, H-6b), 4.53-4.79 (m, 9H, H-1, 
1’, 3½ CH2Ph), 4.85 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.85 (dd, 1H, 2J = 12.2 Hz, ½ 
CH2Ph), 6.78-7.45 (m, 26H, aromatic), 7.70 (dd, 1H, J = 7.7 Hz, aromatic), 7.85 (d, 1H, J 
= 7.8 Hz, aromatic), 8.46 (d, 1H, J = 4.1 Hz, aromatic) ppm; 13C NMR: δ, 18.1, 55.4, 
67.6, 70.2, 72.0, 73.6, 74.9, 75.4 (× 2), 75.6, 75.9, 77.3, 78.0, 78.7, 80.2, 82.0, 98.3, 101.2 
(1JC1,H1 = 167.5 Hz, 1JC1’,H1’ = 155.1 Hz), 125.4, 127.1, 127.6, 127.7, 127.8, 127.9, 128.0 
(× 2), 128.1 (× 2), 128.2 (× 2), 128.3 (× 2), 128.3 (× 3), 128.4 (× 3), 128.5 (× 5), 128.6 (× 
2), 137.0, 138.2, 138.3, 138.4, 138.5, 139.0, 147.8, 150.2, 164.2 ppm; HR-FAB MS 
[M+Na]+ calcd for C54H57NaO11 918.3829, found 918.3774.  
 
Methyl 3,4,6-Tri-O-benzyl-2-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (2.5).    The title compound was obtained as a 
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colorless syrup from glycosyl donor 2.1g and acceptor 2.4 in 93% yield ( > 25/1, 50 
mM).  Analytical data for 2.5: Rf = 0.40 (ethyl acetate/hexane, 1/1, v/v);  [α]D23 +79.4 (c 
= 1.0, CHCl3); 1H NMR: δ, 3.30 (dd, 1H, J5’,6b’ = 3.8 Hz, J6a’,6b’ = 11.0 Hz, H-6b’), 3.41 
(m, 1H, H-6a’), 3.45 (s, 3H, OCH3), 3.57-3.83 (m, 5H, H-2, 4, 5, 6a, 6b), 3.87 (dd, 1H, 
J2’,3’ = 9.8 Hz, H-2’), 4.08 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.15 (dd, 1H, J3’,4’ = 9.2 Hz, H-3’), 
4.25 (m, 1H, H-5’), 4.37 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.56 (dd, 2H, 2J = 12.1 Hz, 
CH2Ph), 4.60 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.73 (dd, 2H, 2J = 11.8 Hz, CH2Ph), 4.74 
(dd, 2H, 2J = 13.5 Hz, CH2Ph), 4.91 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 4.94 (d,1H, J1’,2’ = 3.4 
Hz, H-1’), 4.95 (d, 1H, J1,2 = 3.6 Hz, H-1), 5.46 (dd, 1H, J4’,5’ = 9.8 Hz, H-4’), 6.65-7.70 
(m, 33H, aromatic), 8.70 (d, 1H, J = 4.6 Hz, aromatic) ppm; 13C NMR: δ, 55.1, 68.3, 
68.7, 68.9, 70.4, 71.5, 73.2, 73.6, 73.7, 75.2, 75.3, 75.5, 75.8, 78.2, 79.1, 79.3, 81.0, 94.8, 
96.7, 126.8, 127.5 (× 2), 127.7 (× 2), 127.9 (× 2), 128.0 (× 2), 128.1 (× 4), 128.2 (× 2), 
128.3 (× 5), 128.5 (× 4), 128.6 (× 4), 137.0, 137.9 (× 2), 138.1, 138.3 (× 2), 138.4 (× 2), 
138.9, 147.8, 150.1, 163.7 ppm; HR-FAB MS [M+Na]+ calcd for C61H63O12NNa  
1024.4248, found 1024.4248. 
 
Methyl 2,4,6-Tri-O-benzyl-3-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (2.7).    The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1g and acceptor 2.6 in 87% (= 10/1, 50 mM) 
and 81% yield ( > 25/1, 5 mM) under regular and high dilution reaction conditions, 
respectively. Analytical data for 2.7 Rf = 0.44 (ethyl acetate/hexane, 1/1, v/v);  [α]D23 
+53.9 (c = 1.0, CHCl3); 1H NMR: δ, 3.36 (s, 3H, OCH3), 3.41 (dd, 1H, J6a’,6b’ = 10.9 Hz, 
H-6b’), 3.58 (dd, 1H, J5’,6a’ = 2.5 Hz, H-6a’), 3.63-3.93 (m, 6H, H-2, 2’, 4, 5, 6a, 6b), 4.31 
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(dd, 1H, J3’,4’ = 9.4 Hz, H-3’), 4.33 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.49 (dd, 2H, 2J = 11.9 
Hz, CH2Ph), 4.59 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.64 (m, 2H, H-1, 5’), 4.69 (dd, 2H, 2J = 
11.8 Hz, CH2Ph), 4.73 (dd, 2H, 2J = 11.7 Hz, CH2Ph), 4.76 (dd, 2H, 2J = 11.3 Hz, 
CH2Ph), 4.78 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 5.56 (dd, 1H, J4’,5’ = 10.1 Hz, H-4’), 5.69 
(d,1H, J1’,2’ = 3.5 Hz, H-1’), 7.05-7.60 (m, 31H, aromatic), 7.80 (dd, 1H, J = 7.7 Hz, 
aromatic), 7.90 (d, 1H, J = 7.8 Hz, aromatic), 8.79 (d, 1H, J = 3.2 Hz, aromatic) ppm; 13C 
NMR: δ, 55.3, 68.7, 68.8, 69.0, 69.0, 69.6, 72.3, 73.3, 73.7, 73.8, 74.1, 75.4, 77.5, 78.1, 
78.5, 79.1, 79.5, 79.9, 97.7 (× 2), 125.5, 127.0, 127.3 (× 2), 127.5 (× 2), 127.8, 128.0, 
128.1 (× 5), 128.2 (× 3), 128.3 (× 6), 128.4 (× 2), 128.5 (× 4), 128.6 (× 4), 128.9 (× 2), 
137.0, 138.1 (× 2), 138.2, 138.4, 138.5 (× 2), 148.2, 150.1, 164.2 ppm; HR-FAB MS 
[M+Na]+ calcd for C61H63O12NNa 1024.4248, found 1024.4239. 
 
Methyl 2,3,6-Tri-O-benzyl-4-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (2.9).    The title compound was obtained as a 
colorless syrup from glycosyl donor 2.1g and acceptor 2.8 in 94% (= 12/1, 50 mM) 
and 81% yield ( = 21/1, 5 mM) under regular and high dilution reaction conditions, 
respectively. Analytical data for -isomer of 2.9: Rf = 0.47 (ethyl acetate/hexane, 1/1, 
v/v); 1H NMR: δ, 3.36-3.54 (m, 5H, H-6a’, 6b’, OCH3), 3.58- 3.67 (m, 2H, H-2, 2’), 3.72 
(dd, 1H, J5,6b = 3.8 Hz, J6a,6b = 10.7 Hz, H-6b), 3.87 (m, 1H, H-5), 4.00 (dd, 1H, J5,6a = 1.6 
Hz, J6a,6b = 10.7 Hz, H-6a), 4.08 (dd, 1H, J4,5 = 8.3 Hz, H-4), 4.12-4.24 (m, 3H, H-3, 3’, 
5’), 4.39 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.48-4.71 (m, 7H, H-1, 3 × CH2Ph), 4.76 (d, 1H, 
2J = 12.2 Hz, ½ CH2Ph), 4.81 (d, 1H, 2J = 11.3 Hz, ½ CH2Ph), 4.99 (dd, 2H, 2J = 11.5 Hz, 
CH2Ph), 5.43 (dd, 1H, J4’,5’ = 9.7 Hz, H-4’), 5.57 (d, 1H, J1’,2’ = 3.6 Hz, H-1’), 7.05-7.60 
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(m, 31H, aromatic), 7.80 (dd, 1H, J = 7.8 Hz, aromatic), 7.98 (d, 1H, J = 7.9 Hz, 
aromatic), 8.77 (d, 1H, J = 4.0 Hz, aromatic) ppm; 13C NMR: δ, 55.4, 69.0, 69.4, 69.6, 
69.9, 72.3, 73.4 (× 2), 73.6, 73.7, 74.9, 75.3, 75.4, 79.2, 79.4, 80.1, 81.8, 97.7, 98.0, 
125.6, 127.3, 127.5, 127.6, 127.7, 127.8, 127.9 (× 4), 128.0 (× 2), 128.1, 128.3 (× 4), 
128.4 (× 8), 128.5 (× 2), 128.6 (× 2), 137.0, 138.0, 138.1, 138.3, 138.4 (× 2), 139.3, 
148.0, 150.0, 164.2 ppm; HR-FAB MS [M+Na]+ calcd for C61H63O12NNa  1024.4248, 
found 1024.4242. 
 
Methyl 3,4,6-Tri-O-benzyl-2-O-(2,4-di-O-benzyl-3-O-picoloyl-β-L-
rhamnopyranosyl)-α-D-glucopyranoside (2.10).   The title compound was obtained as 
colorless syrup from glycosyl donor 2.1q and acceptor 2.4 in 90% yield ( 1:25, 50 
mM). Analytical data for 2.10: Rf = 0.49 (acetone/toluene, 3/17, v/v); [α]D22 +65.4 (c = 
1.0, CHCl3);  1H NMR: δ, 1.45 (d, 1H, J5’,6’  = 6.1 Hz, C-6’), 3.42-3.55 (m, 4H, H-5’, 
OCH3), 3.68-3.87 (m, 4H, H-4, 5, 6a, 6b), 3.56 (dd, 1H, J4,5 = 9.3 Hz, H-4), 3.62-3.73 (m, 
2H, H-5, 6b), 3.77 (dd, 1H, J4’,5’ = 9.4 Hz, H-4’), 3.91(dd, 1H, J4’,5’ = 9.5 Hz, H-4’), 3.95-
4.18 (m, 2H, H-2, 3), 4.20 (d, 1H, J2’,3’ = 3.2 Hz, H-2’), 4.61 (dd, 2H, 2J = 12.2 Hz, 
CH2Ph), 4.70 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.76 (dd, 1H, 2J = 12.8 Hz, ½ CH2Ph), 4.78 
(s, 1H, H-1’), 4.79 (dd, 2H, 2J = 10.8 Hz, CH2Ph), 4.79 (dd, 2H, 2J = 10.8 Hz, CH2Ph), 
4.85 (dd, 2H, 2J = 12.8 Hz, CH2Ph), 4.92 (d, 1H, J1,2 = 3.4 Hz, H-1), 5.12-5.25 (m, 2H, 
H-3’, CH2Ph), 6.90-7.65 (m, 26H, aromatic), 7.82 (dd, 1H, J = 7.5 Hz, aromatic), 7.97 (d, 
1H, J = 7.8 Hz, aromatic), 8.84 (d, 1H, J = 4.5 Hz, aromatic) ppm; 13C NMR: δ, 18.2, 
55.3, 68.7, 70.2, 72.2, 73.7, 74.7, 75.2, 75.3, 75.5, 75.7, 77.3 (× 2), 78.2, 78.8, 81.1, 97.6, 
99.1 (1JC1,H1 = 166.9 Hz, 1JC1’,H1’ = 152.6 Hz), 125.4, 127.1, 127. 5 (× 2), 127.8, 127.9 (× 
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2), 128.0 (× 2), 128.1 (× 5), 128.3 (× 2), 128.5 (× 9), 128.6 (× 2), 137.0, 138.2 (× 2), 
138.4, 138.6, 139.2, 147.8, 150.2, 164.3 ppm; HR-FAB MS [M+Na]+ calcd for 
C54H57NaO11 918.3829, found 918.3891. 
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3.1.  Introduction 
Glycosylation reactions are challenging for chemists because of the necessity to 
obtain high stereoselectivity of substitutions at the anomeric carbon, and only pure 
anomers are needed for biological studies or pharmaceutical development.1 A failure to 
control stereoselectivity of glycosylations leads to mixtures of 1,2-cis and 1,2-trans 
diastereomers, which are hard to separate at the glycoside or disaccharide stage, and are 
practically impossible at the oligosaccharide stage. Resultantly, stereocontrolled 
glycosylation has emerged as an important area of modern glycosciences that inspires 
many scientists and has led to many breakthroughs.2-26 The aim of stereocontrolling of 
glycosylations has been approached in a variety of ways, and the effect of a neighboring 
participating group, particularly that of an acyl substituent, has been among the most 
powerful stereodirecting factors known to date.27-29 For instance, if such an acyl 
participating group is used at the neighboring C-2 position, good or even complete 1,2-
trans selectivity can often be achieved.30 Boons and co-workers developed a chiral 
auxiliary group that is capable of participating from the opposite face of the ring leading 
to 1,2-cis-linked products with high stereoselectivity.31,32  
Previously, our group introduced 2-O-picolinyl (2-pyridylmethyl, Pic) 
participating group that can be used to obtain 1,2-trans glycosides. We demonstrated that 
these reactions proceed via the six membered ring intermediate that in all case provided 
complete 1,2-trans or anti-selectivity in respect to the 2-O-picolinyl group.33,34 Our 
further attempt to broaden the scope of this method led to investigation of the picolinyl 
group at remote positions, C-3, C-4, and C-6. Rather unexpectedly, we obtained very 
high syn-stereoselectivities in respect to the picolinyl substituent, which was an 
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indication of a different mode of action by which remote picolinyl substituents influence 
stereoselectivity of glycosylation. To explain the stereoselectivity observed, we acquired 
experimental evidence consistent with a new concept that we call H-bond-mediated 
Aglycone Delivery (HAD).35 The nucleophile, hydroxyl of the glycosyl acceptor, forms 
the hydrogen bond with the picolinyl nitrogen of the glycosyl donors and then gets 
delivered to form the glycosidic linkage from the same face 36 with respect to that of the 
picolinyl group (Scheme 3.1). This typically results in more rapid rates of glycosylations 
in comparison to that of the corresponding benzylated glycosyl donors. This difference 
was particularly evident for experiments performed at low concentrations (5 mM of 
glycosyl acceptor).35  
Scheme 3.1.  H-bond-mediated Aglycone Delivery (HAD) via the remote 
picolinyl/picoloyl substituents 
 
 
3.2.  Results and Discussion 
Using O-picolinyl and structurally similar 4-O-picoloyl (2-pyridinecarbonyl, 
Pico) substituents, we already obtained a range of different linkages ranging from 
relatively accessible 1,2-trans glycosides to much more challenging 1,2-cis glycosides of 
the D-gluco,35 D-manno, and L-rhamno series.35 Yang and co-workers applied the same 
principle to 2-quinolinecarbonyl-assisted synthesis of β-arabinofuranosides.37 As an 
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extension of the earlier study, we decided to investigate whether HAD can be suitable for 
connecting multiple 1,2-cis linked residues. Among other challenging targets, α-
glucosides are arguably most abundant, yet the synthesis of oligosaccharides with 
multiple α-glucose residues may become a major endeavor for chemists.  
We first approached the synthesis of a linear pentasaccharide connected via α-
(14)-linkages postulating that 4-O-picoloyl could be used both as the stereodirecting 
group and as the temporary substituent. Picoloyl can be selectively removed with 
copper(II) acetate,38 reaction conditions under which many protecting groups used in 
carbohydrate chemistry are stable.39-44  
The synthesis depicted in Scheme 3.2 began with the glycosylation of acceptor 
3.245 with 4-O-picoloylated ethyl thioglycoside donor 3.1. This reaction was performed in 
the presence of DMTST (2 equiv.) and -30 °C  rt, conditions that became standard for 
the HAD approach. Resultantly, disaccharide 3.3a was obtained in 83% yield and a high 
stereoselectivity of α/β = 21/1. The diastereomers were separated using column 
chromatorgraphy, and the anomerically pure 3.3a was treated with Cu(OAc)2 to give 4‘-
OH acceptor 3.3b. The latter was glycosylated with donor 3.1 under standard HAD 
glycosylation conditions to afford trisaccharide 3.4a in 72% yield and complete α-
stereoselectivity, conservatively reported as α/β > 25/1 in Scheme 3.2. Depicoloylation of 
trisaccharide 3.4a gave glycosyl acceptor 3.4b, which was coupled with glycosyl donor 
3.1 to afford tetrasaccharide 3.5a in 56% yield and complete α-selectivity. Subsequent 
depicoloylation gave acceptor 3.5b and coupling with donor 3.1 produced 
pentasaccharide 3.6 in 41% yield with complete α-selectivity. 
  
Yasomanee, Jagodige P. | UMSL 2014 | Page 117  
 
 
Scheme 3.2.  Pentasaccharide synthesis via sequential picoloyl-mediated 
glycosylation-deprotection 
 
 
Evidently, over the course of this synthesis, the deprotection efficiency remains 
high (yields 91-93%), whereas glycosylation yields drop steadily. We explain this by the 
increased bulk of the acceptor and the inability of the glycosyl donor to maintain strong 
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H-bonding essential for rapid reactions and high stereoselectivity. Our attempt to “push“ 
the reaction by adding more DMTST resulted in higher yields, but the stereoselectivity 
dropped. This is because excess DMTST “blocks“ the picoloyl nitrogen and makes it 
unavailable to perform HAD. Nevertheless, the stereoselectivities remained complete, 
and the synthesis wherein the same substituent can be used both for controlling the 
stereoselectivity and as the selectively removable protecting group offers a useful 
strategy for streamlining the synthesis of 14-linked α-glucans.  
Subsequently, we turned our attention to investigating whether this methodology 
would offer a viable access to branched oligosaccharides, common in many mamalian 
and baterial systems. In particular, we became interested in synthesizing the trisaccharide 
repeating unit of Lactobacillus spp. G-77 consisting of primary (16) and secondary 
(12) α-gluco linkages.46-48 Concomitant α-glucosylation of 2,6-diol acceptor 3.749 with 
excess of glycosyl donor 3.1 (2.6 equiv.) under standard HAD conditions afforded 
branched trisaccharide 3.8 in 83% yield and a nearly complete stereoselectivity (Scheme 
3.3). 
Scheme 3.3.  Synthesis of trisaccharide 3.8 representing the repeating unit by 
Lactobacillus spp. G-77 
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Another target that has drawn our attention is a 4,6-branched glycogen-like fungal 
cell wall α-glucan motif from Pseudallescheria boydii, which showed potential activity 
towards fungal phagocytosis and activation of innate immune responses.50,51 This stucture 
inspired other synthetic work in the area, and chiral auxiliary-assisted synthesis by Boons 
and co-workers has emerged.31,32,52,53 For our synthesis of the 4,6-branching motif we 
adapted trisaccharide 3.4a obtained en route to pentasaccharide 3.6. Compound 3.4a was 
treated with 2M NaOMe in MeOH to affect concomitant removal of 6-O-benzoyl and 4“-
O-picoloyl protecting groups (Scheme 3.4). The resulting 4“,6-diol acceptor 3.4c was 
glycosylated with glycosyl donor 3.1 (1.3 equiv.) under standard HAD conditions to 
obtain the target branched tetrasaccharide 3.9a in 87% yield. The coupling was entirely 
regioselective at the primary position and no side products resulting from glycosylation 
of 4“-hydroxyl were obtained under these reaction conditions. In contrast to all other 
glycosylations with 4-O-picoloylated donor 3.1, this glycosylation gave poor 
stereoselectivity (α/β = 2.4/1), but pure α-linked tetrasaccharide 3.9a could still be 
isolated in 61% yield with tedious separation by column chromatography.   
It occurred to us that having an additional hydroxyl group in the acceptor unit 
may result in the formation of other H-bonds that would cause slower reactions and, 
possibly, lower stereoselectivity. To rule out this possibility, we protected 4“-hydroxyl of 
glycosyl accetor 3.4c via sequential 6-O-silylation, 4“-O-benzylation, and desylalation as 
shown on the bypass route on Scheme 3.4. The reprotection sequence was rather 
uneventful and glycosyl acceptor 3.4d bearing 6-hydroxyl was obtained in 88% overall 
yield. Coupling of donor 3.1 with acceptor 3.4d under HAD conditions produced 
tetrasacchaaride 3.9b in 76% yield. Unfortunately, the stereoselectivity of this coupling 
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was still low (α/β = 2.9/1) and represented only a very marginal improvement in 
comparison to that obtained for tetrasaccharide 3.9a. The observed low stereoselectivity 
from both mono and diol-acceptors led us to conclude that the presence of other hydroxyl 
does not the deciding affect or the stereoselectivity of HAD. Arguably, other factors, such 
as double stereodifferentiation, or simply low facial accessibility of 6-hydroxyl of 
trisaccharides acceptors 3.4c or 3.4d with donor 3.1 could be also responsible for this 
rather disappointing result.  
Scheme 3.4.  Low selectivity observed in the synthesis of branched α-glucans 3.9a 
and 3.9b 
 
 
Since the stereoselectivity was poor in the final step of the tetrasaccharide 3.9a 
synthesis, at this point we decided to investigate whether other classes of glycosyl donors 
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would provide superior selectivity in comparison to that obtained with the ethyl 
thioglycoside donor 3.1. Disappointingly, and somewhat surprizingly, glycosyl donors of 
all other common series including aryl thioglycosides, O-imidates and S-imidates, all 
gave lower stereoselectivity. In glycosyl donors with nitrogen-containing leaving groups 
(O,S-imidates) we relate reduced stereoselectivity to the fact that glycosyl acceptor may 
form H-bonding with the leaving group rather than with the picoloyl nitrogen. The origin 
of lower stereoselectivity observed within S-phenyl/tolyl series remains illusive. It may 
well be related to lower reactivity of these glycosyl donors in comparison to that of S-
ethyl donors in the presence of DMTST. This may lead to DMTST interfering with 
picololyl, hence blocking the nitrogen atom from forming the hydrogen bond with 
glycosyl acceptor. The full experimental account of this work will be presented in the 
Chapter 4.  
To reduce the influence of the steric bulk that might have prevented giving high 
stereoselectivities during the synthesis of tetrasaccharides 3.9a and 3.9b, we altered our 
strategy as follows. Disaccharide 3.3a was treated with 2M MeONa in methanol to affect 
concomitant debenzoylation and depicoloylation to afford 4‘,6-diol 3.3c (Scheme 3.5). 
The coupling of glycosyl acceptor 3.3c with donor 3.1 under the HAD condition 
proceeded regio and, most importantly, stereoselectively providing the trisaccharide 3.10 
in 89% yield as a pure α-anomer. Subsequent glycosylation of the 4‘-hydroxyl in 
trisaccharide acceptor 3.10 with donor 3.1 was also sucessful and the branched 
tetrasaccharide sequence 3.9c was obtained in 89% yield with complete α-
stereoselectivity.  
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Scheme 3.5.  Stepwise and one-pot synthesis of the branched tetrasaccharide 3.9c 
 
 
We also attempted glycosylation of the diol acceptor 3.3c with excess glycosyl 
donor 3.1 (2.5 equiv.). In this case, we also achieved complete stereoselectivity for the 
formation of both glycosidic linkages, but the desired tetrasaccharide 3.9c was obtained 
in only 40% yield. All attempts to "push" the reaction with the use of extra DMTST led 
to higher yields albeit scrambled stereoselectivity.  
 
3.3.  Conclusions 
This chapter discussed the application of the H-bond-mediated aglycone delivery 
(HAD) method on the synthesis of α-glucans, which are abundant in nature, but represent 
a notable synthetic challenge to chemists. The synthesis of linear oligosaccharide 
sequences was accomplished with complete stereoselectivity in all glycosylations up to 
the pentasaccharide. The efficacy of HAD may diminish with the increased bulk of the 
glycosyl acceptor, which may be an important factor to consider when attempting 
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syntheses of longer oligosaccharide sequences. The synthesis of branched structures were 
shown to be more challenging, particularly with bulky trisaccharide acceptors. The fact 
that some other types of leaving groups may give lower selectivity than that observed 
with S-ethyl glycosides requires further refinement and may enhance the utility of this 
method.  
 
3.4.  Experimental Section 
3.4.1.  General Remarks  
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination 
under UV light and by charring with 10% sulfuric acid in methanol. Solvents were 
removed under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl (1,2-DCE) were 
distilled from CaH2 directly prior to application. Pyridine was dried by refluxing with 
CaH2 and then distilled and stored over molecular sieves (3 Å). Anhydrous DMF was 
used as it is. Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and 
activated in vacuo at 390 °C during 8 h in the first instance and then for 2-3 h at 390 °C 
directly prior to application. AgOTf was co-evaporated with toluene (3 x 10 mL) and 
dried in vacuo for 2-3 h directly prior to application. Optical rotations were measured at 
‘Jasco P-1020’ polarimeter.  Unless noted otherwise, 1H-NMR spectra were recorded in 
CDCl3 at 300 or 600 MHz, 13C-NMR spectra were recorded in CDCl3 at 75 MHz, 125 
MHz or 150 MHz.  Two-dimensional heteronuclear J-resolved spectra (HETERO2DJ)54-
56 were recorded in CDCl3 at 600 MHz.  
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3.4.2.  Synthesis of Glycosyl Donors 
Ethyl 2,3,6-tri-O-benzyl-4-O-picoloyl-1-thio--D-glucopyranoside (3.1). The title 
compound was synthesized according to the reported procedure and the analytical data 
for 3.1 was essentially the same as reported previously.35 
 
3.4.3.  Synthesis of Oligosaccharides  
General procedure for glycosylation in the presence of DMTST (commonly referred 
to as “HAD conditions”). A mixture of a glycosyl donor (0.13-0.15 mmol for mono- or 
0.25 mmol for diglycosylations), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4 Å, 200 mg) in (ClCH2)2 (2.6 mL or 26 mL for 10x dilution) was 
stirred under argon for 1 h. The mixture was cooled to -30 °C and DMTST (0.26-0.50 
mmol) was added. The resulting mixture was allowed to warm to rt over a period of 1 h 
and the reaction mixture was stirred at rt for the time specified in Schemes. Upon 
completion, Et3N (0.3 mL) was added and the resulting mixture was stirred for 30 min. 
The mixture was then diluted with CH2Cl2 (10 mL), the solid was filtered off, and the 
residue was washed sucessively with CH2Cl2. The combined filtrate (30 mL) was washed 
with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). The organic phase was separated, 
dried with magnesium sulfate, filtered, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate - hexane gradient elution). 
Anomeric ratios (or anomeric purity) were determined by comparison of the integral 
intensities of relevant signals in 1H-NMR spectra. 
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Methyl 6-O-benzoyl-2,3-di-O-benzyl-4-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (3.3a).  The title compound was obtained as a 
colorless syrup from glycosyl donor 3.1 (0.30 g, 0.50 mmol) and methyl 6-O-benzoyl-
2,3-di-O-benzyl--D-glucopyranoside (3.2,57 0.19 g, 0.39 mmol) in the presence of 
DMTST in accordance with the general procedure in 83% yield (0.33 g, = 21/1). 
Analytical data for 3.3a: Rf = 0.42 (ethyl acetate/hexane, 1/1, v/v);  [α]D23 +53.2 (c = 1.0, 
CHCl3); 1H NMR: δ, 3.31-3.54 (m, 5H, H-6a’, 6b’, OCH3), 3.58-3.75 (m, 2H, H-2, 2’), 
4.02-4.26 (m, 5H, H-3, 3’, 4, 5, 5’), 4.30 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.53 (d, 1H,  2J = 
12.0 Hz, ½ CH2Ph), 4.57-4.78 (m, 7H, H-1, 6a, 6b, 2 x CH2Ph), 4.81 (d, 1H, 2J = 11.2 Hz, 
½ CH2Ph), 4.99 (dd, 2H, 2J = 11.5 Hz, CH2Ph), 5.51 (dd, 1H, J4’,5’ = 9.8 Hz, H-4’), 5.71 
(d, 1H, J1’,2’ = 3.7 Hz, H-1’), 7.00-7.70 (m, 29H, aromatic), 7.80 (dd, 1H, J = 7.7 Hz, 
aromatic), 7.79-8.15 (m, 2H, aromatic), 8.77 (d, J = 4.7 Hz, aromatic) ppm; 13C NMR: δ, 
55.5, 64.1, 64.4 (×2), 70.0, 71.9, 73.6, 73.7, 73.8, 74.9, 75.1, 75.4, 79.2, 79.3, 80.4, 81.6, 
97.8, 98.0, 125.7, 126.9 (×2), 127.0, 127.3, 127.4, 127.5, 127.7 (×3), 127.9 (×2), 128.0 
(×2), 128.1, 128.2 (×4), 128.3 (×2), 128.4 (×2), 128.5 (×3), 128.6 (×2), 130.0 (×2), 130.1, 
133.3, 137.0, 137.8, 138.0, 138.1, 138.2, 139.1, 147.8, 150.0, 163.9, 166.3 ppm; HR-FAB 
MS [M+H]+ calcd for C61H62O13N 1016.4221, found 1016.4263. 
 
Methyl 6-O-benzoyl-2,3-di-O-benzyl-4-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)--
D-glucopyranoside (3.3b).  To a stirred solution of 3.3a (0.30 g, 0.30 mmol) in CH2Cl2 
(3.0 mL), methanol (300 μL) and Cu(OAc)2 (88.4 mg, 0.44 mmol) were added and the 
resulting mixture was stirred under argon for 16 h at rt. The reaction mixture was then 
diluted with CH2Cl2 (~50 mL) and washed with sat. aq. NaHCO3 (10 mL), and water (2 x 
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10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexane gradient elution) to afford the title compound as a colorless syrup in 
93% yield (0.25 g, 0.28 mmol). Analytical data for 3.3b: Rf = 0.48 (ethyl acetate/hexane, 
2/3, v/v);  [α]D23 +61.1 (c = 1.0, CHCl3); 1H NMR: δ, 2.72 (br. s, 1H, OH), 3.34 (s, 3H, 
OCH3), 3.38-3.50 (m, 3H, H-2’, 6a’, 6b’), 3.54 (dd, 1H, J1,2 = 3.5 Hz, J3,4 = 9.2 Hz, H-2), 
3.58-3.63 (m, 2H, H-4’, 5’), 3.76 (dd, 1H, J3’,4’ = 8.7 Hz, H-3’), 3.93-4.13 (m, 3H, H-3, 4, 
5), 4.26 (dd, 2H, 2J  = 12.2 Hz, CH2Ph),  4.42-4.64 (m, 7H, H-1, 6a, 6b, 2 x CH2Ph), 4.76 
(dd, 2H, 2J  = 11.2 Hz, CH2Ph), 4.87 (dd, 2H, 2J  = 11.6 Hz, CH2Ph), 5.69 (d, 1H, J1’,2’ = 
3.8 Hz, H-1’), 7.00-7.57 (m, 28H, aromatic), 7.95-8.05 (m, 2H, aromatic) ppm; 13C 
NMR: δ, 55.3, 63.8, 68.1, 69.4, 71.2, 71.3, 73.2, 73.4, 73.5 (×2), 74.5, 75.4, 78.8, 80.4, 
81.4, 81.8, 97.3, 97.6, 126.7 (×2), 127.2, 127.6 (×4), 127.7, 127.9 (×2), 128.0, 128.2 (×2), 
128.3 (×6), 128.4 (×2), 128.5 (×6), 129.8 (×2), 129.9, 133.2, 137.8 (×2), 137.9, 138.7, 
138.9, 166.2 ppm; HR-FAB MS [M+H]+ calcd for C55H59O12 911.4007, found 911.4031. 
 
Methyl 2,3-di-O-benzyl-4-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)--D-
glucopyranoside (3.3c).  A solution of 1N NaOMe in MeOH (1.0 mL, 1.0 mmol of 
NaOMe) was added to a stirred suspension of 3.3a (130 mg, 0.13 mmol) in dry methanol 
(4.0 mL) and the resulting mixture was stirred for 1 h at rt. The reaction mixture was then 
neutralized with Dowex (H+), filtered, washed successively with MeOH, and 
concentrated in vacuo to afford crude 3.3c as a colorless syrup in 98% yield (101 mg, 
0.13mmol). Analytical data for 3.3c: Rf = 0.55 (ethyl acetate/hexane, 3/2, v/v); [α]D22 
+50.4 (c = 1.0, CHCl3); 1H NMR: δ, 2.50 (br. s, 1H, 4’-OH), 3.05 (br. s, 1H, 6-OH), 3.43 
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(s, 3H, OCH3), 3.45-3.54 (m, 2H, H-2’, 4’), 3.58-3.67 (m, 2H, H-2, 6a), 3.71-3.92 (m, 
5H, H-3, 5, 5’, 6a’, 6b’), 3.96-4.24 (m, 3H, H-3, 4, 6b), 4.52- 4.75 (m, 8H, H-1, 3½ x 
CH2Ph), 4.92 (d, 1H, 2J = 11.4 Hz, ½ CH2Ph), 4.98 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 5.81 
(d, 1H, J1’,2’ = 3.8 Hz, H-1’), 7.15-7.55 (m, 25H, aromatic) ppm; 13C NMR: δ, 55.3, 61.0, 
69.5, 70.3, 70.7, 71.9, 72.1, 73.3 (×2), 73.7, 74.1, 75.3, 78.8, 80.3, 81.5, 81.9, 97.2, 97.9, 
126.4 (×2), 127.1, 127.5 (×2), 127.7, 127.9 (×2), 128.0 (×2), 128.1 (×2), 128.3 (×2), 
128.4 (×5), 128.6 (×4), 128.7 (×2), 137.5, 137.9 (×2), 138.6, 139.2 ppm; HR-FAB MS 
[M+H]+ calcd for C48H55O11 807.3744, found 807.3761. 
 
Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-
O-benzyl--D-glucopyranosyl)-(14)-6-O-benzoyl-2,3-di-O-benzyl--D-
glucopyranoside (3.4a).  The title compound was obtained as a colorless syrup from 
glycosyl donor 3.1 (0.24 g, 0.34 mmol) and acceptor 3.3b (0.24 g, 0.26 mmol) in 72% 
yield (0.27 g, 0.19 mmol, 93% based on the acceptor recovery, 25/1). Analytical 
data for 3.4a: Rf = 0.57 (ethyl acetate/hexane, 1/1, v/v);  [α]D24 +51.7 (c = 1.0, CHCl3); 1H 
NMR: δ, 3.24-3.38 (m, 5H, H-6a”, 6b”, OCH3), 3.39-3.38 (m, 5H, H-2, 2’, 2”, 5’, 6a’), 
3.72-3.83 (m, 2H, H-4’, 6b’), 3.89-4.15 (m, 6H, H-3, 3’, 3”, 4, 5, 5”), 4.24 (dd, 2H, 2J = 
12.0 Hz, CH2Ph), 4.26-4.58 (m, 10H, H-1, 6a, 4 x CH2Ph), 4.59-5.00 (m, 7H, H-6b, 3 x 
CH2Ph), 5.32-5.44 (m, 2H, H-1”, 4”), 5.57 (d, 1H, J1’,2’ = 3.7 Hz, H-1’), 6.90-7.51 (m, 
44H, aromatic), 7.55-8.05 (m, 4H, aromatic), 8.63 (d, 1H, J = 3.4 Hz, aromatic) ppm; 13C 
NMR: δ, 55.5, 64.1, 68.5, 68.7, 69.2, 69.6, 71.7, 72.1, 73.4, 73.5, 73.6 (×2), 73.7, 74.6, 
74.9, 75.4, 75.9, 79.1, 79.3, 79.4, 79.5, 80.4, 81.2, 81.2, 81.8, 97.5, 97.9, 98.1, 125.6, 
126.9 (×2), 127.0 (×2), 127.2, 127.4 (×2), 127.5 (×2), 127.7 (×4), 127.8 (×2), 127.9 (×2), 
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128.0 (×4), 128.2 (×5), 128.3 (×8), 128.4 (×6), 128.6, 128.7 (×3), 128.8, 129.2, 129.9, 
130.2, 133.2, 137.0, 138.0, 138.1 (×2), 138.3, 138.5 (×2), 139.1 (×2), 164.1, 166.3 ppm; 
HR-FAB MS [M+Na]+ calcd for C88H89O18NNa 1470.5977, found 1470.6012. 
 
Methyl O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--
D-glucopyranosyl)-(14)-6-O-benzoyl-2,3-di-O-benzyl--D-glucopyranoside (3.4b).  
To a stirred solution of 3.4a (100 mg, 0.07 mmol) in CH2Cl2 (2.0 mL), methanol (200 
μL) and Cu(OAc)2 (21 mg, 0.10 mmol) were added and the resulting mixture was stirred 
under argon for 16 h at rt. The reaction mixture was then diluted with CH2Cl2 (~40 mL) 
and washed with sat. aq. NaHCO3 (10 mL), and water (10 mL). The organic phase was 
separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate-hexane gradient elution) 
to afford the title compound as a colorless syrup in 91% yield (84 mg, 0.50 mmol). 
Analytical data for 3.4b: Rf = 0.56 (ethyl acetate/hexane, 2/3, v/v);  [α]D22 +87.1 (c = 1.0, 
CHCl3); 1H NMR: δ, 2.61 (d, 1H, J  = 3.1 Hz, 4”-OH), 3.27- 3.82 (m, 14H, H-2, 2’, 2”, 
3”, 4”, 5’, 5”, 6a’, 6a”, 6b’, 6b”, OCH3), 3.88-4.12 (m, 5H, H-3, 3’, 4, 4’, 5), 4.19-4.56 
(m, 10H, H-1, 6a, 3 x CH2Ph), 4.57-4.70 (m, 4H, H-6b, 1½ x CH2Ph), 4.71-4.84 (m, 4H, 
2 CH2Ph), 4.94 (d, 1H, 2J = 11.6 Hz, ½ CH2Ph), 5.44 (d, 1H,  J1’,2’ = 3.5 Hz, H-1’), 5.57 
(d, 1H, J1”,2” = 3.6 Hz, H-1”), 6.95-7.55 (m, 43H, aromatic), 7.95 (d, 2H, J = 7.3 Hz, 
aromatic) ppm; 13C NMR: δ, 55.4. 64.2, 68.3, 69.0, 69.6, 70.9, 71.4, 71.6, 73.0, 73.3, 73.5 
(×2), 73.6, 74.0, 74.2, 74.3, 74.8, 75.4, 79.1 (×3), 79.3, 80.3, 81.3, 81.5, 81.8, 97.2, 97.5, 
97.7, 126.7 (×2), 126.9 (×2), 127.5, 127.7 (×4), 127.8, 128.0 (×2), 128.1, 128.3 (×7), 
128.4 (×10), 128.5 (×2), 128.6 (×8), 128.7 (×2), 129.1 (×2), 129.9,136.1, 137.9, 138.0, 
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138.1, 138.2, 138.4, 135.9, 139.0 (×2), 166.5 ppm; HR-FAB MS [M+Na]+ calcd for 
C82H87O17 1343.5943, found 1343.5901. 
 
Methyl O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--
D-glucopyranosyl)-(14)-2,3-di-O-benzyl--D-glucopyranoside (3.4c).  A solution of 
1N NaOMe in MeOH (1.0 mL, 1.0 mmol of NaOMe) was added to a stirred suspension 
of 3.4a (115 mg, 0.08 mmol) in dry methanol (4.0 mL) and the resulting mixture was 
stirred for 1 h at rt. The reaction mixture was then neutralized with Dowex (H+), filtered, 
washed successively with MeOH, and concentrated in vacuo to yield crude 3.4c as a 
colorless syrup in 97% yield (96 mg, 0.08 mmol). Analytical data for 3.4c: Rf = 0.47 
(ethyl acetate/hexane, 1/1, v/v);  [α]D24 +54.8 (c = 1.0, CHCl3); 1H NMR: δ, 2.33, 3.17 (2 
br. s, 2H, 2 x OH), 3.34-3.45 (m, 4H, H-2”, OCH3), 3.48-3.65 (m, 9H, H-2, 2’, 3”, 4”, 5”, 
6a, 6a’, 6a”, 6b”), 3.68-3.88 (m, 4H, H-4’, 5, 6b, 6b’), 3.91-4.18 (m, 4H, H-3, 3’, 4, 5’), 
4.38-4.92 (m, 16H, H-1, 7½ x CH2Ph), 5.06 (d, 1H, 2J = 12.0 Hz, ½ CH2Ph), 5.50 (d, 1H, 
J1”,2” = 3.4 Hz, H-1”), 5.72 (d, 1H, J1’,2’ = 3.8 Hz, H-1’), 6.90-7.50 (m, 40H, aromatic) 
ppm; 13C NMR: δ, 55.4. 60.9, 69.6, 69.7, 70.5, 71.2 (×2), 71.3, 72.3, 73.1, 73.3, 73.4, 
73.7, 73.8, 73.9, 74.0, 74.3, 74.5, 78.9, 79.1, 80.3, 81.3 (×2), 82.1, 97.0 (×2), 98.1, 126.7 
(×4), 127.2, 127.3, 127.7 (×2), 127.8 (×2), 127.9 (×2), 128.0 (×3), 128.2, 128.3 (×2), 
128.4 (×8), 128.5 (×6), 128.6 (×6), 128.7 (×2), 137.6, 137.9 (×2), 138.0, 138.1, 138.8, 
138.9, 139.3 ppm; HR-FAB MS [M+Na]+ calcd for C75H82O16Na 1261.5501, found 
1261.5527. 
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Methyl O-(2,3,4,6-tetra-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl-
-D-glucopyranosyl)-(14)-2,3-di-O-benzyl--D-glucopyranoside (3.4d). 
 
TBDMSCl (10.9 mg, 0.07 mmol) and 4-dimethylaminopyridine (0.9 mg, 0.007 mmol) 
were added to a solution of 3.4c (60 mg, 0.05 mmol) in pyridine (3.0 mL) and the 
resulting mixture was stirred under argon for 16 h at rt. After that, pyridine was 
evaporated and co-evaporated with toluene (2×5 mL). The residue was dissolved in 
CH2Cl2 (~50 mL) and washed with cold water (10 mL), 1N HCl (10 mL), sat. aq. 
NaHCO3 (10 mL), and water (2×10 mL). The organic phase was separated, dried with 
magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution) to give methyl O-
(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-
glucopyranosyl)-(14)-2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl--D-
glucopyranoside (3.11) in 89% yield (57 mg, 0.04 mmol) as colorless syrup. Analytical 
data for 3.11: Rf = 0.47 (ethyl acetate/hexane, 3/7, v/v);  [α]D25 +54.1 (c = 1.0, CHCl3);  
1H NMR: δ, 0.03, 0.04 (2 s, 6H, Si(CH3)2), 0.87 (s, 9H, SiC(CH3)3), 2.52 (br. s, 1H, OH), 
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3.34-3.47 (m, 5H, H-2”, 6a”, OCH3), 3.48-3.60 (m, 3H, H-2, 2’, 6b”), 3.61-3.81 (m, 5H, 
H-3”, 4”, 5”, 6a”, 6b”), 3.82-3.96 (m, 5H, H-4, 5, 5’, 6b, 6b’), 3.98-4.14 (m, 3H, H-3, 3’, 
4’), 4.39 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.42-4.63 (m, 8H, H-1, 3½ x CH2Ph), 4.65-4.76 
(m, 3H, 1½ x CH2Ph), 4.87 (d, 1H, 2J = 11.4 Hz, ½ CH2Ph), 4.91 (d, 1H, 2J = 11.9 Hz, ½ 
CH2Ph), 4.92 (dd, 2H, 2J = 11.6 Hz, CH2Ph), 5.63 (d, 1H, J1’,2’ = 3.6 Hz, H-1’), 5.69 (d, 
1H, J1”,2” = 3.5 Hz, H-1”), 7.00-7.45 (m, 40H, aromatic), ppm; 13C NMR: δ, -4.9, -4.8, 
18.7, 26.3 (×3), 55.1, 63.0, 69.2, 69.9, 70.6, 71.1, 71.2, 71.7, 72.6, 72.9, 73.2, 73.5 (×2), 
73.6, 73.7, 74.2, 74.6, 75.5, 79.2, 79.7, 80.4, 81.5, 81.9 (×2), 96.5, 97.0, 97.6, 126.7, 
127.0 (×2), 127.6 (×5), 127.7 (×2), 127.9 (×6), 128.0 (×3), 128.3 (×2), 128.4 (×11), 128.5 
(×2), 128.6 (×7), 138.0, 138.1, 138.2, 138.3, 138.6, 139.0, 139.3 ppm; HR-FAB MS 
[M+Na]+ calcd for C81H96O16SiNa 1375.6365, found 1375.6284. 
 
To a solution of 3.11 (55 mg, 0.04 mmol) in DMF (5.0 mL) NaH (60% in mineral oil, 4.8 
mg, 0.12 mmol) and benzyl bromide (10 µL, 0.08 mmol) were added and the resulting 
mixture was stirred for 1.5 h at rt. The reaction mixture was poured into ice-water (~5 
mL, 30 min) and stirred for 30 min and extracted with ethyl acetate/diethyl ether (1/1, 
v/v, 3 × 20 mL). The combined extract (~60 mL) was washed with cold water (3 × 10 
mL). The organic phase was separated, dried with magnesium sulfate, filtered, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexane gradient elution) to give methyl O-(2,3,4,6-tetra-O-benzyl--D-
glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-2,3-di-O-
benzyl-6-O-tert-butyldimethylsilyl--D-glucopyranoside (3.12) as a white amorphous 
solid in 86% (54.9 mg, 0.035 mmol). Analytical data for 3.12: Rf = 0.58 (ethyl 
Yasomanee, Jagodige P. | UMSL 2014 | Page 132  
 
 
acetate/hexane, 3/7, v/v);  [α]D24 +58.9 (c = 1.0, CHCl3); 1H NMR: δ, 0.02, 0.03 (2 s, 6H, 
Si(CH3)2), 0.86 (s, 9H, SiC(CH3)3), 3.35-3.43 (m, 4H, H-6a”, OCH3), 3.45-3.59 (m, 4H, 
H-2, 2’, 2”, 6b”), 3.62-3.79 (m, 4H, H-4”, 5, 5”, 6a), 3.82-3.96 (m, 5H, H-3”, 4, 5’, 6a’, 
6b, ), 3.97-4.12 (m, 4H, H-3, 3’, 4’, 6b’), 4.27 (d, 1H, 2J = 12.01 Hz, ½ CH2Ph), 4.42 (d, 
1H, 2J = 10.9 Hz, ½ CH2Ph), 4.44-4.56 (m, 8H, H-1, 3½ x CH2Ph), 4.64 (dd, 2H, 2J = 12.0 
Hz, CH2Ph), 4.73-4.84 (m, 5H, 2½ x CH2Ph), 4.89 (d, 1H, 2J = 12.1 Hz, ½ CH2Ph), 5.00 
(d, 1H, 2J = 11.6 Hz, ½ CH2Ph), 5.62 (d, 1H, J1’,2’ = 3.6 Hz, H-1’), 5.66 (d, 1H, J1”,2” = 3.6 
Hz, H-1”), 7.00- 7.45 (m, 45H, aromatic), ppm; 13C NMR: δ, -4.9, -4.8, 18.7, 26.3 (×3), 
55.1, 63.1, 68.4, 69.3, 71.2 (×2), 71.3, 73.0, 73.1, 73.3, 73.5, 73.6, 73.7 (×2), 74.3, 74.6, 
75.1, 75.7, 77.8, 79.7 (×2), 80.4, 81.8, 81.9, 82.3, 96.6, 97.2, 97.6, 126.7 (×2), 127.0 (×2), 
127.1, 127.3, 127.6 (×5), 127.7 (×3), 127.8, 127.9 (×2), 128.0 (×8), 128.1, 128.2 (×3), 
128.3 (×2), 128.4 (×8), 128.5 (×3), 128.6 (×4), 138.0, 138.2 (×2), 138.5, 138.6, 138.8, 
139.0, 139.3 ppm; HR-FAB MS [M+Na]+ calcd for C88H102O16SiNa  1465.6835, found 
1465.6801. 
 
A 1 M soln. of tert-butylammonium fluoride in THF (85 µL, 0.085 mmol) was added to a 
solution of 3.12 (54 mg, 0.034 mmol) in THF (2.0 mL) and the resulting mixture was 
stirred for 3 h at rt. After that, the reaction mixture was neutralized with Et3N (~0.1 mL), 
diluted with CH2Cl2 (~30 mL), and washed with cold water (5 mL), sat. aq. NaHCO3 (5 
mL), and water (3 x 5 mL).  The organic phase was separated, dried with magnesium 
sulfate, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate-hexane gradient elution) to afford the title compound 3.4d in 
94% yield (47.1 mg, 0.03 mmol) as a colorless syrup. Analytical data for 3.4d: Rf = 0.58 
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(ethyl acetate/hexane, 1/1, v/v); [α]D24 +51.7 (c = 1.0, CHCl3);  1H NMR: δ, 3.19 (br. dd, 
1H, OH), 3.39 (s, 3H, OCH3), 3.37-3.66 (m, 9H, H-2, 2’, 2”, 5, 5”, 6a’, 6a”, 6b’, 6b”), 
3.68-3.88 (m, 4H, H-3”, 4’, 4”, 6a), 3.90-4.18 (m, 5H, H-3, 3’, 4, 5’, 6b), 4.35-4.90 (m, 
18H, H-1, 8½ x CH2Ph), 5.05 (d, 1H, 2J = 11.9 Hz, ½ CH2Ph), 5.49 (d, 1H, J1”,2” = 3.5 
Hz, H-1”), 5.71 (d, 1H, J1’,2’ = 3.8 Hz, H-1’), 6.90-7.90 (m, 45 H, aromatic) ppm; 13C 
NMR: δ, 55.4. 60.9, 68.4, 69.5, 70.5, 71.1, 71.5, 72.4, 73.4 (×3), 73.7 (×2), 74.0, 74.1, 
74.3, 75.2, 75.7, 77.9, 78.8, 79.5, 80.2, 81.2, 82.0, 82.1, 97.1, 97.3, 98.1, 126.6 (×2), 
126.7 (×2), 127.2, 127.3, 127.6, 127.7 (×5), 127.8 (×3), 127.9, 128.0 (×4), 128.1 (×4), 
128.2 (×3), 128.4 (×8), 128.5 (×5), 128.6 (×5), 137.4, 138.0 (×2), 138.1 (×2), 138.5, 
138.8, 138.9, 139.3 ppm; HR-FAB MS [M+Na]+ calcd for C82H88O16Na 1351.5970, 
found 1351.5943. 
 
Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-
O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-
(14)-6-O-benzoyl-2,3-di-O-benzyl--D-glucopyranoside (3.5a).  The title compound 
was obtained as a colorless syrup from glycosyl donor 3.1 (56 mg, 0.09 mmol) and 
acceptor 3.4b (84 mg, 0.06 mmol) in 56% (63 mg, 0.03 mmol, 79% with the acceptor 
recovery, 23/1). Analytical data for 3.5a: Rf = 0.51 (ethyl acetate/hexane, 1/1, v/v); 
[α]D24 +72.1 (c = 1.0, CHCl3); 1H NMR: δ, 3.33 (dd, 1H, J6a’’’,5’’’ = 3.4 Hz, J6a’’’,6b’’’ = 10.7 
Hz, H-6a’’’), 3.35-3.44 (m, 4H, H-6b’’’, OCH3), 3.46-3.63 (m, 5H, H-2, 2’ 2”, 2’”, 5’, 
6a’), 3.47-3.93 (m, 4H, H-4’, 6b’, 6a”, 6b”), 3.97-4.17 (m, 7H, H-3’, 3”, 3’”, 4”, 5, 5” 
5”’), 4.23 (d, 1H, 2J = 12.0 Hz, ½ CH2Ph), 4.30-4.44 (m, 7H, 3½ x CH2Ph), 4.45-4.63 (m, 
8H, H-1, 6a, 3 x CH2Ph), 4.68-4.74 (m, 3H, H-6b, CH2Ph), 4.81-4.94 (m, 5H, 2½ x 
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CH2Ph), 5.01 (d, 1H, 2J  = 11.4 Hz, ½ CH2Ph), 5.42 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 5.45 
(dd, 1H, J4”’,5”’ = 9.7 Hz, H-4”’), 5.60 (d, 1H, J1”’,2”’ = 3.5 Hz, H-1”’), 5.62 (d, 1H, J1”,2” = 
3.7 Hz, H-1”), 6.95-7.85 (m, 60H, aromatic), 7.92 (d, 1H, J  = 7.9 Hz, aromatic), 8.04 (d, 
2H, J = 7.4 Hz, aromatic), 8.72 (d, 1H, J = 4.2 Hz, aromatic) ppm; 13C NMR: δ, 55.5, 
64.1, 68.5, 68.8, 69.0, 69.2, 69.5, 71.2, 71.7, 72.3, 73.2, 73.3, 73.5 (×3), 73.6 (×2), 73.7, 
74.5, 74.6, 74.9 (×2), 75.3 (×2), 79.1, 79.4, 79.5, 79.7, 80.4, 81.4, 81.5, 81.8, 97.3, 97.5, 
97.7, 97.8, 125.6, 126.9 (×3), 127.0 (×4), 127.2 (×2), 127.4 (×2), 127.5 (×3), 127.7 (×5), 
127.8 (×3), 127.9 (×3), 128.0 (×4), 128.2 (×5), 128.3 (×6), 128.4 (×8), 128.5 (×7), 128.6, 
128.7 (×2), 130.1 (×3), 133.2, 137.0, 138.0, 138.1, 138.2 (×3), 138.4, 138.5, 138.6, 139.1, 
139.2 (×2), 148.2, 150.0, 164.2, 166.3 ppm; HR-FAB MS [M+Na]+ calcd for 
C115H117O23NNa 1902.7914, found 1902.7853. 
 
Methyl O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--
D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-6-O-
benzoyl-2,3-di-O-benzyl--D-glucopyranoside (3.5b).  To a stirred solution of 3.5a (63 
mg, 0.04 mmol) in CH2Cl2 (2.0 mL), methanol (100 μL) and Cu(OAc)2 (10 mg, 0.05 
mmol) were added and the resulting mixture was stirred under argon for 16 at rt. The 
reaction mixture was then diluted with CH2Cl2 (~30 mL) and washed with sat. aq. 
NaHCO3 (6 mL), and water (2 x 6 mL). The organic phase was separated, dried with 
magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethylacetate-hexane gradient elution) to afford the title 
compound as a colorless syrup in 96% yield (57 mg, 0.04 mmol). Analytical data for 
3.5b: Rf = 0.52 (ethyl acetate/hexane, 2/3, v/v);  [α]D24 +65.8 (c = 1.0, CHCl3); 1H NMR: 
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δ, 2.55 (d, 1H, J = 2.6 Hz, OH), 3.32-4.17 (m, 25H, H-2, 2’, 2”, 2”’, 3, 3’, 3”, 3”’, 4, 4’, 
4”, 4”’, 5, 5’, 5”, 5”’, 6a’, 6a”, 6a”’, 6b’, 6b”, 6b”’, OCH3), 4.26-4.77 (m, 18H, H-1, 6a, 
6b, 7½ x CH2Ph), 4.79-5.05 (m, 7H, 3½ x CH2Ph), 5.40 (d, 1H, J1’,2’ = 3.4 Hz, H-1’), 
5.64 (1H, J1”,2” = 3.7 Hz, H-1”), 5.69 (1H, J1”’,2”’ = 3.5 Hz, H-1”’), 6.95- 7.60 (m, 58H, 
aromatic), 8.02 (d, 2H, J = 8.5 Hz, aromatic), 8.72 (d, 1H, J = 4.2 Hz, aromatic) ppm; 13C 
NMR: δ, 55.5, 64.1, 68.5, 68.9, 69.9, 70.5, 71.0, 71.7, 72.1, 73.0 (×2), 73.4 (×2), 73.5, 
73.6, 73.7, 74.1, 74.5, 74.7, 74.9, 75.4, 79.0, 79.1, 79.3 (×3), 79.9, 80.4, 81.4, 81.5, 81.8, 
81.9, 96.8, 97.1, 97.6, 97.8, 126.7, 126.9, 127.0, 127.2, 127.3, 127.5, 127.7 (×2), 128.8, 
127.9 (×3), 128.0 (×2), 128.2, 128.3 (×5), 128.4 (×8), 128.5 (×2), 128.5 (×3), 128.7 (×6), 
128.8 (×12), 129.2 (×6), 136.0 (×3), 138.1 (×6), 138.3, 138.6, 139.0, 139.1 (×3), 166.3 
ppm; HR-FAB MS [M+Na]+ calcd for C109H114O22Na  1797.7699, found 1797.7731. 
 
Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-
O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-
(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-6-O-benzoyl-2,3-di-O-
benzyl--D-glucopyranoside (3.6).  The title compound was obtained as a colorless 
syrup from glycosyl donor 3.1 (35 mg, 0.06 mmol) and acceptor 3.5b (57 mg, 0.04 
mmol) in 41% (31 mg, 0.01 mmol, 81% with acceptor recovery, 25/1). Analytical 
data for 3.6: Rf = 0.55 (ethyl acetate/hexane, 1/1, v/v); [α]D25 +71.1 (c = 1.0, CHCl3); 1H 
NMR: δ, 3.30-3.43 (m, 5H, H-6a””, 6b””, OCH3), 3.45-3.63 (m, 8H, H-2, 2’, 2”, 2”’, 2””, 
6a”’, 6b”, 6b”’), 3.73-3.95 (m, 6H, H-3’, 4’, 4”, 5’, 5”, 5”’), 3.95-4.18 (m, 12H, H-3, 3”, 
3”’, 3””, 4, 4”’, 5, 5””, 6a’, 6a”, 6b’, 6b”), 4.23 (d, 1H, 2J = 12.0 Hz, ½ CH2Ph), 4.28-
4.63 (m, 19 H, H-1, 6a, 8½ x CH2Ph), 4.65-4.95 ( m, 10H, H-6b, 4½ x CH2Ph), 5.00 (d, 
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1H, 2J = 11.5 Hz, ½ CH2Ph), 5.37-5.50 (m, 2H, H-1’, 4””), 5.55-5.68 (m, 3H, H-1”, 1”’, 
1””), 6.80-7.55 (m, 74H, aromatic), 7.60-8.15 (m, 4H, aromatic), 8.75 (d, 1H, J = 3.2 Hz, 
aromatic) ppm; 13C NMR: δ, 55.5, 64.1, 68.6, 68.9, 69.0, 69.2, 69.5, 71.1, 71.2, 71.7, 
72.3, 72.9, 73.1 (×2), 73.3, 73.5 (×4), 73.6 (×2), 73.7, 74.2, 74.4, 74.6 (×2), 74.8, 74.9, 
75.0, 75.3, 79.2, 79.4, 79.5, 79.7 (×2), 80.4, 81.4, 81.7 (×2), 81.8, 96.5, 97.2, 97.6, 97.7, 
97.9, 125.8, 126.8 (×2), 126.9 (×2), 127.0 (×2), 127.1 (×2), 127.2 (×3), 127.4 (×2), 127.5 
(×3), 127.6, 127.7 (×7), 127.8 (×4), 127.9 (×4), 128.0 (×6), 128.2 (×3), 128.3 (×11), 
128.4 (×16), 128.5 (×5), 128.6, 128.7 (×2), 130.0 (×2), 130.2, 136.9, 138.2 (×2), 138.3, 
138.4, 138.5, 138.6, 138.7, 139.1, 139.2 (×4), 148.2, 150.0, 164.2, 166.2 ppm; HR-FAB 
MS [M+Na]+ calcd for C142H145O28NNa 2334.9851, found 2334.9789. 
 
Methyl 3,4-di-O-benzyl-2,6-di-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (3.8).  The title compound was obtained as a 
colorless syrup from glycosyl donor 3.1 (90 mg, 0.15 mmol) and methyl 3,4-di-O-benzyl-
-D-glucopyranoside (3.7,49 20 mg, 0.05 mmol) in 83% (53 mg, 0.04 mmol, 22/1). 
Analytical data for 3.8: Rf = 0.46 (ethyl acetate/hexane, 3/2, v/v); 1H NMR: δ, 3.22 (1H, 
dd, J5°,6a° = 3.5 Hz, J6a°,6b° = 11.0 Hz, H-6a°), 3.32 (dd, 1H, J5°,6b° = 2.5 Hz, H-6b°), 3.43 
(s, 3H, OCH3), 3.45-3.71 (m, 6H, H- 2, 2’, 6a, 6b, 6a’, 6b’), 3.73-3.92 (m, 4H, H-2, 3, 4, 
5), 4.06-4.22 (m, 4H, H-3°, 3’, 5°, 5’), 4.28 (dd, 2H, 2J = 11.8 Hz, CH2Ph), 4.43 (dd, 2H, 
2J = 12.0 Hz, CH2Ph), 4.53-4.91 (m, 11H, H-1, 5 x CH2Ph), 4.92 (dd, 2H, 2J = 11.3 Hz, 
CH2Ph), 4.94 (d, 1H, J1°,2° = 3.6 Hz, H-1°), 5.03 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 5.39 (dd, 
1H, J4’,5’ = 9.8 Hz, H-4’), 5.45 (dd, 1H, J4°,5° = 9.7 Hz, H-4°), 6.95-7.95 (m, 46H, 
aromatic), 7.55-7.80 (m, 2H, aromatic), 7.87 (d, 1H, J = 7.8 Hz, aromatic), 8.70 (dd, 1H, 
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J = 5.4 Hz, aromatic) ppm; 13C NMR: δ, 55.1, 66.1, 68.1, 69.0, 70.7, 71.3, 72.0, 73.1, 
73.2, 73.6, 73.7, 75.1, 75.2, 75.3, 75.7, 75.9, 77.4, 77.5, 78.4, 78.7, 79.1, 79.2, 80.0, 81.1, 
94.8, 96.3, 97.3, 126.8, 127.0, 127.5 (×3), 127.6, 127.9 (×2), 128.0 (×6), 128.1 (×4), 
128.2 (×16), 128.3 (×4), 128.5 (×2), 128.6 (×5), 136.9, 137.0, 137.9, 138.0, 138.3, 138.4 
(×2), 138.5, 138.6, 147.8, 147.9, 150.0, 150.1, 163.7, 164.2  ppm; HR-FAB MS [M+H]+ 
calcd for C87H89O18N 1449.6110, found 1449.6103. 
 
Methyl O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--
D-glucopyranosyl)-(14)-2,3-di-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (3.9a). The title compound was obtained as a 
colorless syrup from glycosyl donor 3.1 (26 mg, 0.04 mmol) and acceptor 3.4c (36 mg, 
0.03 mmol) in 87% (47 mg, 0.03 mmol, 2.4/1). Analytical data for α-3.9a: Rf = 
0.55 (acetone/toluene, 3/17, v/v); [α]D25 +75.3 (c = 1.0, CHCl3); 1H NMR: δ, 3.31-3.46 
(m, 6H, H-2, 2”, 6a’, OCH3), 3.48-3.61 (m, 4H, H-2’, 6a°, 6b’, 6b°), 3.63 (dd, 1H, J2°,3° = 
3.7 Hz, H-2°), 3.67-3.97 (m, 10H, H-3”, 4’, 4”, 5, 5’, 5”, 6a, 6a”, 6b, 6b”), 3.98-4.27(m, 
5H, H-3, 3’, 3°, 4, 5°), 4.31-5.00 (m, 23H, H-1, 11 x CH2Ph), 5.30 (d, 1H, J1°,2° = 3.5 Hz, 
H-1°), 5.41 (dd, 1H, J4°,5° = 9.7 Hz, H-4°), 5.60 (d, 1H, J1’,2’ = 3.6 Hz, H-1’), 5.67 (d, 1H, 
J1”,2” = 3.5 Hz, H-1”), 6.90-8.00 (m, 58H, aromatic), 8.65 (d, 1H, J = 3.4 Hz, aromatic) 
ppm; 13C NMR: δ, 55.5, 65.0, 68.9, 69.1, 69.6, 69.7, 71.2, 71.4, 71.5, 72.3, 72.9 (×2), 
73.1, 73.5, 73.6, 73.7 (×2), 74.1, 75.0, 75.3 (×2), 77.3, 77.7, 78.2, 79.2, 79.3, 79.9, 80.1 
(×2), 81.7 (×2), 81.8, 96.7, 97.0, 97.2, 97.8, 125.7, 126.8 (×2), 127.2 (×2), 127.3, 127.4 
(×2), 127.5, 127.6, 127.7 (×8), 127.8 (×2), 127.9 (×7), 128.0 (×4), 128.1, 128.2, 128.3 
(×4), 128.4 (×12), 128.5 (×7), 128.6 (×2), 128.7 (×2), 138.1, 138.2, 138.3 (×3), 138.7, 
Yasomanee, Jagodige P. | UMSL 2014 | Page 138  
 
 
138.8, 139.1 (×2), 139.4, 149.8, 164.0 ppm; HR-FAB MS [M+Na]+ calcd for 
C108H113O23NNa 1816.0355, found 1816.0309. 
 
Methyl O-(2,3,6-tetra-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--
D-glucopyranosyl)-(14)-2,3-di-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (3.9b).  The title compound was obtained as a 
colorless syrup from glycosyl donor 3.1 (26 mg, 0.04 mmol) and acceptor 3.4d (36 mg, 
0.03 mmol) in 82% (47 mg, 0.03 mmol, 3/1). Selected analytical data for α-3.9b: 
Rf = 0.56 (ethyl acetate/hexane, 1/1, v/v); [α]D25 +50.4 (c = 1.0, CHCl3); 1H NMR: δ, 
3.24-3.36 (m, 5H, H-6a’, 6b’, OCH3), 3.37-3.71 (m, 12H, H-2, 2’, 2”, 2°, 4’, 5’, 5”, 6a, 
6a”, 6a°, 6b”, 6b°), 3.72-3.91 (m, 4H, H-3’, 4’, 5, 6b), 3.93-4.12 (m, 5H, H-3, 3”, 3°, 4, 
5°), 4.15 (d, 1H, 2J = 12.1 Hz, ½ CH2Ph), 4.27-4.73 (m, 21H, H-1, 10 x CH2Ph), 4.75-
4.99 (m, 4H, 2 x CH2Ph), 5.13 (d, 1H, J1°,2° = 3.4 Hz, H-1°), 5.36 (dd, 1H, J4°,5° = 9.9 Hz, 
H-4°), 5.44 (d, 1H, J1”,2” = 3.5 Hz, H-1”), 5.60 (d, 1H, J1’,2’ = 3.6 Hz, H-1’), 6.90-8.00 (m, 
63H, aromatic), 8.60 (d, 1H, J = 5.7 Hz, aromatic) ppm; 13C NMR: δ, 55.5, 66.0, 68.4, 
68.9, 69.1, 69.5, 71.0, 71.2, 71.4, 72.1, 72.8, 72.9 (×2), 73.3, 73.4, 73.6 (×2), 73.7 (×2), 
74.2, 75.2, 75.3 (×2), 75.7, 77.9, 79.1, 79.6, 79.8, 80.0 (×2), 81.4, 81.6, 82.3, 97.0, 97.2, 
97.3, 97.8, 125.4, 126.9 (×3), 127.2 (×3), 127.4 (×3), 127.5 (×2), 127.6 (×2), 127.7, 127.8 
(×4), 127.9 (×13), 128.0 (×3), 128.2 (×6), 128.3 (×6), 128.4 (×8), 128.5 (×3), 128.6 (×4), 
136.9, 138.1, 138.2 (×3), 138.3 (×2), 138.6 (×2), 138.7, 139.0 (×2), 139.5, 148.0, 150.0, 
164.2 ppm; HR-FAB MS [M+Na]+ calcd for C115H119O23NNa 1904.8071, found 
1904.8123. 
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Selected analytical data for β-3.9b: Rf = 0.40 (ethyl acetate/hexane, 1/1, v/v);  [α]D25 
+33.9 (c = 1.0, CHCl3); δ, 3.30-3.40 (m, 4H, H-6a’, OCH3), 3.45-3.61 (m, 7H, H-2, 2’, 
2”, 2°, 5’, 6a°, 6b’), 3.62-3.87 (m, 7H, H-3°, 4’, 4°, 5°, 6a, 6b, 6b°), 3.88-3.95 (m, 3H, H-
3’, 4, 5), 3.96-4.12 (m, 5H, H-3, 3”, 4”, 5”, 6a”), 4.19-4.27 (m, 2H, H-6b”, ½ CH2Ph), 
4.32-4.45 (m, 6H, 3 x CH2Ph), 4.46-4.64 (m, 8H, H-1, 1°, 3 x CH2Ph), 4.65-4.81 (m, 6H, 
3 x CH2Ph), 4.83-5.02 (m, 5H, 2½ x CH2Ph), 5.33 (dd, 1H, J4°,5° = 9.8 Hz, H-4°), 5.46 (d, 
1H, J1”,2” = 3.3 Hz, H-1”), 5.67 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 6.90-8.00 (m, 63H, 
aromatic), 8.69 (d, 1H, J = 4.8 Hz, aromatic) ppm; 13C NMR: δ, 55.6, 68.3, 68.8, 69.2, 
69.9, 70.3, 71.2, 71.3, 72.7 (×2), 73.1, 73.3, 73.4 (×2), 73.5, 73.6 (×2), 74.1, 74.8, 75.1, 
75.3, 75.4, 75.7, 77.1, 77.8, 79.5, 79.6, 80.0, 81.3, 81.7, 81.9, 82.3 (×2), 97.1, 97.9 (×2), 
103.7, 125.7, 126.8 (×2), 126.9 (×2), 127.0, 127.1, 127.2, 127.5 (×4), 127.6 (×2), 127.7 
(×4), 127.8 (×6), 127.9 (×2), 128.0 (×4), 128.1 (×3), 128.3 (×7), 128.4 (×9), 128.5 (×7), 
128.6 (×6), 137.0, 138.1 (×2), 138.2 (×2), 138.3 (×2), 138.6 (×2), 138.8, 138.9, 139.0, 
139.5, 147.9, 150.0, 164.3 ppm; HR-FAB MS [M+Na]+ calcd for C115H119O23NNa 
1904.8071, found 1904.8100. 
 
Methyl O-(2,3,6-Tri-O-benzyl-4-O-picoloyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-
O-benzyl--D-glucopyranosyl)-(14)-2,3-di-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.9c).  The title compound was 
obtained as a colorless syrup from glycosyl donor 3.1 (26 mg, 0.04 mmol) and acceptor 
3.10 (36 mg, 0.03 mmol) in 43% yield (91% with acceptor 3.10 recovery, 23 mg, 0.01 
mmol, 23/1). Analytical data for α-3.9c: Rf = 0.47 (ethyl acetate/hexane, 3/2, v/v); 
[α]D23 +37.6 (c = 1.0, CHCl3); 1H NMR: δ, 3.32 (dd, 1H, J5’,6a’ = 3.8 Hz, J6a’,6b’ = 10.8 Hz, 
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H-6a’), 3.37-3.45 (m, 4H, H-6b’, OCH3), 3.47 (dd, 1H, J2,3 = 8.9 Hz, H-2), 3.52-3.67 (m, 
5H, H-2’, 2”, 2°, 6a”, 6b”), 3.74 (dd, 1H, J6a,6b = 10.8 Hz H-6a), 3.85(dd, 1H, J5°,6a° = 3.6 
Hz, J6a°,6b° = 9.3 Hz, H-6a°), 3.89-4.00 (m, 2H, H-5, 6b), 4.20-4.27 (m, 10H, H-3, 3’, 3”, 
3°, 4, 4’, 5°, 5’, 5”, 6b°), 4.30 (dd, 2H, 2J = 11.7 Hz, CH2Ph), 4.32-4.61 (m, 15H, J1,2 = 
3.6 Hz, H-1, 7 x CH2Ph), 4.62-4.71 (m, 2H, CH2Ph), 4.72-4.86 (m, 4H, 2 x CH2Ph), 5.00 
(dd, 2H, 2J = 11.3 Hz, CH2Ph), 5.24 (d, 1H, J1°,2° = 3.4 Hz, H-1°), 5.38 (m, 2H, H-4”, 4°), 
5.51 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 5.58 (d, 1H, J1”,2” = 3.6 Hz, H-1”), 6.90- 8.00 (m, 61H, 
aromatic), 8.60-8.70 (m, 2H, aromatic) ppm; 13C NMR: δ, 55.5, 66.0, 68.9 (×2), 69.1, 
69.6, 69.8, 71.1, 71.5, 72.1, 72.3, 72.8, 72.9, 73.4, 73.5, 73.6, 73.7 (×2), 74.4, 74.9, 75.3 
(×2), 75.5, 77.5, 79.2, 79.4 (×2), 79.6, 79.9, 80.0, 81.2, 81.4, 97.2, 97.3, 97.7, 97.9, 125.5, 
126.9, 127.0 (×2), 127.2 (×2), 127.4 (×3), 127.5 (×2), 127.6 (×4), 127.7, 127.8, 127.9 
(×11), 128.0 (×7), 128.2 (×5), 128.3 (×6), 128.4 (×6), 128.5 (×3), 128.6 (×3), 128.7 (×3), 
136.9, 138.1 (×2), 138.2 (×2), 138.3, 138.4, 138.5, 138.6, 138.7, 139.1, 139.6, 148.0, 
148.1, 150.0 (×2), 164.2 ppm; HR-FAB MS [M+Na]+ calcd for C114H116O24N2Na 
1919.7816, found 1919.7792. 
 
Methyl 2,3-Di-O-benzyl-4-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-6-O-(2,3,6-tri-
O-benzyl-4-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.10).  The title 
compound was obtained as a colorless syrup from glycosyl donor 3.1 (65 mg, 0.11 mmol) 
and acceptor 3.3c (67 mg, 0.08 mmol) in 89% yield (94 mg, 0.07 mmol, 24/1). 
Analytical data for 3.10: Rf = 0.66 (ethyl acetate/hexane, 3/2, v/v); [α]D24 +64.5 (c = 1.0, 
CHCl3);  1H NMR: δ, 3.37 (s, 3H, OCH3), 3.46-3.61 (m, 4H, H-2, 2’, 6a°, 6b°), 3.65 (dd, 
1H, J2°,3° = 9.5 Hz, H-2°), 3.75-4.10 (m, 7H, H-3’, 5, 5’, 6a, 6a’, 6b, 6b’), 4.03-4.21 (m, 
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4H, H-3, 3°, 4, 4’), 4.26 (m, 1H, H-5°), 4.34 (d, 1H, 2J = 12.2 Hz, ½ CH2Ph), 4.38-4.83 
(m, 14H, H-1, 6½ x CH2Ph), 4.88 (d, 1H, 2J = 11.3 Hz, ½ CH2Ph), 5.03 (d, 1H, 2J = 11.5 
Hz, ½ CH2Ph), 5.13 (d, 1H, J1°,2° = 3.5 Hz, H-1°), 5.45 (dd, 1H, J4°,5° = 9.8 Hz, H-4°), 
5.70 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 6.90-8.10 (m, 41H, aromatic), 8.63 (d, 1H, J = 4.1 Hz, 
aromatic) ppm; 13C NMR: δ, 55.4, 66.1, 68.6, 68.8, 69.7, 70.0, 71.0, 71.6, 72.0, 72.4, 
72.5, 73.3, 73.6, 73.7 (×2), 74.5, 75.2, 75.6, 77.3, 79.5, 79.8, 80.8, 81.6, 82.0, 95.9, 97.7, 
97.8, 125.7, 127.1 (×2), 127.2, 127.4 (×2), 127.5 (×3), 127.6, 127.8 (×4), 127.9, 128.0 
(×6), 128.1 (×3), 128.2 (×2), 128.3 (×5), 128.4 (×4), 128.6 (×7), 137.5, 138.0, 138.1, 
138.3, 138.4, 138.6, 138.8, 139.0, 139.2, 147.6, 149.7, 163.8 ppm; HR-FAB MS 
[M+Na]+ calcd for C81H85O18NNa 1382.5664, found 1382.5603. 
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CHAPTER 4 
 
 
 
Hydrogen bond-mediated aglycone 
delivery: leaving group and promoter 
effect on 1,2-cis glucoside synthesis 
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4.1.   Introduction 
O-Glycosylation reactions form a new chirality center and uncontrolled reactions 
commonly provide mixtures of 1,2-cis () and 1,2-trans () diastereomers. Obtaining an 
O-glycosidic linkage with complete stereoselectivity requires special care and the last few 
decades have witnessed a number of new techniques that have been developed to address 
this challenge in many different ways.1 Among a plethora of methods developed, a very 
successful technique involving the participatory assistance of the neighboring acyl 
substituent has been developed for the synthesis of 1,2-trans glycosides.2-4 On the other 
hand, although a number of dedicated methodologies have been developed for 1,2-cis 
glycosylation, obtaining complete stereoselectivity in 1,2-cis glycoside synthesis still 
remains a challenge.5  
Our group has been studying picolinyl and picoloyl substituents both at the 
neighboring (C-2) and remote positions (C-3, 4, and 6) and, among other interesting 
findings, introduced H-bond mediated aglycone delivery concept. Over the course of this 
study we acquired a compelling evidence of the nucleophile, the hydroxyl of the glycosyl 
acceptor, forms hydrogen bond with the picolinyl (or picoloyl) nitrogen and it is 
delivered at the anomeric center in the syn fashion with respect to the picolinyl (or 
picoloyl) group to form the new glycosidic bond (Scheme 4.1).  
Scheme 4.1.  1,2-cis glycosylation via H-bond-mediated Aglycone Delivery (HAD) 
assisted by picolinyl/picoloyl substituents. 
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This new mode to control stereoselectivity of glycosylation allowed for the 
synthesis of both 1,2-trans- and 1,2-cis glycosidic linkages and has been proven to be 
applicable to the synthesis of challenging α-glucosides, β-rhamnosides, and β-
mannosides with high or even complete selectivity.6  We also have applied this technique 
to the synthesis of both linear and branched α-glucans. Although the synthesis of these 
oligosaccharides was successful, we also encountered some intrinsic problems with this 
method related to the weakening of the H-bonding with some bulky or sterically hindered 
acceptors, as well as some loss of reactivity/stereoselectivity in certain cases.  
The study detailed herein is solely dedicated to the refinement of the synthesis of 
one glycosidic linkage, 1,2-cis-glucose, which is among the most abundant linkages in 
nature, yet remains challenging to chemists. Our preliminary results dedicated to this 
important linkage are summarized in Table 4.1. In particular, the 4-O-picoloylated S-
ethyl glycosyl donor 4.1a was found to be very beneficial in this particular application. In 
most cases, high stereoselectivity was only obtained under high dilution, reaction 
conditions that became standard for this type of glycosylation. DMTST was found to be 
the promoter of choice because it does not interfere with the N-atom of the picoloyl 
group. Both primary 4.2 and secondary glycosyl acceptors 4.4, 4.6, and 4.8 with 4-O-
picoloylated donor 4.1a gave very high or near complete 1,2-cis selectivity.6 
Disaccharides 4.3, 4.5, 4.7, and 4.9 were obtained in high yields of 73-91% and 
exceptional α-selectivity (Table 4.1).  
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Table 4.1. Survey of the previous results on the 4-O-picolinyl/picoloyl-assisted 
stereoselective glycosylation.6  
+
DMTST, 1,2-DCE
MS 3 Å
-30 --> 25 oC
donor 4.1a
O
OBn
O
BnO
BnO
SEt
OR
O
BnO
BnO
OBn
PicoO
O
N
O
NPico =
ROH
acceptor
(5 mM) product
 
Entry Acceptor Time Product Yield α/β Ratio 
1 
 
4.2 
4 h 
 
4.3 
73% >25 / 1 
2a 
 
4.4 
5 h 
 
4.5 
93% >25 / 1 
3 
 
4.6 
16 h 
 
4.7 
81% >25 / 1 
4 
 
4.8 
24 h 
4.9 
81% 21 / 1 
        a  5 mM of glycosyl acceptor was used 
 
 
4.2.   Results and Discussion 
As an extension of this study we have decided to perform further refinement of 
this methodology for the synthesis of α-gluco linkage in application to other classes of 
glycosyl donors, activators, systems, etc. to see the applicability of this method for other 
types of leaving groups for 1,2-cis glycosylation. As the first attempt of identifying better 
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glycosyl donors for HAD, 4-O-picoloylated thiophenyl glycoside 4.1b was coupled with 
glycosyl acceptor 4.27 to obtain the disaccharide 4.3 under the previously reported 
standard glycosylation condition.6 To our surprise, only a moderate stereoselectivity was 
obtained ( = 5.3/1, 85%, entry 1, Table 4.2).  A very similar result in terms of the 
yield and stereoselectivity was obtained in the glycosidation of p-tolyl thioglycoside 4.1c 
( = 6.7/1, 90%, entry 2).  
Table 4.2.  Effect of the leaving group and promoters on the stereoselectivity. 
 
Entry Donor Conditionsa Yield, ratio 
1 
 
4.1b 
DMTST (2 equiv.), 2.5 h 4.3 (85%, 5.3/1) 
2 
4.1c 
DMTST (2 equiv.), 3 h 4.3 (90%, 6.7/1) 
3 
4.1d 
AgOTf (2 equiv.), 2 h 4.3 (79%, 1/1.9) 
4 4.1d DMTST (2 equiv.), 6 h 4.3 (80%, 6.1/1) 
5 
 
4.1e 
AgOTf (2 equiv.), 6 h 4.3 (86%, 6.3/1) 
6 
 
4.1f  
TMSOTf (0.5 equiv.), 3 h 4.3 (44%, 5.9/1) 
7 4.1f TfOH (0.5 equiv.), 2 h 4.3 (92%, 9.7/1) 
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Having no success with other types of thioglycosides, we decided to study O/S-
imidates, another popular class of glycosyl donors.8-10 When the S-benzoxazolyl (SBox) 
glycosyl donor 4.1d was first activated with AgOTf, a reverse selectivity was obtained 
with a slight shift towards the 1,2-trans linked 4.3 ( = 1/1.9, 79%, entry 3). A higher, 
yet far from being satisfactory α-selectivity was obtained when SBox donor 4.1d was 
activated with DMTST. In this case disaccharide 4.3 was obtained in 80% yield ( = 
6.1/1, entry 4). A similar outcome was achieved upon AgOTf-promoted activation of S-
thiazolinyl (STaz) donor 4.1e ( = 6.3/1, 86%, entry 5).  Finally, we tested O-
trichloroacetimidate (TCAI) donor 4.1f. Over the course of this study, we noticed that 
moderate selectivity and yield of 4.3 obtained in the TMSOTf-promoted activation of 
TCAI donor 4.1f ( = 5.9/1, 44%, entry 6) could be significantly enhanced by 
performing the activation in the presence of TfOH instead. In the latter case disaccharide 
4.3 was isolated in 92% yields and high α-selectivity ( = 9.7/1, entry 7). This was the 
highest stereoselectivity observed in this series of experiments, but it also indicated that 
the S-ethyl leaving group used in our original study remains the best for the purpose of 
HAD.  
As a rationale for lower selectivity observed with other leaving groups we 
propose the following. In case of S-aryl glycosides, the sulfur atom is less nucleophilic 
than that of their S-ethyl counterparts. Therefore, interaction of the S-aryl glycosides with 
DMTST is sluggish and as a result, excess DMTST would begin interfering with the 
picoloyl nitrogen making it unavailable to perform HAD.  A similar reduction of 
selectivity was previously observed even with S-ethyl glycosides if a large excess of 
DMTST (6 equiv.) was used.6 In case of O/S-imidates, the basis for the reduced 
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selectivity is arguably different. It is our assumption that the presence of the additional N-
atom of the leaving group, and as a result additional H-bond acceptor sites, might be the 
reason for decreased stereoselectivity recorded with glycosyl imidates. This effect is 
particularly strong in case of the SBox leaving group, which is activated by the direct 
pathway via the anomeric sulfur.11,12 This leaves the nitrogen atom of the leaving group 
available to form the undesirable H-bond with glycosyl acceptor. In turn, this effect is 
weakened in case of STaz and TCAI, which are activated via the remote N-atom.12-14  A 
lower selectivity in case of STaz in comparison to that of TCAI could be related due to 
the complexation of Ag(I) used for the activation of STaz with picoloyl nitrogen making 
it less effective in conducting efficient HAD.  
Scheme 4.2.  Bromine-promoted activation of thioglycosides.15 
 
 
Having concluded that the S-ethyl is the best leaving group for reactions via 
HAD, it came to our attention that another approach for α-glucosylation recently 
introduced by our laboratory was also based on the S-ethyl leaving group.15 From this 
study we have demonstrated that ethyl thioglycosides activated with bromine provide 
exclusive α-stereoselectivity in glucosylations. In case of S-ethyl glycosides equipped 
with the superdisarming protecting group pattern (2-O-benzyl-3,4,6-tri-O-benzoyl)16 
these bromine-mediated reactions proceed via the highly reactive 1,2-trans bromide 
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intermediate while 1,2-cis bromide remains unreactive (Scheme 4.2). Since the 1,2-trans 
bromide is the only intermediate leading to products, and the displacement is performed 
in the concerted bimolecular fashion, this reaction gives exclusive α-stereoselectivity.15  
For instance, 2-O-benzyl-3,4,6-tri-O-benzoyl thioglycoside β-4.10 was coupled 
with acceptor 4.2 in the presence of bromine to afford disaccharide 4.11 with exclusive 
1,2-cis selectivity (entry 1, Table 4.3). The low yield of 28% was due to the fact that β-
4.10 forms predominantly α-bromide (~68%), which is unable to react under these 
reaction conditions. As a result, β-bromide is formed in ~32%; it gave the disaccharide in 
28%, with the remaining 4% accounting for the concomitant isomerization into the α-
bromide. We were able to enhance the utility of this reaction by using glycosyl donor α-
4.10, which, upon reaction with bromine, produced the β-bromide predominantly. As a 
result, disaccharide 4.11 was obtained in a good yield of 67% and with exclusive α-
selectivity (entry 2). The yield could be further improved by using HgBr2 as the co-
promoter and in this case disaccharide 4.11 was isolated in 86% yield (entry 3). However, 
the stereoselectivity dropped unremarkably ( = 8.0/1) because mercury(II) salts can 
readily activate α-bromides (Helferich conditions).17  
Other more reactive thioglycosides, such as the standard armed thioglycoside 
donor 4.12,18 failed to produce high levels of stereoselectivity. This is because per-O-
benzylated α-bromide is sufficiently reactive to produce glycosides, and it does so with 
scrambled selectivity. Thus, coupling of glycosyl donor 4.12 with acceptor 4.2 in the 
presence of Br2 produced disaccharide 4.13 in 68% yield and poor selectivity ( = 
2.4/1, entry 4). The glycosidation of the 4-O-benzoylated donor 4.14 with acceptor 4.2 
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was even less selective and disaccharide 4.15 was produced in 75% yield and  = 1/1.8 
(entry 5).  
Table 4.3.  Bromine-mediated activation of different S-ethyl donors. 
 
Entry Donor Conditionsa Product Yield, ratio 
115 
 β-4.10 
Br2, 16 h 
 
4.11 
28%, α only 
215 
 α-4.10 
Br2, 16 h 4.11 67%, α only 
315 α-4.10 Br2/HgBr2, 5 h 4.11 86%, 8.0/1 
4 
 
4.12 
Br2, 0.25 h 
4.13
68%, 2.4/1 
5 
 
4.14 
Br2, 16 h 
4.15
75%, 1/1.8 
a  Br2 (1equiv.) or Br2/HgBr2 (1/1 equiv.) was used  
 
The series of results presented in Table 4.3 clearly demonstrated that bromine-
mediated activation of thioglycosides offers a promising method for the synthesis of α-
glucosides. However, notable limitations including modest yields and high substrate 
specificity (only works for superdisarmed α-thioglycoside) limit the application of this 
very highly stereoselective method. Having also encountered some limitations of the 
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HAD approach, we wondered whether combining these two promising techniques would 
allow us to develop a more flexible and a well-rounded methodology for α-glycosylation. 
With this idea in mind, a test glycosylation reaction of 4-picoloylated thioglycoside donor 
4.1a with glycosyl acceptor 4.2 in the presence of Br2 produced disaccharide 4.3 in 77% 
yield and complete α-selectivity (entry 1, Table 4.4). The use of HgBr2 as an additive 
further enhanced the yield to 83% and the stereoselectivity still remained complete (entry 
2). Both reactions were performed under normal dilution (50 mM of 4.3), conditions 
which DMTST-promoted activation of 4.1a gave very low selectivity (entry 3).6 In our 
opinion this is because the H-bonded acceptor is in competition with the free acceptor in  
Table 4.4.  Effect of the leaving group on Br2 activation. 
 
Entry Donor Conditions Yield, ratio 
1 4.1a  Br2, 4.5 h 77%, α only 
2 4.1a Br2/HgBr2, 2 h 83%, α only 
3 4.1a DMTST, 4 h 85%, 2.8/1 
4 4.1b Br2, 5.5 h 72%, α only 
5 4.1b Br2/HgBr2, 3 h 79%, α only 
6 4.1c Br2, 16 h 70%, α only 
7 4.1c Br2/HgBr2, 16 h 86%, α only 
8 4.1d Br2, 16 h 71%, α only 
9 4.1e Br2, 16 h 87%, α only 
10 4.1f Br2, 0.5 h 89%, 18/1 
 
solution. This issue was addressed by using high dilution conditions, mandatory for most 
reactions using HAD.6 The result with bromine-promoted activation indicates that HAD 
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reactions can now be successfully conducted under normal dilution conditions. 
Encouraged by this intriguing finding, we decided to reinvestigate other glycosyl donors 
4.1b-f, which were found less compatible with HAD due to lower selectivity (vide 
supra). To our delight, both thioglycoside (4.1b and 4.1c) and thioimidate (4.1d and 4.1e) 
glycosyl donors produced disaccharide 4.3 in high yields of 72-87% and complete 1,2-cis 
selectivity in each case (entries 4-9, Table 4.4). The highly reactive trichloroacetimidate 
donor 4.1f also gave high α-selectivity upon activation with Br2, although the 
stereoselectivity was slightly lower ( = 18/1, entry 10) than that obtained with more 
stable donors (vide supra). The high -selectivity obtained from all 4-O-picoloylated 
glycosyl donors 4.1a-f indicates that, unlike previously tested promoter systems, 
bromine-promoted glycosylations are less sensitive to the nature of the leaving group.  
These results also indicate that bromine may serve as a convenient and inexpensive 
promoter for a variety of glycosylation reactions. Some of the leaving groups tested here 
have never been previously activated with bromine.  
A low temperature (-40 °C) NMR monitoring of the reaction of glycosyl donor 
4.1a with Br2 showed direct and rapid formation of α-bromide. However, we cannot yet 
exclude the possibility of the partial formation of β-bromide at the beginning of the 
reaction, in the highly benzylated system, which very rapidly equilibrates into a more 
thermodynamically stable α-bromide. Therefore, the β-bromide intermediate would be a 
very insignificant intermediate en route to glycoylation products. This type of bromide is 
reactive under these reaction conditions, as seen from experiments with perbenzylated 
and 4-benzoyl thioglycosides 4.12 and 4.14, respectively (Table 4.3). In case of 4-
picoloylated glycosyl donor, bromide leaving group departs and the HAD kicks in to 
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deliver the nucleophile from the bottom face (Scheme 4.3). Minimal formation of other 
electrophilic species in bromine-promoted HAD maybe the key for success of this 
method unlike in case with DMTST wherein excess promoter may interfere with the 
hydrogen bond acceptor. 
Scheme 4.3.  Cooperative use of bromine-promoted activation and HAD. 
 
 
 Since all 4-O-picoloylated glycosides gave high 1,2-cis selectivity upon coupling 
with primary acceptor 4.2 in the presence of Br2, we attempted to expand the approach to 
different acceptors. Although a vast majority of reactions proceeded with high selectivites 
and yields (Table 4.5), we noticed some unusual trends. For instance, glycosyl donor 4.1a 
was practically ineffective when reacted with secondary glycosyl acceptors, even in the 
presence of HgBr2. Interestingly, S-phenyl donor 4.1b could be efficiently coupled both 
with primary and secondary glycosyl acceptors. Most reactions produced high yields and 
very high 1,2-cis selectivity (entries 4-7). Meanwhile, coupling of glycosyl donors 4.1c-f 
provided comparable results and consistently high α-selectivities (entries 8-11).    
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Table 4.5.  Probing the scope and limitations of Br2-promoted HAD. 
  
Entry Donor Acceptor Product (yield, ratio) 
1 4.1a  
4.16  4.17 (49%, 21/1) 
2 4.1a  
4.18  4.19 (51%, 17.1/1) 
3 4.1a 
 
4.8 
 
4.9 (<10%) 
4 4.1b 4.8 4.9 (60%, α only) 
5 4.1b 
4.4  
4.5 (72%, α only) 
6 4.1b 4.18 4.19 (60%, 18.2/1) 
7 4.1b  
4.20  
4.21 (47%, 13/1) 
8 4.1c 4.16 4.17 (68%, 19.3/1) 
9 4.1d  4.4 4.5 (43%, α only) 
10 4.1e 4.4 4.5 (58%, α only) 
11 4.1f 4.4 4.5 (78%, >21/1)a 
a reaction was completed in 2.5 h 
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4.3.  Conclusions 
We have expanded the HAD concept to different 4-O-picoloylated glycosyl 
donors with widely used leaving groups including SPh, STol and S/O-imidates to study 
the compatibility of the aforementioned method with various leaving groups and 
promoter systems. Having investigated a variety of promoter systems we determined the 
superior properties of Br2 as promoter for HAD. Very high selectivities and acceptable 
yields have been recorded in most cases with all classes of glycosyl donors at room 
temperature. All bromine-promoted reactions have been performed under regular dilution 
(50 mM concentration of the acceptor) unlike other promoter systems that would mainly 
work under the high dilution conditions (5 mM). In our opinion, the bromine-promoted 
HAD enhances the utility of the two previously developed techniques, HAD6 and 
bromine-assisted glycosidation of thioglycosides,15 by complementing each other.  The 
utility of this method that allows to reduce the amount of the reaction solvent by ten-fold 
should not be underestimated, particularly in cases of the large-scale or industrial 
preparations of α-glucosides.  
 
4.4.   Experimental Section 
4.4.1.   General Remarks 
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination 
under UV light and by charring with 10% sulfuric acid in methanol. Solvents were 
removed under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl (1,2-DCE) were 
distilled from CaH2 directly prior to application. Pyridine was dried by refluxing with 
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CaH2 and then distilled and stored over molecular sieves (3 Å). Anhydrous DMF was 
used as is. Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated 
in vacuo at 390 °C during 8 h in the first instance and then for 2-3 h at 390 °C directly 
prior to application. AgOTf was co-evaporated with toluene (3 x 10 mL) and dried in 
vacuo for 2-3 h directly prior to application. Optical rotations were measured at ‘Jasco P-
1020’ polarimeter.  Unless noted otherwise, 1H NMR spectra were recorded in CDCl3 at 
300, 500 or 600 MHz, 13C NMR spectra were recorded in CDCl3 at 75 or 125 MHz. 
 
4.4.2.  Synthesis of Glycosyl Donors 
Ethyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-1-thio-β-D-glucopyranoside (4.1a). The title 
compound was synthesized according to the reported procedure and the analytical data 
for 4.1b was essentially the same as reported previously.6 
 
Phenyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-1-thio-β-D-glucopyranoside (4.1b). To a 
solution of phenyl 2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside19 (0.50 g, 0.92 mmol) 
in CH2Cl2 (10 mL) picolinic acid (0.23 g, 1.84 mmol), N,N'-dicyclohexylcarbodiimide 
(0.38 g, 1.84 mmol), and 4-dimethylaminopyridine (23 mg, 0.19 mmol) were added at rt. 
The reaction mixture was stirred 30 min under argon and the solid was filtered off. The 
filtrate was diluted with CH2Cl2 (100 mL) and washed with brine solution (2x10 mL), 
separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate/ hexane gradient elution) 
to give the title compound as a white solid in 94% yield (0.56 g, 0.87 mmol). Analytical 
data for 4.1b: Rf = 0.44 (ethyl acetate/hexane, 1/1, v/v); [α]D25 -38.7 (c = 1.0, CHCl3); 1H 
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NMR: δ, 3.62 (dd, 1H, J2,3 = 8.8 Hz, H-2), 3.64-3.70 (m, 2H, H- 6a, 6b), 3.89 (m, 1H, H-
5), 3.94 (dd, 1H, J3,4 = 8.9 Hz, H-3), 4.48 (s, 2H, CH2Ph), 4.73 (dd, 2H, 2J = 11.2 Hz, 
CH2Ph),  4.76 (d, 1H, J1,2 = 8.5 Hz, H-1), 4.81 (dd, 2H, 2J =10.3 Hz, CH2Ph), 5.40 (dd, 
1H, J4,5 = 9.8 Hz, H-4), 7.00-8.00 (m, 23H, aromatic), 8.72 (d, 1H, J = 3.1 Hz, aromatic) 
ppm; 13C NMR: δ, 69.7, 72.3, 73.6, 75.7 (×2), 77.5, 80.8, 84.0, 87.6, 125.7, 127.2, 127.6, 
127.7, 127.8 (×2), 128.1 (×3), 128.3 (×5), 128.5 (×2), 128.6 (×2), 129.1 (×2), 132.1 (×2), 
133.6, 137.1, 138.0 (×2), 138.1, 147.6, 150.0, 164.3 ppm. HR FAB MS [M+H]+ calcd for 
C39H38NO6S 648.2420, found 648.2437. 
   
Tolyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-1-thio-β-D-glucopyranoside (4.1c). To a 
solution of tolyl 2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside20 (0.50 g, 0.90 mmol) in 
CH2Cl2 (10 mL) picolinic acid (0.22 g, 1.80 mmol), N,N'-dicyclohexylcarbodiimide (0.37 
g, 1.80 mmol), and 4-dimethylaminopyridine (22 mg, 0.18 mmol) were added at rt. The 
reaction mixture was stirred for 30 min under argon and the solid was filtered off. The 
filtrate was diluted with CH2Cl2 (100 mL) and washed with brine solution (2x10 mL), 
separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate/ hexane gradient elution) 
to give the title compound as a white solid in 96% yield (0.57 g, 0.86 mmol). Analytical 
data for 4.1c: Rf = 0.44 (ethyl acetate/hexane, 1/1, v/v); [α]D25 -38.7 (c = 1.0, CHCl3); 1H 
NMR: δ, 2.30 (s, 3H, CH3), 3.59 (dd, 1H, J2,3 = 8.9 Hz, H-2), 3.85 (m, 1H, H- 5), 3.93 
(dd, 1H, J3,4 = 9.0 Hz, H-3), 4.47 (s, 2H, CH2Ph), 4.69 (d, 1H, J1,2 =9.8 Hz, H-1), 4.71 
(dd, 2H, 2J = 11.1 Hz, CH2Ph), 4.81 (dd, 2H, 2J =10.4 Hz, CH2Ph), 5.38 (dd, 1H, J4,5 = 
9.7 Hz, H-4), 6.90-8.15 (m, 22H, aromatic), 8.12 (d, 1H, J = 3.9 Hz, aromatic) ppm; 13C 
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NMR: δ, 21.2, 69.6, 72.2, 73.5, 75.6 (×2), 77.4, 80.7, 83.9, 87.7, 125.6, 127.1, 127.4, 
127.6, 127.7 (×2), 127.9 (×2), 128.2 (×5), 128.5 (×2), 128.7 (×2), 129.4, 129.8 (×2), 
132.8  (×2), 137.0, 137.9 (×2), 138.0, 138.1, 147.5, 149.9, 164.2 ppm. HR FAB MS 
[M+H]+ calcd for C40H40NO6S 662.2576, found 662.2539. 
 
Benzoxazolyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-1-thio-β-D-glucopyranoside (4.1d). 
The solution of 4.1a (0.50 g, 0.83 mmol) and activated molecular sieves 3Å (0.42 g) in 
CH2Cl2 (12.6 mL) was stirred under an atmosphere of argon for 1 h. Freshly prepared 
solution of Br2 in CH2Cl2 (8.0 mL, 1/165, v/v) was then added and the reaction mixture 
was kept for 10 min at rt. After that, CH2Cl2 was evaporated off under reduced pressure 
at rt and dried under high vacuum for 3 h. Crude residue was then treated with KSBox 
(0.47 mmol) in dry acetone (10.0 mL) under an atmosphere of argon for 2 h at rt. Upon 
completion, the mixture was diluted with toluene, the solid was filtered-off and the 
residue was washed with toluene. The combined filtrate (90 mL) was washed with 1% aq. 
NaOH (15 mL) and water (3x10 mL), the organic layer was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by silica gel (ethyl acetate/ 
hexane gradient elution) to give the title compound as pale yellow syrup in 82% yield 
(0.47 g, 0.68 mmol). Analytical data for 4.1d: Rf = 0.42 (ethyl acetate/hexane, 3/2, v/v);  
[α]D23 +42.3 (c = 1.0, CHCl3); 1H NMR: δ, 3.75- 3.87 (m, 2H, H- 6a, 6b), 4.02 (dd, 1H, 
J2,3 = 9.8 Hz, H-2), 4.12- 4.23 (m, 2H, H- 3,5), 4.55 (dd, 2H, , 2J = 11.9 Hz, CH2Ph), 4.90 
(dd, 2H, 2J = 11.2 Hz, CH2Ph), 4.98 (dd, 2H, 2J = 10.6 Hz, CH2Ph), 5.65 (dd, 1H, J4,5 = 
9.7 Hz, H-4), 5.68 (dd, 1H, J1,2 = 9.9 Hz, H-1), 7.15- 7.98 (m, 21H, aromatic), 8.12 (d, 
1H, J = 7.8 Hz, aromatic), 8.87 (d, 1H, J = 4.6 Hz, aromatic) ppm; 13C NMR: δ, 69.1, 
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71.9, 75.6, 75.7, 75.9, 78.3, 80.6, 84.0, 84.9, 110.3, 119.2, 124.5, 124.6, 125.7, 127.2, 
127.5, 127.8, 127.9 (×2), 128.2 (×3), 128.3 (×2), 128.4 (×2), 128.5 (×2), 128.6 (×2), 
137.1, 137.5, 137.9 (×2), 142.0, 147.6, 150.1, 152.0, 161.5, 164.2 ppm; HR-FAB MS 
[M+Na]+ calcd for C40H36O7N2SNa  711.2141, found 711.2164. 
 
2-Thiazolinyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-1-thio-β-D-glucopyranoside (4.1e).  
The solution of 4.1a (0.50 g, 0.83 mmol) and activated molecular sieves 3 Å (0.42 g) in 
CH2Cl2 (12.6 mL) was stirred under an atmosphere of argon for 1 h. Freshly prepared 
solution of Br2 in CH2Cl2 (8.0 mL, 1/165, v/v) was then added and the reaction mixture 
was kept for 5 min at rt. After that, CH2Cl2 was evaporated off under reduced pressure at 
rt and dried in the high vacuum for 3 h. Crude residue was then treated with NaSTaz 
(0.35 g, 2.5 mmol) in dry acetonitrile (10.0 mL) under an atmosphere of argon for 3½ h at 
rt. Upon completion, the solvent was evaporated under high vacuo, the residue was 
diluted with CH2Cl2 and, the solid was filtered-off. The residue was washed with CH2Cl2. 
The combined filtrate (90 mL) was washed with 1% aq. NaOH (15 mL) and water (3x10 
mL), the organic layer was separated, dried with MgSO4, and concentrated in vacuo. The 
residue was purified by silica gel (ethyl acetate/ hexane gradient elution) to give the title 
compound as a colorless syrup in 84% yield (0.46 g, 0.70 mmol). Analytical data for 
4.1e: Rf = 0.45 (acetone/toluene, 1/4, v/v); [α]D23 +42.3 (c = 1.0, CHCl3); 1H NMR: δ, 
3.32 (t, 2H, J = 8.1 Hz, SCH2), 3.58- 3.68 (m, 2H, H- 6a, 6b), 3.71 (dd, 1H, J2,3 = 9.3 Hz, 
H-2), 3.94 (dd, 1H, J3,4 = 9.1 Hz, H-3), 3.95 (m, 1H, H-5), 4.03- 4.28 (m, 2H, NCH2), 
4.46 (s, 2H, CH2Ph), 4.71 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 4.78 (dd, 2H, 2J = 10.2 Hz, 
CH2Ph), 5.34 (d, 1H, J1,2 = 10.0 Hz, H-1), 5.43 (dd, 1H, J4,5 = 9.7 Hz, H-4), 6.95- 8.00 
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(m, 18H, aromatic), 8.70 (d, 1H, J = 4.7 Hz, aromatic) ppm; 13C NMR: δ, 35.2, 64.3, 
69.2, 72.0, 73.5, 75.6, 75.8, 77.8, 80.7, 83.9, 84.8, 125.7, 127.2, 127.5, 127.7, 127.9 (×2), 
128.1 (×2), 128.2 (×23), 128.3 (×4), 128.6 (×2), 129.2, 129.9, 137.1, 137.6, 137.9, 138.0, 
147.6, 150.0, 164.1 ppm; HR-FAB MS [M+Na]+ calcd for C36H36O6N2S2Na  679.1912, 
found 679.1943. 
 
2,3,6-Tri-O-benzyl-4-O-picoloyl-β-D-glucopyranosyl trichloroacetimidate (4.1f).  To 
a stirred solution of 4.1a (0.5 g, 0.84 mmol) in CH2Cl2 (10 mL), water (0.5 mL) and 
Hg(CF3CO2)2 (0.7 g, 1.67 mmol) were added at 0 °C and the resulting mixture was 
stirred 1 hr at that temperature. Then the reaction mixture was removed from the ice bath 
and stirred at rt overnight. Thereafter, the reaction mixture was diluted with CH2Cl2 
(~100 mL) and washed with sat. NaHCO3 (10 mL), and water (10 mL). The organic 
phase was separated, dried with magnesium sulfate, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethylacetate/ hexane 
gradient elution) to afford 2,3,6-tri-O-benzyl-4-O-picoloyl-D-glucopyranose (4.22) as a 
colorless syrup in 87% yield (0.41 g, 0.74 mmol). Analytical data for 4.22 Rf = 0.38 
(acetone/toluene, 3/7, v/v); 1H NMR of α-4.22: δ, 3.47-3.63 (m, 3H, H-5, 6a, 6b), 3.82- 
3.95 (m, 2H, H-3, 5), 4.44 (d, 1H, J1,2 =9.7 Hz, H-1), 4.55- 5.03 (m, 6H, 3 CH2Ph), 5.35 
(dd, 1H, J4,5 = 9.5 Hz, H-4), 7.00-8.80 (m, 19H, aromatic) ppm; 1H NMR of β-4.22: δ, 
3.68 (dd, 1H, d, 1H, J1,2 =3.4 Hz, J2,3 = 9.4 Hz H-2), 4.28- 4.51 (m, 4H, H-3, 5, 6a, 6b), 
4.55- 5.03 (m, 6H, 3 CH2Ph), 5.25- 5.44 (m, 2H, H-1, 4), 7.00- 8.80 (m, 19H, aromatic) 
ppm; Selected 13C NMR data for 4.22: δ, 68.6, 69.1, 69.5, 72.3, 73.0, 73.3, 73.6, 73.7, 
Yasomanee, Jagodige P. | UMSL 2014 | Page 168 
 
74.9, 75.4, 75.5, 79.1 (×2), 80.0, 81.7, 83.0, 91.5, 97.6 ppm. HR FAB MS [M+H]+ calcd 
for C33H34NO7 556.2335, found 556.2317. 
To a solution of 4.22 (0.41 g, 0.74 mmol) in CH2Cl2 (5 mL) trichloroacetonitrile (0.22 
mL, 2.21 mmol), K2CO3 (0.20 g, 1.48 mmol) were added at rt. The reaction mixture was 
stirred overnight under argon and the solid was filtered off. The filtrate was concentrated 
in vacuo and the residue was purified by flash column chromatography on silica gel 
(acetone/ toluene gradient elution) to give the title compound as a white solid in 64% 
yield (0.33 g, 0.47 mmol). Analytical data for 4.1f: Rf = 0.43 (acetone/ toluene, 3/7, v/v); 
[α]D25 -38.7 (c = 1.0, CHCl3); 1H NMR: δ, 3.57-3.74 (m, 2H, H- 6a, 6b), 3.85 (dd, 1H, J2,3 
= 8.0 Hz, H-2), 3.93-4.04 ( m, 2H, H-3, 5), 4.47 (s, 2H, CH2Ph), 4.71 (dd, 2H, 2J = 11.4 
Hz, CH2Ph), 4.84 (dd, 2H, 2J = 10.8 Hz, CH2Ph), 5.48 (dd, 1H, J4,5 = 9.6 Hz, H-4), 5.87 
(d, 1H, J1,2 =7.9 Hz, H-1), 6.95- 8.05 (m, 17H, aromatic), 8.74 (m, 2H, aromatic) ppm; 
13C NMR: δ, 68.9, 71.8, 73.5, 74.4, 75.3, 79.2, 81.0, 81.7, 91.0, 98.3, 127.2, 127.6 (×2), 
127.9 (×2), 128.1 (×2), 128.2 (×2), 128.3 (×4), 128.6 (×2), 128.7, 129.2, 137.2, 138.0 
(×2), 138.1, 147.5, 149.9, 161.3, 164.1 ppm. HR FAB MS [M+Na]+ calcd for 
C35H33O7N2Cl3Na 721.1251, found 721.1289. 
 
4.4.3.   Synthesis of oligosaccharides  
General procedure for glycosylation in the presence of DMTST. A mixture of a 
glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4 Å, 200 mg) in ClCH2CH2Cl (26 mL, 5 mM) was stirred under argon 
for 1 h. The mixture was then cooled to -30 °C and DMTST (0.26 mmol) was added. The 
resulting mixture was allowed to warm to rt over a period of 1 h and stirreed at rt for the 
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time specified in Schemes. Upon completion, Et3N (0.3 mL) was added and the resulting 
mixture was stirred for 30 min. The mixture was diluted with CH2Cl2 (10 mL), the solid 
was filtered off, and the residue was washed sucessively with CH2Cl2. The combined 
filtrate (~30 mL) was washed with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). 
The organic phase was separated, dried with magnesium sulfate, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate-
hexane gradient elution). Anomeric ratios (or anomeric purity) were determined by 
comparison of the integral intensities of relevant signals in 1H NMR spectra. 
 
General procedure for glycosylation in the presence of AgOTf. A mixture of a 
glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4 Å, 200 mg) in ClCH2CH2Cl (26 mL, 5 mM) was stirred under argon 
for 1 h. The mixture was then cooled to -30 °C and AgOTf (0.26 mmol) was added. The 
resulting mixture was allowed to warm to rt over a period of 1 h and stirreed at rt for the 
time specified in Schemes. Upon completion, Et3N (0.3 mL) was added and the resulting 
mixture was stirred for 30 min. The mixture was diluted with CH2Cl2 (10 mL), the solid 
was filtered off, and the residue was washed sucessively with CH2Cl2. The combined 
filtrate (~30 mL) was washed with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). 
The organic phase was separated, dried with magnesium sulfate, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate-
hexane gradient elution). Anomeric ratios (or anomeric purity) were determined by 
comparison of the integral intensities of relevant signals in 1H NMR spectra. 
Yasomanee, Jagodige P. | UMSL 2014 | Page 170 
 
General procedure for glycosylation in the presence of TMSOTf (or TfOH). A 
mixture of a glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly 
activated molecular sieves (4 Å, 200 mg) in ClCH2CH2Cl (26 mL, 5 mM) was stirred 
under argon for 1 h. The mixture was then cooled to -30 °C and TMSOTf (or TfOH, 0.07 
mmol) was added. The resulting mixture was allowed to warm to rt over a period of 1 h 
and stirreed at rt for the time specified in Schemes. Upon completion, Et3N (0.3 mL) was 
added and the resulting mixture was stirred for 30 min. The mixture was diluted with 
CH2Cl2 (10 mL), the solid was filtered off, and the residue was washed sucessively with 
CH2Cl2. The combined filtrate (~30 mL) was washed with 20% aq. NaHCO3 (10 mL) and 
water (3 x 10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexane gradient elution). Anomeric ratios (or anomeric purity) were 
determined by comparison of the integral intensities of relevant signals in 1H NMR 
spectra. 
 
General procedure for glycosylation in the presence of Br2. A mixture of a glycosyl 
donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (3 Å, 200 mg) in ClCH2CH2Cl (26 mL, 5 mM) was stirred under argon for 1 h. 
Then Br2 (0.14 mmol) was added and the resulting mixture was stirreed at rt for 2- 24 hrs 
as specified in Tables. Upon completion, mixture was diluted with CH2Cl2 (10 mL), the 
solid was filtered off, and the residue was washed sucessively with CH2Cl2. The 
combined filtrate (~30 mL) was washed with 20% aq. NaHCO3 (10 mL) and water (3 x 
10 mL). The organic phase was separated, dried with magnesium sulfate, and 
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concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexane gradient elution). Anomeric ratios (or anomeric purity) were 
determined by comparison of the integral intensities of relevant signals in 1H NMR 
spectra. 
 
General procedure for glycosylation in the presence of Br2/ HgBr2. A mixture of a 
glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (3 Å, 200 mg) in ClCH2CH2Cl (26 mL, 5 mM) was stirred under argon 
for 1 h. Then Br2 (0.14 mmol) was added and stirreed at rt for 15 minuites. Thereafter, 
mercury (II) bromide (HgBr2, 0.14 mmol) was added and the resulting mixture was 
stirred for the time specified in Schemes. Upon completion, mixture was diluted with 
CH2Cl2 (10 mL), the solid was filtered off, and the residue was washed sucessively with 
CH2Cl2. The combined filtrate (~30 mL) was washed with 20% aq. NaHCO3 (10 mL) and 
water (3 x 10 mL). The organic phase was separated, dried with magnesium sulfate, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexane gradient elution). Anomeric ratios (or anomeric purity) were 
determined by comparison of the integral intensities of relevant signals in 1H NMR 
spectra. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-picoloyl-α-D-
glucopyranosyl)-α-D-glucopyranoside (4.3).  The title compound was obtained as a 
white solid from 4-O-picoloylated glycosyl donors and acceptor 4.2 in yields and 
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stereoselectivity as listed in tables. Analytical data for 4.3 was in accordance with that 
reported previously.6 
 
Methyl 3,4,6-Tri-O-benzyl-2-O-(2,3,6-tri-O-benzyl-4-O-picoloyl-α-D-
glucopyranosyl)-α-D-glucopyranoside (4.5).  The title compound was obtained as a 
white solid from 4-O-picoloylated glycosyl donors and acceptor 4.4 in yields and 
stereoselectivity as listed in tables. Analytical data for 4.5 was in accordance with that 
reported previously.6 
 
Methyl 2,3,6-Tri-O-benzyl-4-O-(2,3,6-tri-O-benzyl-4-O-picoloyl-α-D-
glucopyranosyl)-α-D-glucopyranoside (4.9).  The title compound was obtained as a 
white solid from 4-O-picoloylated glycosyl donors and acceptor 4.8 in yields and 
stereoselectivity as listed in table (5 mM). Analytical data for 4.9 was in accordance with 
that reported previously.6 
 
Cyclohexyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-α-D-glucopyranoside (4.17).  The title 
compound was obtained from Br2 activation method as colorless syrup from 4-O-
picoloylated glycosyl donors and cyclohexanol, 4.16 (50 mM), in yields and 
stereoselectivity as listed in Table 4.5. Analytical data for 4.17: Rf = 0.58 (acetone/ 
toluene, 1/4, v/v); 1H NMR: δ, 1.05-2.10 (m, 10H, OC6H10),  3.50-3.62 (m, 3H, H- 6a, 6b, 
OCH), 3.65 (dd, 1H, J2,3 = 9.6 Hz, H-2), 4.19 (dd, 1H, J3,4 = 9.5 Hz, H-3), 4.23 ( m, 1H, 
H-5), 4.46 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.72 (dd, 2H, 2J = 12.0 Hz, CH2Ph), 4.84 (dd, 
2H, 2J = 11.3 Hz, CH2Ph), 4.96 (d, 1H, J1,2 =3.7 Hz, H-1), 5.42 (dd, 1H, J4,5 = 9.8 Hz, H-
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4), 6.95- 8.15 (m, 18H, aromatic), 8.74 (m, 1H,  J = 3.9 Hz, aromatic) ppm; 13C NMR: δ, 
24.4, 24.7, 25.8, 31.7, 33.7, 68.7, 69.1, 72.4, 73.4, 73.7, 75.5, 76.2, 79.5, 80.0, 95.3, 
125.9, 127.2,  127.4, 127.5, 127.9 (×2), 128.0 (×2), 128.1, 128.3 (×6), ), 128.6 (×2), 
137.3, 138.1, 138.4, 138.8, 147.8, 149.9, 164.2 ppm. HR FAB MS [M+H]+ calcd for 
C39H44O7N 638.3118, found 638.3097. 
 
Benzyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-α-D-glucopyranoside (4.19).  The title 
compound was obtained from Br2 activation method as colorless syrup from 4-O-
picoloylated glycosyl donors and benzyl alcohol, 4.18 (50 mM), in yields and 
stereoselectivity as listed in Table 4.5. Analytical data for 4.19: Rf = 0.55 (acetone/ 
toluene, 1/4, v/v); 1H NMR: δ, 3.48-3.55 (m, 2H, H- 6a, 6b), 3.64 (dd, 1H, J2,3 = 9.5 Hz, 
H-2), 3.14 ( m, 1H, H-5), 4.21(dd, 1H, J3,4 = 9.5 Hz, H-3), 4.45 (dd, 2H, 2J = 11.9 Hz, 
CH2Ph), 4.50- 4.77 (m, 5H, 2 ½ CH2Ph), 4.80- 4.90 (m, 2H, H- 1, ½ CH2Ph), 5.42 (dd, 
1H, J4,5 = 9.8 Hz, H-4), 7.05- 8.10 (m, 23H, aromatic), 8.72 (d, 1H,  J = 4.1 Hz, aromatic) 
ppm; 13C NMR: δ, 68.9, 69.0, 69.4, 72.1, 73.4, 73.7, 75.6, 79.5, 79.9, 95.7, 125.8, 127.1, 
127.5, 127.6, 128.0 (×3), 128.1 (×2), 128.2 (×3), 128.3 (×4), 128.6 (×4), 128.8 (×2), 
137.1, 137.2, 138.0, 138.2, 138.6, 147.8, 149.9, 164.2 ppm. HR FAB MS [M+H]+ calcd 
for C40H40O7N 646.2805, found 646.2841. 
 
Isopropyl 2,3,6-Tri-O-benzyl-4-O-picoloyl-α-D-glucopyranoside (4.21).  The title 
compound was obtained from Br2 activation method as colorless syrup from 4-O-
picoloylated glycosyl donor 4.1b and isopropanol, 4.20 in 47% yield (α/β = 13/1). 
Analytical data for 4.21: Rf = 0.57 (acetone/ toluene, 1/4, v/v); 1H NMR: δ, 1.17 (m, 6H, 
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2 CH3), 3.43-3.52 (m, 2H, H- 6a, 6b), 3.58 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.85 (m, 1H, 
OCH(CH3)2), 4.38 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.66 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 
4.70 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 4.80 (d, 1H, J1,2 =3.8 Hz, H-1), 5.37 (dd, 1H, J4,5 = 
10.0 Hz, H-4), 6.90- 8.10 (m, 18H, aromatic), 8.68 (d, 1H,  J = 3.5 Hz, aromatic) ppm; 
13C NMR: δ, 21.5, 23.5, 68.7, 69.0, 70.0, 72.3, 73.5, 73.7, 75.6, 79.6, 79.9, 95.4, 125.9, 
127.1, 127.4, 127.5, 127.9 (×2), 128.0 (×2), 128.1, 128.3 (×4), 128.4 (×2), 128.7 (×3), 
129.9, 137.3, 138.0, 138.4, 138.7, 149.9 ppm. HR FAB MS [M+H]+ calcd for C36H40O7N 
598.2805, found 598.2837. 
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Development of picolinyl-based 
glycosyl donors with switchable 
stereoselectivity  
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5.1.   Introduction  
Current knowledge about the key roles of carbohydrates is still limited. However, 
thanks to the explosive growth of the field of glycobiology in recent years, we know that 
carbohydrates are involved in a broad range of vital biological processes.1 Carbohydrates 
are also involved in many harmful processes and the fact that many of these processes are 
directly associated with pathogenesis of many if not all diseases has been particularly 
stimulating for major scientific efforts in the field of modern glycosciences.2-4  It is 
already appreciated that a chemical or enzymatic synthesis5 could lead to natural 
glycostructures for studying their composition,6 conformation,7 interaction with other 
molecules,8 and determining their roles.9 Also, only the synthetic approach can provide 
unnatural mimetics that are often of interest due to their therapeutic and diagnostic 
potential.10 However, even with significant progress, the stereocontrolled chemical 
synthesis of complex carbohydrates remains difficult.  
Complex carbohydrates consist of monomeric sugar units (e.g. glucose), which 
are connected via O-glycosidic linkages into elaborate oligosaccharide networks. A 
glycosylation reaction, a promoter/activator (A)-assisted monomolecular nucleophilic 
displacement of a leaving group (LG) of the glycosyl donor with a hydroxyl moiety of 
the glycosyl acceptor (NuH, Scheme 5.1) forms a new O-glycosidic linkage. Other 
reactive functional groups on both the donor and acceptor are temporarily masked with 
protecting groups (P) for the ease of the reaction control. Upon the leaving group 
departure, the flattened oxacarbenium ion is formed that often leads to anomeric 
mixtures.11 Therefore, particular care has to be taken with regards to the stereoselectivity 
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of glycosylation. This requirement represents a major challenge in comparison to that of 
the synthesis of other natural biopolymers, peptides and nucleosides.  
The aim of stereocontrolling of the glycosylation has been approached in a variety 
of ways and the anchimeric assistance effect of a neighboring acyl-type participating 
group has been widely used to obtain 1,2-trans glycosides.12  Recently our group has 
expanded methods available for 1,2-trans glycosylation by developing neighboring 2-O-
picolinyl (pyridylmethyl) participating group.13,14 Thus, it has been demonstrated that the 
picolinyl-assisted glycosylation proceeds via the formal six-membered intermediate 
resulting in the formation of 1,2-trans glycosides with complete stereocontrol ( Scheme 
5. 1). The outcome of these reactions differs drastically from the effect of other ether-type 
substituents (benzyl) that are unable to provide anchimeric assistance and is typically 
limited to steric effect.  
 Scheme 5.1.  Traditional method and recent enhancements. 
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Our group has also expanded methods available for 1,2-cis glycosylation, the 
topic that remains one of the challenges of modern glycosciences.15 For instance, we 
demonstrated that metal coordination can have a noteworthy effect offering a significant 
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5-fold enhancement in 1,2-cis stereoselectivity in comparison to that obtained with 
conventional non-complexed counterparts.16 Specifically engineered building blocks 
were designed to ensure that platinum(IV) complexation would hinder the top (trans) 
face of the sugar ring, hence helping to direct the nucleophilic attack to the opposite (cis) 
face (Scheme 5.1).  
 
5.2.   Results and Discussion 
The main goal of this Chapter is the development of a novel method for 
stereocontrolled glycosylation. The study proposed herein is based on and is expected to 
complement other studies in this field that have been reported by our research group: 
picolinyl-assisted synthesis and the formation of transition metal complex intermediates 
en route to products of glycosylation.14,16 A major driving force for developing of the 
study presented herein is to investigate whether the coordination chemistry tools can help 
to solve the long-standing challenge of stereoselective glycoside synthesis by means of 
metal complexation of carbohydrate ligands of enhanced affinity.  It should be noted that 
the role of metal complexation in chemical glycosylation is practically unexplored 
because common oxygen-containing carbohydrates typically form unstable flexidentate 
complexes.17,18 It was our expectation that targeted coordination can be achieved by the 
introduction of N-Lewis base substituents. Among other possibilities, the picolinyl group 
would be suitable for providing nitrogen atoms for subsequent complexation.  This would 
allow us to obtain metal complexes with enhanced stability, which is the key to their 
ability to survive during the entire glycosylation process, hence providing the desired 
effects that may include enhanced stereocontrol.  
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As aforementioned, previous studies in our laboratory have clearly shown that 2-
O-picolinyl protecting group can be used to provide complete 1,2-trans stereoselectivity 
of glycosylation. This is achieved via N-participation at the anomeric center. We 
conceptualize that if the nitrogen atom of the picolinyl moiety were temporarily blocked 
by coordination to the metal center, it would become unavailable to provide the 
anchimeric assistance in glycosylation and hence the stereoselectivity could be 
“switched”. The anticipated significance of this approach would be the use of a single 
glycosyl donor for the synthesis of either 1,2-cis or 1,2-trans linkage on demand, a trait 
that is rather uncommon in glycosylation. 
We assumed that the complexation of two picolinyl groups in the same molecule 
will open the oxacarbenium ion for the nucleophilic attack leading to the enhanced 1,2-
cis selectivity. With the purpose of verifying the concept of switchable stereoselectivity, 
we obtained a range of building blocks bearing 2,3-di-O-picolinyl protection. In an 
unrelated study, we already refined methods for synthesizing building blocks equipped 
with remote picolinyl protecting groups.19 This allowed for a straightforward synthesis of 
ethylthio glycosyl donor 5.1a equipped with picolinyl groups at C-2 and C-3. We then 
attempted to obtain a Pd(II) complex of 5.1a. The precedent of this type of complexation 
exists as our group has developed a number of concepts for temporary deactivation of 
sugar building blocks using PdBr2 along with specifically developed series of leaving 
groups.20,21   
 Palladium metal complexes in general are promising candidates for these studies 
because their complexes with sugars form readily, are relatively stable and the 
complexation modes can be detected by spectral or crystallographic techniques. Indeed, 
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reaction of 5.1a with PdBr2 afforded the complex 5.2a and, the structure of the latter was 
verified by X-ray crystallography (vide infra, refer to Figure 5.1), ultimately confirming 
that Pd (II) forms a bidentate trans-square planar complex with the two picolinyl groups. 
Preliminary glycosidations of donors 5.1a and 5.2a with acceptor 5.3 have been 
performed in the presence of dimethyl(thiomethyl) sulfonium triflate (DMTST)22 as a 
promoter of choice that does not interfere with picolinyl protecting groups.14 
Glycosidation of non-complexed donor 5.1a gave the anticipated 1,2-trans 
stereoselectivity due to the participation of the 2-O-picolinyl group. Thus, disaccharide 
5.4a was obtained in 83% yield in complete β-selectivity (Scheme 5.2). A very different 
outcome was obtained with palladium(II) complex 5.2a that showed a shift toward 1,2-cis 
selectivity: disaccharide 5.4a was obtained in 89% yield as a mixture of diastereomers 
(α/β = 1/1.4, Scheme 5.2).  
Scheme 5.2.  Comparative glycosidation of donors 5.1a vs. 5.2a. 
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This set of results clearly proves the concept that the complexed picolinyl moiety 
is unable to provide participation at the anomeric center. In our opinion, this result also 
demands to search for conditions to enhance 1,2-cis stereoselectivity. Therefore, we 
envisaged further enhancements to emerge from studying common modes to enhance 
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stereoselectivity including protecting groups, reaction solvents, promoters, and leaving 
groups.23 This search began with screening the protecting groups at C-4 and C-6 of the 
donor. While, for simplicity, the preliminary study was conducted with 4,6-O-
benzylidene protected glycosyl donor 5.2a, we wanted to study other protecting groups as 
well.  
Table 5.1.  Investigation of protecting groups, solvents, and promoters. 
 
Entry Donor Promoter (2 equiv. ) Solvent,* time 
Temperature 
(°C) Yield Product α/β ratio 
1 5.2a DMTST 1,2-DCE, 24 h -30 → 40 89% 5.4a 1/1.4 
2 5.2b DMTST 1,2-DCE, 6 h -30 → 40 91% 5.4b 1/1.5 
3 5.2c DMTST 1,2-DCE, 6 h -30 → 40 53% 5.4c 1/1.7 
4 5.2d DMTST 1,2-DCE, 7 h -30 → rt 83% 5.4d 1/1.9 
5 5.2a DMTST Toluene, 16 h -5 → 40 85% 5.4a 1/1.6 
6 5.2a DMTST Tol/Dxn, 16 h -5 → 40 71% 5.4a 1.6/1 
7 5.2b DMTST Tol/Dxn, 8 h -5 → 40 84% 5.4b 1/1.2 
8 5.2a IDCP Tol/Dxn, 48 h -5 → 40 <5% 5.4a n/a 
9 5.2b IDCP Tol/Dxn, 8 h -5 → 40 81% 5.4b 1.8/1 
10 5.2a NIS/TfOH Tol/Dxn, 16 h -5 → 40 76% 5.4a 1.9/1 
11 5.2b NIS/TfOH Tol/Dxn, 16 h -5 → 40 65% 5.4b 1/2.0 
   * - 1,2-DCE – 1,2-dichloroethane; Tol/Dxn - Toluene/1,4-Dioxane (1/3, v/v).   
 
For this purpose we synthesized 4,6-di-O-benzyl and 4,6-di-O-benzoyl donors 
5.2b and 5.2c, respectively. In addition, to investigate the effect of β-face shielding by 
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steric hindrance, particularly those at the C-6 position,24-26 we synthesized glycosyl donor 
5.2d equipped with bulky O-tert-butyldimethylsilyl (TBDMS) groups. The result of this 
comparative study is summarized in Table 5.1 (entries 1-4). Unfortunately, the effect of 
the remote protecting group was very minor and although the respective disaccharides 
5.4a-d were isolated in 53-91% yield, stereoselectivity of glycosylations remained rather 
poor (α/β = 1/1.0-1.9).  
The stereodirecting effect of different reaction solvents is often used to obtain 
enhanced stereoselectivity. As a rule of thumb, nitrile-type solvents are used to obtain 
equatorial and ether-type solvents to obtain axial glycosides.27 In most part, this approach 
is limited to only marginal effect on stereoselectivity (although examples of significant 
enhancements are also known).23 To explore the possible effect of reaction solvent, we 
decided to study the effect of toluene neat or in combination with 1,4-dioxane, the solvent 
mixture that was found the best amongst other ethereal solvents.28  It should be noted that 
Pd-complexed thioglycosides 5.2a and 5.2b showed very poor solubility in other ethereal 
solvents such as diethyl ether and THF, either neat or in combination with 1,2-
dichloroethane or toluene. Selected results of the solvent screening study for enhancing 
the 1,2-cis selectivity of Pd-complexed 2,3-di-picolinyl donors are summarized in the 
Table 5.1 (entries 5-7). A slight improvement of stereoselectivity was noted with both 
donors 5.2a and 5.2b using toluene-dioxane solvent mixture; therefore, we used this 
solvent system to perform the screening of various promoters.  
The presence of the reactive picolinyl nitrogen atom limits the application of 
many common electrophilic promoters used for the activation of thioglycosides: 
iodonium(di-γ-collidine)perchlorate (IDCP), MeOTf, iodine, N-iodosuccinimide (NIS) 
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along with additives such as TfOH. That is because glycosyl donors turn into unreactive 
N+E- salts under practically all of these activation conditions.14 However, we deemed that 
these promoters should be suitable for the activation of the precomplexed donors since 
the nucleophilic picolinyl nitrogen in these compounds is already blocked by metal 
coordination. This study will help us to establish the promoter stereoselectivity 
relationship and to understand the reactivity of metal coordinated building blocks in 
general. Thereby we have tested glycosidation of complexed donor 5.2a in the presence 
of IDCP as the promoter in toluene/1,4-dioxane (1/3, v/v). This coupling only gave a 
trace amount of 5.4a even after 48 h (entry 8), which was attributed to the disarming 
effect of 4,6-O-benzylidene group.29 Indeed, similar coupling of the armed donor 5.2b in 
the presence of IDCP in toluene/dioxane (1/3, v/v) was much more rapid, and the 
corresponding disaccharide 5.4b was obtained in 81% yield in 8 h. However, no 
enhancement of stereoselectivity was detected (α/β = 1.8/1, entry 9). Expectedly a similar 
reaction in 1,2-dichloromethane gave even lower α-selectivity (the result is not shown). 
Glycosylations of 5.2a and 5.2b in the presence of NIS/ TfOH were uneventful and 
smoothly produced the respective disaccharides in good yields, but marginal selectivity 
(5.4a, α/β = 1.9/1, entry 10; 5.4b, α/β = 1/2.0, entry 11).   
 In order to investigate possible leaving group involvement, we committed to a 
systematic study. However, the outcome of this study was somewhat disappointing.  
Although more reactive leaving groups such as O/S-imidates 30-32 that have already been 
tested and showed compatibility with 2-O-picolinyl derivatives and activation thereof,14 
we could not generate and purify the Pd complexes. In all cases, 2,3-di-picolinyl O/S-
imidates gave inseparable mixtures of metal-sugar complexes, most likely due to the 
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presence of the additional N-atom in the leaving group. On the other hand, S-tolyl 
glycosides were too stable to undergo glycosylation at suitable reaction rates.  
Overall, all traditional modes to enhance stereoselectivity did not give us the 
desired enhancement. As the last resort, we wanted to see whether Br2-mediated 
glycosidation of 1,2-cis thioglycoside, a method recently developed in our laboratory, 
would help to achieve higher 1,2-cis stereoselectivity. The rationale for the enhanced 
stereoselectivity is that these reactions were found to proceed via a very reactive 1,2-
trans bromide intermediate.33 We anticipated that this approach would be advantageous 
herein, but the success of this reaction is truly dependent on our ability to generate a 
stable β-bromide and control its isomerization into its α-counterpart that would remain 
inert under these reaction conditions. Previously, this was accomplished with α-
thioglycoside of the superdisarmed series, equipped with remote acyl substituents. With 
applying this approach to our system in mind, we have synthesized the 2,3-di-picolinyl-α-
thioglycosides α-5.1a-c.  Expectedly, glycosidation of these donors was completely β-
stereoselective in the presence of DMTST. For instance, glycosidation of α-5.1a in the 
presence of DMTST (2 equiv.) gave disaccharide 5.4a in 74% with exclusive β-
stereoselectivity (Scheme 5.3).   
 Scheme 5. 3.  Bromine-assisted glycosidation of complexed α-thioglycoside donors. 
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We then obtained Pd-complexed donors α-5.2a-c and to our delight the coupling 
of α-5.2a with 5.3 using Br2 as the promoter gave disaccharide 5.4a in 35% yield with 
complete 1,2-cis selectivity and α-bromide of the donor was isolated as the major 
byproduct. It should be emphasized that the stereoselectivity of this reaction was 
complete, and the poor yield reflect the accumulation of the α-bromide that is totally 
unreactive under these conditions. The rapid competing anomerization of reactive β-
bromide into its stable α-counterpart is the reason that donors α-5.2b and α-5.2c failed to 
produce any of the anticipated disaccharides.  
Figure 5.1.  X-Ray crystal structure of 5.2a (a) and a possible reason why traditional 
modes to enhance α-selectivity fail (b). 
(a)    (b)  
 
5.3.   Conclusions and Outlook 
As a result of the extended screening of common conditions to enhance 
stereoselectivity we only managed to achieve very marginal variation of the reaction 
selectivities and yields.  A very modest effect of toluene-dioxane, a known powerful 1,2-
cis-directing solvent system should be particularly emphasized. It is possible that the 
trans-ligand square planar metal complex obtained from PdBr2 hinders the access to the 
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α-face of the ring (Figure 5.1b). Some indication of this can be deducted from the X-ray 
crystal structure of 5.2a (Figure 5.1a).   
Certainly, bromine-mediated glycosylation helps to obtain enhanced 
stereoselectivity in these reactions because as proven by our prior mechanistic work the 
anomeric displacement of β-bromide follows the concerted bimolecular pathway. It is 
quite possible that the trans-ligand orientation is disadvantageous in general because the 
nucleophilic attack would be parallel in respect to the electron rich ligands.  It is also 
possible that 2,3-dipicolinyl complexation restrains the conformational mobility of the 
ring, withdraws electron density from the carbohydrate, and may disfavor the bottom face 
of the oxacarbenium ion towards the nucleophilic attack. It is already appreciated that 
glycosyl donors in unusual conformations may have very unusual implications on the 
stereoselectivity and reactivity profile.34 Further studies of the metal-assisted switching of 
anomeric stereoselectivity are currently underway in our laboratory. 
 
5.4.  Experimental Section 
5.4.1.  General Remarks  
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination 
under UV light and by charring with 10% sulfuric acid in methanol. Solvents were 
removed under reduced pressure at <40 °C. CH2Cl2 ClCH2CH2Cl (1,2-DCE) and toluene 
were distilled from CaH2 directly prior to application. Pyridine was dried by refluxing 
with CaH2 and then distilled and stored over molecular sieves (3 Å). Anhydrous DMF 
and dioxane were used as is. Molecular sieves (3 Å or 4 Å), used for reactions, were 
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crushed and activated in vacuo at 390 °C during 8 h in the first instance and then for 2-3 
h at 390 °C directly prior to application. AgOTf was co-evaporated with toluene (3 x 10 
mL) and dried in vacuo for 2-3 h directly prior to application. Optical rotations were 
measured at ‘Jasco P-1020’ polarimeter.  Unless noted otherwise, 1H NMR spectra were 
recorded in CDCl3 at 300, 500 or 600 MHz, 13C NMR spectra were recorded in CDCl3 at 
75 or 125 MHz. 
 
5.4.2.  Synthesis of Glycosyl Donors  
Ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio--D-glucopyranoside (5.1a). To a 
solution of ethyl 4,6-O-benzylidene-1-thio--D-glucopyranoside35 (1.0 g, 3.2 mmol) in 
DMF (10 mL) NaH (60% in mineral oil, 0.77 g, 19.2 mmol) and picolinyl bromide 
hydrobromide (3.2 g, 12.8 mmol) were added at 0 °C. The reaction mixture was stirred 
for 1.5 h, quenched with ice-water (~10 mL, 30 min) and then extracted with ethyl 
acetate /diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was 
washed with cold water (3 × 30 mL). The organic phase was separated, dried with 
magnesium sulfate, filtered, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to give the 
title compound as a white amorphous solid in 86% yield (1.3 g, 2.8 mmol).  Analytical 
data for 1a: Rf = 0.37 (ethyl acetate/hexane, 7/3, v/v); []D20 -39.1 (c = 1.0, CHCl3); 1H-
NMR: δ, 1.25 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.71 (m, 2H,  SCH2CH3), 3.45 (m, 1H, H-5), 
3.52 (dd, 1H, J2,3 = 8.3 Hz, H-2), 3.65-3.78 (m, 2H, H-4, 6a), 3.84 (dd, 1H, J3,4 = 9.2 Hz, 
H-3), 4.31 (dd, 1H, J5,6b = 5.0 Hz, J6a,6b = 10.4 Hz, H-6b), 4.55 (d, 1H, J1,2 = 9.8 Hz, H-1), 
4.80- 5.08 (m, 4H, 2 CH2Ph), 5.50 (s, 1H, >CHPh), 6.90-7.65 (m, 11H, aromatic), 8.35- 
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8.55 (m, 2H, aromatic) ppm; 13C-NMR: δ, 15.2, 25.1, 68.8, 70.2, 75.7, 76.5, 81.4, 82.0, 
83.4, 85.7, 101.3, 121.6, 121.8, 122.3, 122.4, 126.1 (×2), 128.3 (×2), 129.1, 136.6(×2), 
137.2, 148.8, 148.9, 158.2, 158.6 ppm; HR FAB MS [M+H]+ calcd for C27H31N2O5S 
495.1954, found 495.1982. 
 
Ethyl 4,6-di-O-benzyl-2,3-di-O-picolinyl-1-thio--D-glucopyranoside (5.1b) To a 
stirring mixture of 5.1a (0.50 g, 1.00 mmol) in CH2Cl2 (10 mL), water (150 μL) and 
trifluoroacetic acid (TFA)/CH2Cl2 (1/9, v/v, 1.0 mL) were added at rt. The reaction 
mixture was stirred for 3 h, neutralized with Et3N (3 mL) and then diluted with 
dichloromethane (200 mL) and washed with cold water (20 mL), sat. aq. NaHCO3 (20 
mL), and cold water (20 mL).  The organic phase was separated, dried with magnesium 
sulfate, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (methanol - dichloromethane gradient elution) to afford ethyl 2,3-di-O-
picolinyl-1-thio--D-glucopyranoside as a white amorphous solid in 89% yield (0.36 g, 
0.89 mmol). Analytical data: Rf = 0.52 (methanol/dichloromethane, 1/9, v/v); []D19 -
110.7 (c = 1.0, CHCl3);  1H-NMR: δ, 1.24 (t, 3H, J = 7.4 Hz, SCH2CH3), 2.70 (m, 2H, 
SCH2CH3), 3.33-3.48 (m, 2H, H-2, 5), 3.58 (dd, 1H, J3,4 = 8.6 Hz, H-3), 3.67 (dd, 1H, J4,5 
= 9.0 Hz, H-4), 3.79 (dd, 1H, J5,6a = 5.6 Hz, J6a,6b = 11.7 Hz, H-6a), 3.95 (dd, 1H, J5,6b = 
3.7 Hz, H-6b), 4.49 (d, 1H, J1,2 = 9.7 Hz, H-1), 4.78- 5.09 (m, 4H, 2 CH2Ph), 6.95-7.80 
(m, 6H, aromatic), 8.40- 8.60 (m, 2H, aromatic) ppm; 13C NMR: δ, 15.1, 24.9, 63.1, 71.2, 
74.1, 76.0, 80.0, 81.8, 84.8, 89.5, 121.8, 122.0, 122.5, 122.9, 136.7, 137.4, 148.6, 149.0, 
158.1, 158.2 ppm; HR FAB MS [M+Na]+ calcd for C20H26N2O5SNa 429.1460, found 
429.1425.  
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To a solution of ethyl 2,3-di-O-picolinyl-1-thio--D-glucopyranoside (0.36 g, 0.89 mmol) 
in DMF (5.0 mL), NaH (60% in mineral oil, 0.21 g, 5.3 mmol) and benzyl bromide (0.21 
mL, 1.8 mmol) were added at rt. The reaction mixture was stirred for 2 h, then quenched 
with ice water (15 mL, 30 min) and extracted with ethyl acetate/ diethyl ether (1/1, v/v, 3 
× 30 mL). The combined organic extract (~90 mL) was washed with cold water (3 × 10 
mL). The organic phase was separated, dried with magnesium sulfate, filtered, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to give ethyl 4,6-di-O-benzyl-2,3-di-O-picolinyl-
1-thio--D-glucopyranoside as a white amorphous solid in 83% yield (0.43 g, 0.74 
mmol). Analytical data for 5.1b: Rf = 0.49 (methanol/dichloromethane, 1/9, v/v); []D20 
+6.3 (c = 1.0, CHCl3);  1H NMR: δ, 1.30 (t, 3H, J = 7.5 Hz, SCH2CH3), 2.76 (m, 2H, 
SCH2CH3), 3.51 (m, 1H, H-5), 3.54 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.63-3.84 (m, 4H, H-3, 
4, 6a, 6b), 4.49 (d, 1H, J1,2 = 9.7 Hz, H-1), 4.59 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.67 (dd, 
2H, 2J = 10.7 Hz, CH2Ph), 4.97 (dd, 2H, 2J = 12.5 Hz, CH2Ph), 5.51 (s, 2H, CH2Ph), 7.00-
7.70 (m, 16H, aromatic), 8.49 (m, 2H, aromatic) ppm; 13C NMR: δ, 15.3, 25.0, 69.2, 73.6, 
75.2, 76.1, 76.3, 78.0, 79.3, 82.3, 85.0, 87.1, 121.5, 121.9, 122.4 (×2), 127.8, 127.9 (×3), 
128.3 (×2), 128.5 (×4), 136.7 (×2), 138.1, 138.4, 149.0, 149.1, 158.3, 158.6 ppm; HR 
FAB MS [M+H]+ calcd for C34H39N2O5S 587.2580, found 587.2597. 
 
Ethyl 4,6-di-O- benzylidene -2,3- di-O- picolinyl-1-thio--D-glucopyranoside (-5.1a) 
To a solution of ethyl 4,6-O-benzylidene-1-thio--D-glucopyranoside35 (1.0 g, 3.2 mmol) 
in DMF (10 mL) NaH (60% in mineral oil, 0.77 g, 19.2 mmol) and picolinyl bromide 
hydrobromide (3.2 g, 12.8 mmol) were added at 0 °C. The reaction mixture was stirred 
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for 1.5 h, quenched with ice-water (~10 mL, 30 min) and then extracted with ethyl 
acetate /diethyl ether (1/1, v/v, 3 × 50 mL). The combined organic extract (~150 mL) was 
washed with cold water (3 × 30 mL). The organic phase was separated, dried with 
magnesium sulfate, filtered, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to give the 
title compound as a white amorphous solid in 89% yield (1.4 g, 2.9 mmol). Analytical 
data for Analytical data for -5.1a: Rf = 0.40 (methanol/dichloromethane, 1/19, v/v); 
[]D19 +157.8 (c = 1.0, CHCl3); 1H NMR: δ, 1.23 (t, 3H, J = 7.5 Hz, SCH2CH3), 2.52 (m, 
SCH2CH3), 3.60- 3.80 (m, 2H, H-4, 5), 3.88- 4.02 (m, 2H, H-2. 3), 4.17- 4.35 (m, 2H, H-
6a, 6b), 4.80 (dd, 2H, 2J = 13.2 Hz, CH2Ph), 4.96 (dd, 2H, 2J = 13.9 Hz, CH2Ph), 5.51 (s, 
1H, >CHPh), 5.56 (d, 1H, J1,2 = 4.7 Hz, H-1), 6.90- 7.70 (m, 11H, aromatic), 8.47 (m, 
2H, aromatic) ppm; 13C NMR: δ, 14.9, 23.9, 62.9, 68.9, 73.2, 75.8, 79.5, 79.8, 81.8, 83.7, 
101.5, 121.5, 121.8, 122.2, 122.5, 126.2 (×2), 128.3 (×2), 129.0, 136.5, 136.8, 137.3, 
148.8, 148.9, 158.1, 159.1 ppm; HR FAB MS [M+H]+ calcd for C27H31N2O5S 495.1954, 
found 495.1994. 
 
Ethyl 4,6-tri-O-benzyl-2,3-di-O-picolinyl-1-thio--D-glucopyranoside (-5.1b) To a 
stirred solution of -5.1a  (0.50 g, 1.00 mmol) in CH2Cl2 (10 mL), water (150 μL) and 
trifluoroacetic acid (TFA)/CH2Cl2 (1/9, v/v, 1.0 mL) were added at rt. The reaction 
mixture was stirred for 3 h, then neutralized with Et3N (3 mL) and then diluted with 
dichloromethane (200 mL) and washed with cold water (20 mL), sat. aq. NaHCO3 (20 
mL), and cold water (20 mL).  The organic phase was separated, dried with magnesium 
sulfate, and concentrated in vacuo. The residue was purified by column chromatography 
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on silica gel (methanol - dichloromethane gradient elution) to afford ethyl 2,3-di-O-
picolinyl-1-thio--D-glucopyranoside as a white amorphous solid in 87% yield (0.35 g, 
0.87 mmol). Analytical data: Rf = 0.46 (methanol/ dichloromethane, 1/9, v/v); []D19 
+57.8 (c = 1.0, CHCl3); 1H NMR: δ, 1.27 (t, 3H, J = 7.5 Hz, SCH2CH3), 2.57 (m, 2H, 
SCH2CH3), 3.68-3.98 (m, 5H, H-2, 3, 4, 6a, 6b), 4.10 (m, 1H, H-5), 4.85 (dd, 2H, 2J = 
13.3 Hz, CH2Ph), 5.01 (dd, 2H, 2J = 14.9 Hz, CH2Ph), 5.58 (d, 1H, J1,2 = 5.3 Hz, H-1), 
7.05-7.35 (m, 3H, aromatic), 7.50-7.40 (m, 3H, aromatic), 8.55 (m, 2H, aromatic) ppm; 
13C NMR: δ, 14.8, 23.7, 62.9, 71.0, 72.0, 72.8, 73.8, 79.7, 82.7, 84.9, 121.6, 121.7, 122.7, 
123.0, 136.9, 137.4, 148.6, 149.1, 158.3, 158.5 ppm; HR FAB MS [M+H]+ calcd for 
C20H27N2O5S 407.1641, found 407.1627.  
To a solution of ethyl 2,3-di-O-picolinyl-1-thio--D-glucopyranoside (0.35 g, 0.87 mmol) 
in DMF (5.0 mL), NaH (60% in mineral oil, 0.21 g, 5.3 mmol) and benzyl bromide (0.21 
mL, 1.8 mmol) were added at rt. The reaction mixture was stirred for 2 h, then quenched 
with ice water (15 mL, 30 min) and extracted with ethyl acetate/ diethyl ether (1/1, v/v, 3 
× 30 mL). The combined organic extract (~90 mL) was washed with cold water (3 × 10 
mL). The organic phase was separated, dried with magnesium sulfate, filtered, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to give the title compound as a white amorphous 
solid in 88% yield (0.45 g, 0.77 mmol). Analytical data for -5.1b: Rf = 0.53 
(methanol/dichloromethane, 1/9, v/v);  []D20 +146.0 (c = 1.0, CHCl3); NMR: δ, 1.27 (t, 
3H, J = 7.4 Hz, SCH2CH3), 2.56 (m, 2H, SCH2CH3), 3.66 (dd, 1H, J5,6a = 1.7 Hz, J6a,6b = 
10.6 Hz, H-6a), 3.68-3.78 (m, 1H, H- 4), 3.80 (dd, 1H, J5,6b = 3.6 Hz, H-6b), 3.88- 4.03 
(m, 2H, H- 2,3), 4.22 (m, 1H, H-5), 4.56 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.66 (dd, 2H, 2J 
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= 11.9 Hz, CH2Ph), 4.79 (dd, 2H, 2J = 13.3 Hz, CH2Ph), 5.02 (dd, 2H, 2J = 13.0 Hz, 
CH2Ph), 5.60 (d, 1H, J1,2 = 4.2 Hz, H-1), 6.95-7.65 (m, 16H, aromatic), 8.40- 8.60 (m, 
2H, aromatic) ppm; 13C NMR: δ, 14.9, 23.8, 68.6, 70.6, 72.8, 73.6, 75.1, 76.2, 77.6, 80.0, 
82.8, 83.1, 121.5, 121.7, 122.3, 122.5, 127.8 (×2), 128.1 (×4), 128.4 (×2), 128.5 (×2), 
136.6, 136.8, 138.0, 138.3, 148.9, 149.1, 158.2, 159.0 ppm; HR FAB MS [M+H]+ calcd 
for C34H39N2O5S 587.2580, found 587.2579. 
 
Ethyl 4,6-di-O-benzoyl-2,3-di-O-picolinyl-1-thio--D-glucopyranoside (5.1c). To a 
solution of ethyl 2,3-di-O-picolinyl-1-thio--D-glucopyranoside (0.36 g, 0.89 mmol)   in 
CH2Cl2 (10 mL), benzoic acid (0.19 g, 1.52 mmol), N,N'-dicyclohexylcarbodiimide (0.31 g, 1.52 
mmol), and 4-dimethylaminopyridine (25 mg, 0.20 mmol) were added at rt. The reaction mixture 
was stirred for 3 h under argon, the solid was filtered off and rinsed successively with CH2Cl2. 
The combined filtrate (~100 mL) was washed with brine (2 x 10 mL). The organic phase was 
separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to give the title 
compound as a white amorphous solid in 83% yield (0.46 g, 0.74 mmol). Analytical data for 5.1c: 
Rf = 0.57 (methanol/dichloromethane, 1/9, v/v); []D20 +13.6 (c = 1.0, CHCl3);  1H NMR: δ, 
1.26 (t, 3H, J = 7.5 Hz, SCH2CH3), 2.73 (m, 2H, SCH2CH3), 3.73 (dd, 1H, J2,3 = 9.1 Hz, H-2), 
3.95 (m, 1H, H-5), 4.09 (dd, 1H, J3,4 = 8.9 Hz, H-3), 4.40 (dd, 1H, J5,6a = 5.7 Hz, J6a,6b = 12.2 
Hz, H-6a), 4.55 (dd, 1H, J5,6b = 2.9 Hz, H-6b), 4.67 (d, 1H, J1,2 =9.7 Hz, H-1), 4.98 (dd, 2H, 
2J =13.6 Hz, CH2Ph), 5.09 (dd, 2H, 2J = 12.8 Hz, CH2Ph), 5.49 (dd, 1H, J4,5 = 9.6 Hz, H-4), 6.80-
7.60 (m, 12H, aromatic), 7.75-8.70 (m, 4H, aromatic) ppm; 13C NMR: δ, 15.2, 25.1, 63.8, 71.2, 
74.9, 75.2, 75.9, 81.9, 84.7, 85.0, 122.1, 122.2, 122.7, 122.9, 128.4, 128.5 (× 3), 129.2, 129.8 (× 
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2), 130.1 (× 2), 130.4, 133.2, 133.4, 137.7, 137.8, 147.3, 147.9, 157.4, 165.4, 166.3, 170.8 ppm; 
HR FAB MS [M+Na]+ calcd for C34H34N2O7SNa 637.1984, found 637.1992. 
 
Ethyl 4,6-di-O-tert-butyldimethylsilyl-2,3-di-O-picolinyl-1-thio--D-glucopyranoside 
(5.1d). 2,6-Lutidine (0.57 mL, 4.9 mmol) was added to a solution. of ethyl 2,3-di-O-
picolinyl-1-thio--D-glucopyranoside (0.50 g, 1.2 mmol) in anhydrous THF (10 mL) and 
the resulting mixture was stirred under argon for 10 min at rt. After that, the mixture was 
cooled to -78 oC, TBDMSOTf (0.71 mL, 3.1 mmol) was added. The resulting reaction 
mixture was stirred for 2 hr at -78 oC and the volatiles were evaporated in vacuo. The 
residue was diluted with CH2Cl2 (~150 mL) and washed with 20% aq. NaHCO3 (30 mL) 
and water (3 x 30 mL). The organic phase was separated, dried with magnesium sulfate, 
and concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate - hexane gradient elution) to afford the title compound in 87% yield 
(0.68 g, 1.1 mmol) as a white amorphous solid. Analytical data for 5.1d: Rf = 0.69 
(methanol/dichloromethane, 1/9, v/v); []D20 +39.6 (c = 1.0, CHCl3); 1H NMR: δ, -0.12-
.06 (4s, 12H, SiCH3), 0.75-0.95 (2s, 18H, SiC(CH3)3), 1.25 (t, 3H, J = 7.5 Hz, 
SCH2CH3), 2.70 (m, 2H, SCH2CH3), 3.22 (m, 1H, H-5), 3.45 (dd, 1H, J2,3 = 8.8 Hz, H-2), 
3.53 (dd, 1H, J3,4 = 8.6 Hz, H-3), 3.66 (dd, 1H, J4,5 = 9.0 Hz, H-4), 3.71 (dd, 1H, J5,6a = 
5.0 Hz, J6a,6b = 11.3 Hz, H-6a), 3.85 (dd, 1H, J5,6b = 1.9 Hz, H-6b), 4.48 (d, 1H, J1,2 = 9.4 
Hz, H-1), 4.84 (dd, 2H, 2J = 12.5 Hz, CH2Ph), 4.93 (dd, 2H, 2J = 13.4 Hz, CH2Ph), 6.90-
7.70 (m, 6H, aromatic), 8.30- 8.45 (m, 2H, aromatic) ppm; 13C NMR: δ, -5.2, -4.9, -4.7, -
3.9, 15.2, 18.2, 18.6, 24.6, 26.1(×6), 62.6, 70.5, 75.9, 76.1, 81.5, 83.0, 84.4, 87.1, 120.9, 
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121.6, 122.0, 122.3, 136.5, 136.6, 148.8, 148.9, 158.3, 158.9 ppm; HR FAB MS [M+H]+ 
calcd for C32H55N2O5SSi2 635.3370, found 635.3397. 
 
[PdBr2][5.1a] (5.2a). A mixture of ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio--
D-glucopyranoside (5.1a, 200 mg, 0.41 mmol) and freshly activated molecular sieves (4 
Å, 400 mg) in CH2Cl2 (5.0 mL) was stirred under argon for 1 h. Then PdBr2 (161.4 mg, 
0.60 mmol) was added at rt and the resulting mixture was srirred for 18 h. The solid was 
filtered off and the residue was concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (methanol- dichloromethane gradient elution) to 
afford the title compound in 94% yield (290 mg, 0.38 mmol) as a bright orange 
amorphous solid. Analytical data for 5.2a: Rf = 0.71 (methanol/dichloromethane, 1/19, 
v/v); []D20 -49.4 (c = 1.0, CHCl3); 1H-NMR: δ, 1.19 (t, 3H, J = 7.5 Hz, SCH2CH3), 2.64 
(m, 2H,  SCH2CH3), 3.42 (m, 1H, H-5), 3.62-3.86 (m, 3H, H-2, 4, 6a), 4.11 (dd, 1H, J3,4 = 
8.9 Hz, H-3), 4.23 (dd, 1H, J5,6b = 5.0 Hz, J6a,6b = 10.4 Hz, H-6b), 4.56 (d, 1H, J1,2 = 9.7 
Hz, H-1), 5.33 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 5.48 (s, 1H, >CHPh), 5.53 (dd, 2H, 2J = 9.1 
Hz, CH2Ph), 6.85-7.80 (m, 11H, aromatic), 8.90- 9.10 (m, 2H, aromatic) ppm; 13C-NMR: 
δ, 15.2, 25.1, 68.8, 70.0, 75.1, 76.2, 81.1, 82.6, 82.7, 85.8, 101.2, 124.4, 124.7, 126.0 
(×2), 126.6, 127.3, 128.5 (×2), 129.2, 137.3, 138.9, 139.0, 154.6, 154.8, 157.6, 158.1 
ppm; HR FAB MS [M-Br]+ calcd for C27H30BrN2O5SPd 681.0091, found 681.0094. 
 
[PdBr2][5.1b] (5.2b). A mixture of ethyl 4,6-di-O-benzyl-2,3-di-O-picolinyl-1-thio--D-
glucopyranoside (5.1b, 200 mg, 0.34 mmol) and freshly activated molecular sieves (4 Å, 
400 mg) in CH2Cl2 (5.0 mL) was stirred under argon for 1 h. Then PdBr2 (134 mg, 0.5 
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mmol) was added at rt and the resulting mixture was srirred for 18 h. The solid was 
filtered off and the residue was concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (methanol- dichloromethane gradient elution) to 
afford the title compound in 89% yield (259 mg, 0.30 mmol) as a bright orange 
amorphous solid. Analytical data for 5.2b: Rf = 0.67 (methanol/dichloromethane, 1/19, 
v/v); []D20 -26.2 (c = 1.0, CHCl3); 1H-NMR: δ, 1.29 (t, 3H, J = 7.5 Hz, SCH2CH3), 2.76 
(m, 2H,  SCH2CH3), 3.52 (m, 1H, H-5), 3.63-3.75 (m, 3H, H-2, 6a, 6b), 3.84 (dd, 1H, J4,5 
= 9.5 Hz, H-4), 3.92 (dd, 1H, J3,4 = 9.1, H-3), 4.54 (dd, 2H, 2J = 9.6 Hz, CH2Ph), 4.55 (d, 
1H, J1,2 = 9.4 Hz, H-1), 4.75 (dd, 2H, 2J = 11.8 Hz, CH2Ph), 5.45 (dd, 2H, 2J = 10.3 Hz, 
CH2Ph), 5.59 (dd, 2H, 2J = 9.3 Hz, CH2Ph), 6.50-7.80 (m, 16H, aromatic), 9.05- 9.25 (m, 
2H, aromatic) ppm; 13C-NMR: δ, 15.3, 25.1, 69.1, 73.7, 74.5, 76.5, 79.4, 80.1, 81.0, 85.4, 
85.9, 89.8, 124.3, 124.5, 126.9, 127.1 (×2), 127.5, 127.8(×2), 127.9 (×2), 128.5, 
128.6(×2), 128.8 (×3), 138.3, 138.4, 138.8, 138.9, 158.1, 158.5 ppm; HR FAB MS [M-
Br]+ calcd for C34H38BrN2O5SPd 773.0720, found 773.0719. 
 
5. 4. 3  Synthesis of Oligosaccharides  
General procedure for glycosylation in the presence of DMTST. A mixture of a 
glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4 Å, 200 mg) in solvent specified in Tables (2.6 mL, 50 mM) was 
stirred under argon for 1 h. The mixture was then cooled to the specified temperature and 
DMTST (0.26 mmol) was added. The resulting mixture was allowed to warm to rt over a 
period of 1 h and stirreed at rt for the time specified in Schemes. Upon completion, Et3N 
(0.3 mL) was added and the resulting mixture was stirred for 30 min. The mixture was 
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diluted with CH2Cl2 (10 mL), the solid was filtered off, and the residue was washed 
sucessively with CH2Cl2. The combined filtrate (~30 mL) was washed with 20% aq. 
NaHCO3 (10 mL) and water (2 x 10 mL). The organic phase was separated, dried with 
magnesium sulfate, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (acetone- toluene gradient elution). Anomeric ratios (or 
anomeric purity) were determined by comparison of the integral intensities of relevant 
signals in 1H NMR spectra. 
 
General procedure for glycosylation in the presence of IDCP. A mixture of a glycosyl 
donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4 Å, 200 mg) in solvent specified in Tables (2.6 mL, 50 mM) was stirred under 
argon for 1 h. The mixture was cooled to the specified temperature, IDCP (0.26 mmol) 
was added, and the reaction mixture was allowed to warm to rt and stirred until the 
completion (see tables). The resulting mixture was diluted with CH2Cl2 (~10 mL), the 
solid was filtered off and the residue was washed with CH2Cl2. The combined filtrate 
(~30 mL) was washed with 10% aq. Na2S2O3 (10 mL) and water (2 x 10 mL). The 
organic phase was separated, dried with MgSO4 and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (acetone- toluene gradient elution). 
Anomeric ratios (or anomeric purity) were determined by comparison of the integral 
intensities of relevant signals in 1H NMR spectra. 
 
General procedure for glycosylation in the presence of NIS/ TfOH. A mixture of a 
glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
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molecular sieves (4 Å, 200 mg) in solvent specified in Tables (2.6 mL, 50 mM) was 
stirred under argon for 1 h. The mixture was cooled to the specified temperature, NIS 
(0.26 mmol) and TfOH (0.026 mmol) were added, and the reaction mixture was allowed 
to warm to rt and stirred until the completion (see tables). The resulting mixture was 
diluted with CH2Cl2 (~10 mL), the solid was filtered off and the residue was washed with 
CH2Cl2. The combined filtrate (~30 mL) was washed with 10% aq. Na2S2O3 (10 mL) and 
water (2 x 10 mL). The organic phase was separated, dried with MgSO4 and concentrated 
in vacuo. The residue was purified by column chromatography on silica gel (acetone- 
toluene gradient elution). Anomeric ratios (or anomeric purity) were determined by 
comparison of the integral intensities of relevant signals in 1H NMR spectra. 
 
Methyl 2,3,4-tri-O-benzyl-6-O-(4,6-O-benzylidene-2,3-di-O-picolinyl--D- 
glucopyranosyl)--D-glucopyranoside (β-5.4a) 
The title compound was obtained as a white amorphous solid from glycosyl donor 5.1a 
and acceptor 5.3 in 83% ( 1/25). Analytical data for 5.4a: Rf = 0.43 
(acetone/hexane, 2/3, v/v); []D20 +1.7 (c = 1.0, CHCl3); 1H NMR: δ, 3.32 (s, 3H, OCH3), 
3.40 (m, 1H, H-5’), 3.48-3.53 (m, 2H, H-2, 4), 3.62 (dd, 1H, J2’,3’ = 8.1 Hz, H-2’), 3.68-
3.89 (m, 5H, H-3’, 4’, 5, 6a, 6a’), 3.95 (dd, 1H, J3,4 = 9.3 Hz, H-3), 4.12 (dd, 1H, J6a,6b = 
9.8 Hz, H-6b), 4.32 (dd, 1H, J5,6b’ = 4.9 Hz, J6a’,6b’ = 10.4 Hz, H-6b’), 4.46 (d, 1H, 2J = 
10.9 Hz, ½ CH2Ph), 5.52 (d, 1H, J1’,2’ = 7.9 Hz, H-1’), 5.58 (d, 1H, J1,2 = 3.5 Hz, H-1), 
4.60-4.69 (m, 2H, CH2Ph), 4.72-4.82 (m, 2H, CH2Ph), 4.87-5.15 (m, 5H, 2½ CH2Ph), 
5.53 (s, 1H, >CHPh), 6.95-7.60 (m, 26H, aromatic), 8.44 (m, 2H, aromatic) ppm; 13C 
NMR: δ, 55.5, 66.3, 68.9 (× 2), 69.8, 73.7, 75.0, 75.9, 77.4, 77.6, 77.9, 79.9, 81.3, 82.2 (× 
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2), 82.4, 98.4, 101.5, 104.1, 122.5, 126.3 (× 4), 127.8, 127.9 (× 6), 128.2 (× 3), 128.4 (× 
2), 128.5 (× 7), 128.6 (× 2), 128.7 (× 3), 129.2, 137.3, 138.4, 138.5, 140.0 ppm; HR-FAB 
MS [M+Na]+ calcd for C53H56N2O11Na 919.3782, found 919.3756. 
 
[Methyl 2,3,4-tri-O-benzyl-6-O-(4,6-O-benzylidene-2,3-di-O-picolinyl--D-
glucopyranosyl)--D-glucopyranoside] PdBr2 ([α-5.4a] PdBr2)   
The title compound was obtained as a white amorphous solid from glycosyl donor α-5.2a  
and acceptor 5.3 in 35% (> 25/1) upon activation with bromine. Analytical data for 
[α-5.4a] PdBr2: Rf = 0.41 (acetone/hexane, 2/3, v/v); []D20 -31.1 (c = 1.0, CHCl3); 1H 
NMR: 3.30 (s, 3H, OCH3), 3.47 (dd, 1H, J1,2 = 3.5 Hz, J2,3 = 9.6 Hz, H-2), 3.54 (dd, 1H, 
J4,5 = 9.2 Hz, H-4), 3.69-3.91 (m, 5H, H-4’, 5, 6a’, 6b, 6b’), 3.92-4.01 (m, 2H, H-3, 5’), 
4.08 (dd, 1H, J2’,3’ = 9.4 Hz, H-2’), 4.28 (dd, 1H, J5,6a = 4.7 Hz, J6a,6b = 10.1 Hz, H-6a), 
4.45 (dd, 1H, J3’,4’ = 9.2 Hz, H-3’), 4.58-4.79 (m, 6H, H-1, 2 ½ CH2Ph), 4.93 (d, 1H, 2J = 
10.4 Hz, ½ CH2Ph), 4.13 (dd, 2H, 2J = 10.2 Hz, CH2Ph), 5.37 (dd, 1H, J1’,2’ = 3.7 Hz, H-
1’), 5.41(dd, 2H, 2J = 10.4 Hz, CH2Ph), 5.56 (s, 1H, >CHPh), 7.10-7.70 (m, 26H, 
aromatic), 9.25 (m, 2H, aromatic) ppm; 13C NMR: δ, 55.7, 62.4, 65.7, 69.4, 71.0, 72.6, 
73.3, 75.3, 75.9, 76.2, 77.8, 78.1, 79.8, 80.2, 82.2, 83.2, 97.2, 98.0, 101.7, 124.2, 124.3, 
126.3 (× 3), 126.6, 127.9 (× 2), 128.0 (× 2), 128.3 (× 3), 128.6 (× 6), 128.7 (× 4), 129.3, 
137.7, 138.1, 138.5, 138.6, 138.8, 138.9, 155.8, 155.9, 157.8, 158.7 ppm; HR-FAB MS 
[M-Br]+ calcd for C53H56BrN2O11Pd 1083.2099, found 1083.2093. 
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CDCl3 300 MHz 
Figure A-1: 1H NMR spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picolinyl-1-thio--D-
glucopyranoside (2.1c) 
 
 
 
 
CDCl3 75 MHz 
Figure A-2: 13C NMR spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picolinyl-1-thio--D-
glucopyranoside (2.1c) 
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CDCl3 300 MHz 
Figure A-3: 2-D NMR COSY spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picolinyl-1-thio--D-
glucopyranoside (2.1c) 
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CDCl3 300 MHz 
Figure A-4: 1H NMR spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picolinyl-1-thio--D-
glucopyranoside (-2.1c) 
 
CDCl3 75 MHz 
Figure A-5: 13C NMR spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picolinyl-1-thio--D-
glucopyranoside (-2.1c) 
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CDCl3 300 MHz 
Figure A-6: 2-D NMR COSY spectrum of Ethyl 2,4,6-tri-O-benzyl-3-O-picolinyl-1-thio--D-
glucopyranoside (-2.1c) 
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CDCl3 300 MHz 
Figure A-7: 1H NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picolinyl-1-thio--D-
glucopyranoside (2.1d) 
 
 
CDCl3 75 MHz 
Figure A-8: 13C NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picolinyl-1-thio--D-
glucopyranoside (2.1d) 
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CDCl3 300 MHz 
Figure A-9: 2-D NMR COSY spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picolinyl-1-thio--D-
glucopyranoside (2.1d) 
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CDCl3 300 MHz 
Figure A-10: : 1H NMR spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picolinyl-1-thio--D-
glucopyranoside (2.1e) 
 
CDCl3 75 MHz 
Figure A-11: 13C NMR spectrum of Ethyl 2,3,4-Tri-O-benzyl-6-O-picolinyl-1-thio--D-
glucopyranoside (2.1e) 
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CDCl3 300 MHz 
Figure A-12:  2-D NMR COSY spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picolinyl-1-thio--D-
glucopyranoside (2.1e) 
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CDCl3 300 MHz 
Figure A-13: 1H NMR spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picolinyl-1-thio--D-
glucopyranoside (-2.1e) 
 
CDCl3 75 MHz 
Figure A-14: 13C NMR spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picolinyl-1-thio--D-
glucopyranoside (-2.1e) 
20253035404550556065707580859095100105110115120125130135140145150155 ppm
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CDCl3 300 MHz 
Figure A-15: 2-D NMR COSY spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picolinyl-1-thio--D-
glucopyranoside (-2.1e) 
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CDCl3 300 MHz 
Figure A-16: 1H NMR spectrum of Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picolinyl-1-thio--
D-glucopyranoside (2.1f)  
 
 
CDCl3 75 MHz 
Figure A-17: 13C NMR spectrum of Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picolinyl-1-thio-
-D-glucopyranoside (2.1f) 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm
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CDCl3 300 MHz 
Figure A-18: 2-D NMR COSY spectrum of Ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-picolinyl-
1-thio--D-glucopyranoside (2.1f) 
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CDCl3 300 MHz 
Figure A-19: 1H NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picoloyl-1-thio--D-
glucopyranoside (2.1g) 
 
CDCl3 75 MHz 
Figure A-20: 13C NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picoloyl-1-thio--D-
glucopyranoside (2.1g) 
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CDCl3 300 MHz 
Figure A-21: 2-D NMR COSY spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picoloyl-1-thio--D-
glucopyranoside (2.1g) 
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CDCl3 300 MHz 
Figure A-22: 1H NMR spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-1-thio--D-
glucopyranoside (2.1h) 
 
CDCl3 75 MHz 
Figure A-23: 13C NMR spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-1-thio--D-
glucopyranoside (2.1h)    
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CDCl3 300 MHz 
Figure A-24: 2-D NMR COSY spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-1-thio--D-
glucopyranoside (2.1h) 
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CDCl3 300 MHz 
Figure A-25: 1H NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picolinyl-1-thio--D-
galactopyranoside (2.1m) 
 
CDCl3 75 MHz 
Figure A-26: 13C NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picolinyl-1-thio--D-
galactopyranoside (2.1m) 
20253035404550556065707580859095100105110115120125130135140145150155160 ppm
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CDCl3 300 MHz 
Figure A-27: 2-D NMR COSY spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picolinyl-1-thio--D-
galactopyranoside (2.1m) 
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CDCl3 300 MHz  
Figure A-28: 1H NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picoloyl-1-thio--D-
galactopyranoside (2.1n) 
 
CDCl3 75 MHz 
Figure A-29: 13C NMR spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picoloyl-1-thio--D-
galactopyranoside (2.1n) 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
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CDCl3 300 MHz 
Figure A-30: 2-D NMR COSY spectrum of Ethyl 2,3,6-tri-O-benzyl-4-O-picoloyl-1-thio--D-
galactopyranoside (2.1n) 
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CDCl3 300 MHz 
Figure A-31: 1H NMR spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-1-thio--D-
mannopyranoside (2.1o) 
 
 
CDCl3 75 MHz  
Figure A-32: 13C NMR spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-1-thio--D-
mannopyranoside (2.1o) 
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CDCl3 300 MHz 
Figure A-33: 2-D NMR COSY spectrum of Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-1-thio--D-
mannopyranoside (2.1o) 
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CDCl3 300 MHz 
Figure A-34: 1H NMR spectrum of Ethyl 2,4-di-O-benzyl-3-O-picoloyl-1-thio--L-
rhamnopyranoside (2.1q) 
 
CDCl3 75 MHz 
Figure A-35: 13C NMR spectrum of Ethyl 2,4-di-O-benzyl-3-O-picoloyl-1-thio--L-
rhamnopyranoside (2.1q) 
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CDCl3 300 MHz 
Figure A-36: 2-D NMR COSY spectrum of Ethyl 2,4-di-O-benzyl-3-O-picoloyl-1-thio--L-
rhamnopyranoside (2.1q) 
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CDCl3 300 MHz 
Figure A-37: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4,6-tri-O-benzyl-3-O-
picolinyl--D-glucopyranosyl)--D-glucopyranoside (2.3c) 
 
CDCl3 75 MHz 
 
Figure A-38: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4,6-tri-O-benzyl-3-O-
picolinyl--D-glucopyranosyl)--D-glucopyranoside (2.3c) 
3.54.04.55.05.56.06.57.07.58.08.5 ppm
6 06 57 0758 08 59 09510 01 051 1 01 1 512 01 251 3 01 3 514 01 451 5 01 5 516 0 p pm
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CDCl3 300 MHz 
Figure A-39: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4,6-tri-O-benzyl-
3-O-picolinyl--D-glucopyranosyl)--D-glucopyranoside (2.3c) 
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CDCl3 300 MHz 
Figure A-40: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside (2.3g) 
 
CDCl3 75 MHz 
Figure A-41: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-4-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside (2.3g) 
3 .54 .04.55 .05 .56 .06.57 .07 .58 .08.5 ppm
6 0657 07 580859 09 510 010 51 1 01 1512 012 51 3 01 351 4014 51 5 01 551 6016 5 p pm
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CDCl3 300 MHz 
Figure A-42: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,6-tri-O-benzyl-
4-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside (2.3g) 
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CDCl3 300 MHz 
Figure A-43: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside (2.3h) 
 
CDCl3 75 MHz 
Figure A-44: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside (2.3h) 
3.54 .04 .55 .05 .56.06.57.07.58 .08.5 ppm
6 0657 07 580859 09 510 010 51 1 01 1512 012 51 3 01 3514 014 51 5 01 551 6016 5 p pm
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CDCl3 300 MHz 
Figure A-45: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-
6-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside (2.3h) 
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CDCl3 300 MHz 
Figure A-46: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-
picoloyl--D-mannopyranosyl)--D-glucopyranoside (2.3o) 
 
 
CDCl3 75 MHz 
Figure A-47: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-
picoloyl--D-mannopyranosyl)--D-glucopyranoside (2.3o) 
3 .54 .04 .55. 05. 56 .06 .57 .07.58. 08. 5 p pm
5 5606 57 07 58 0859 09 51 0 01 051 1 01 151 2 01 2 513 01 3 51 4014 51 5015 51 6 016 5 p pm
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CDCl3 300 MHz 
Figure A-48: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-
6-O-picoloyl--D-mannopyranosyl)--D-glucopyranoside (2.3o) 
 
ppm
3.23.43.63.84.04.24.44.64.85.0 ppm
3.2
3.4
3.6
3.8
4.0
4.2
4.4
4.6
4.8
5.0
Yasomanee, Jagodige P. | UMSL 2014 | Page 240 
 
 
 
CDCl3 300 MHz 
Figure A-49: 1H NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4-di-O-benzyl-3-O-
picoloyl-β-L-rhamnopyranosyl)-α-D-glucopyranoside (2.3q)
 
CDCl3 75 MHz 
Figure A-50: 13C NMR spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4-di-O-benzyl-3-O-
picoloyl-β-L-rhamnopyranosyl)-α-D-glucopyranoside (2.3q) 
2030405060708090100110120130140150160 ppm
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CDCl3 300 MHz 
Figure A-51: 2-D NMR COSY spectrum of Methyl 2,3,4-tri-O-benzyl-6-O-(2,4-di-O-benzyl-3-
O-picoloyl-β-L-rhamnopyranosyl)-α-D-glucopyranoside (2.3q) 
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      CDCl3 600 MHz 
 
Figure A-52: 1H NMR spectrum of  Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-
benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-6-O-
benzoyl-2,3-di-O-benzyl--D-glucopyranoside (3.6) 
 
3.54.04.55.05.56.06.57.07.58.08.5 ppm
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CDCl3 150 MHz 
Figure A-53: 13C NMR spectrum of  Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-
benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-6-O-
benzoyl-2,3-di-O-benzyl--D-glucopyranoside (3.6) 
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CDCl3 600 MHz 
Figure A-54: 2-D NMR COSY spectrum of  Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-
benzyl--D-glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-6-O-
benzoyl-2,3-di-O-benzyl--D-glucopyranoside (3.6) 
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CDCl3 300 MHz 
Figure A-55: : 1H NMR spectrum of Methyl 3,4-di-O-benzyl-2,6-di-O-(2,3,6-tri-O-benzyl-4-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.8) 
 
 
CDCl3 75 MHz 
Figure A-56:  13C NMR spectrum of Methyl 3,4-di-O-benzyl-2,6-di-O-(2,3,6-tri-O-benzyl-4-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.8) 
3.03.54.04.55.05.56.06.57.07.58.08.5 ppm
556065707580859095100105110115120125130135140145150155160165 ppm
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CDCl3 300 MHz 
Figure A-57: 2-D NMR COSY spectrum of  Methyl 3,4-di-O-benzyl-2,6-di-O-(2,3,6-tri-O-
benzyl-4-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.8) 
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CDCl3 600 MHz 
Figure A-58: : 1H NMR spectrum of  Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-2,3-di-O-benzyl-6-O-
(2,3,6-tri-O-benzyl-4-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.9c) 
 
 
CDCl3 150 MHz 
Figure A-59:  13C NMR spectrum of  Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-2,3-di-O-benzyl-6-O-
(2,3,6-tri-O-benzyl-4-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.9c) 
 
3.54.04.55.05.56.06.57.07.58.08.5 ppm
556065707580859095100105110115120125130135140145150155160165 ppm
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CDCl3 600 MHz 
 
Figure A-60: 2-D NMR COSY spectrum of  Methyl O-(2,3,6-tri-O-benzyl-4-O-picoloyl--D-
glucopyranosyl)-(14)-O-(2,3,6-tri-O-benzyl--D-glucopyranosyl)-(14)-2,3-di-O-benzyl-6-O-
(2,3,6-tri-O-benzyl-4-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside (3.9c) 
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CDCl3 300 MHz 
Figure A-61: : 1H NMR spectrum of  Ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio--D-
glucopyranoside (5.1a) 
CDCl3 75 MHz 
Figure A-62:  13C NMR spectrum of Ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio--D-
glucopyranoside (5.1a) 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm
102030405060708090100110120130140150160 ppm
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CDCl3 300 MHz 
Figure A-63: 2-D NMR COSY spectrum of Ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio-
-D-glucopyranoside (5.1a) 
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CDCl3 300 MHz 
Figure A-64: : 1H NMR spectrum of [Ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio--D-
glucopyranoside] PdBr2 (5.2a) 
CDCl3 75 MHz 
Figure A-65:  13C NMR spectrum of [Ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio--D-
glucopyranoside] PdBr2 (5.2a) 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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CDCl3 300 MHz 
Figure A-66: 2-D NMR COSY spectrum of [Ethyl 4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio-
-D-glucopyranoside] PdBr2 (5.2a) 
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Figure A-67: X-Ray crystal structure projection view with 50% thermal ellipsoids of [Ethyl 
4,6-O-benzylidene-2,3-di-O-picolinyl-1-thio--D-glucopyranoside] PdBr2 (5.2a) 
 
 
Table 1: Crystal data and structure refinement for [Ethyl 4,6-O-benzylidene-2,3-di-O-
picolinyl-1-thio--D-glucopyranoside] PdBr2 (5.2a) 
Identification code  d13811/lt/x8/dipic-Pd 
Empirical formula  C27 H30 Br2 N2 O5 Pd S 
Formula weight  760.81 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 8.3369(4) Å = 90°. 
 b = 20.8048(10) Å = 112.222(3)°. 
 c = 8.5721(4) Å  = 90°. 
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Volume 1376.38(11) Å3 
Z 2 
Density (calculated) 1.836 Mg/m3 
Absorption coefficient 3.694 mm-1 
F(000) 756 
Crystal size 0.27 x 0.18 x 0.16 mm3 
Theta range for data collection 1.96 to 27.63°. 
Index ranges -10≤h≤10, -26≤k≤27, -11≤l≤11 
Reflections collected 47541 
Independent reflections 6314 [R(int) = 0.0420] 
Completeness to theta = 27.63° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5947 and 0.4399 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6314 / 22 / 306 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0317, wR2 = 0.0734 
R indices (all data) R1 = 0.0371, wR2 = 0.0757 
Absolute structure parameter 0.007(7) 
Largest diff. peak and hole 1.205 and -1.018 e.Å-3 
 
